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As the Greek philosopher Aristotle said, “Man is by nature a social animal”, 
and as such, it tends to associate with other individuals and form societies. 
 Well, microorganisms too. 
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RIASSUNTO 
 
 Introduzione 
Durante la storia della microbiologia, i microrganismi sono stati principalmente 
studiati nella loro forma planctonica, in cui le singole cellule fluttuano liberamente in 
un mezzo liquido. Solo a partire dal XVII secolo ha iniziato a diffondersi la 
consapevolezza che i microrganismi sono capaci di colonizzare superfici di varia 
natura e formare, ad esse associati, delle vere e proprie comunità, i biofilm. 
La nostra concezione di biofilm si è evoluta nel tempo; ad oggi, esso viene definito 
come “un aggregato di microrganismi in cui le cellule, inglobate in una matrice 
autoprodotta di sostanze polimeriche extracellulari (EPS), aderiscono l'una all'altra 
e/o ad una superficie”. 
La formazione di un biofilm non è la risultante di un processo casuale ma, al 
contrario, lo è di una sequenza ben definita di passaggi che, idealmente, possono 
essere descritti in tre fasi principali: una fase di adesione, regolata da interazioni 
elettrostatiche, interazioni idrofobiche e forze di Van der Waals, durante la quale le 
cellule prendono contatto con una superficie e successivamente la legano 
tenacemente; una fase di maturazione, in cui le cellule irreversibilmente adese alla 
superficie iniziano a duplicarsi, formando microcolonie, e producono EPS, 
permettendo così la formazione delle prime strutture tridimensionali del biofilm, 
ovvero le macrocolonie, che andranno poi a formare la complessa matrice del 
biofilm; infine, una fase di dispersione, che prevede il distacco di singole cellule o di 
gruppi di cellule dalla struttura del biofilm, al fine di colonizzare siti circostanti o a 
distanza e promuovere l’origine di un nuovo biofilm. Un giusto equilibrio tra adesione, 
maturazione e dispersione è importante per la produzione e il mantenimento di una 
comunità funzionale all'interno del biofilm. 
La straordinaria capacità di diffusione di un microrganismo spiega come mai i biofilm 
riescono a formarsi nei luoghi più disparati. Le carene delle imbarcazioni sono 
spesso ricoperte di biofilm, i quali aumentano l’attrito durante la navigazione, 
compromettendo la velocità. Alcuni biofilm danneggiano pesantemente l’industria 
petrolifera facilitando la corrosione microscopica dei metalli e riducendo la durata 
degli oleodotti. Infine, ma non per importanza, i biofilm microbici assumono un ruolo 
rilevante in campo sanitario, in quanto implicati nella patogenesi di molte infezioni 
croniche. Si va da malattie come le prostatiti e le infezioni renali a patologie associate 
all’impianto di dispositivi medici come articolazioni artificiali e cateteri, fino alla carie e 
alle infiammazioni gengivali. In quasi tutti i casi, il biofilm ha un ruolo di primo piano 
nell’aiutare i microrganismi a sopravvivere o a diffondersi all’interno dell’ospite perché 
la matrice dei biofilm svolge un ruolo di barriera, proteggendo le cellule dalle risposte 
del sistema immunitario dell’ospite e dall’azione di agenti antimicrobici.  
Purtroppo, ad oggi, data l’elevata complessità della struttura dei biofilm e dei loro 
meccanismi di difesa da insulti esterni, l'arsenale di terapie disponibili per il 
trattamento di queste infezioni risulta nella maggior parte dei casi inefficace.  
In uno studio recente, sono stati identificati le 5 specie batteriche più frequenti tra 
oltre 3 milioni di isolati clinici da degenti ospedalieri, e Staphylococcus epidermidis è 
risultato una delle cause più comuni di infezioni nosocomiali in Nord America, con 
una frequenza del 11,5%, in America latina, con il 13,3% ed in Europa, con il 14,6%. 
In particolare, S. epidermidis è più comunemente causa di infezioni associate a 
dispositivi medici, come cateteri vascolari ed urinari e protesi ortopediche e 
cardiache. Uno dei contributi maggiori al meccanismo etio-patogenetico di queste 
infezioni, risiede proprio nella capacità di S. epidermidis di formare biofilm su 
superfici biotiche e abiotiche. 
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Data la persistenza di infezioni biofilm-associate, riluttanti ai classici trattamenti 
antibiotici, risulta evidente la necessità di sviluppare nuove terapie anti-infettive. 
A tal proposito, nel tentativo di trovare fonti valide di agenti anti-biofilm, molti 
ricercatori hanno iniziato ad esplorare l'ambiente marino, in quanto rappresenta una 
inestimabile risorsa di biodiversità. Di circa 2 milioni di specie marine stimate, sono 
attualmente conosciute circa il 10%. Tra gli organismi marini, quelli che vivono in 
ambienti estremi, anche detti estremofili, hanno sviluppato numerosi sistemi di 
adattamento per sopravvivere a condizioni ambientali difficili. E date le loro differenti 
capacità metaboliche, sono in grado di sintetizzare numerosissimi metaboliti primari e 
secondari dotati di attività interessanti dal punto di vista biotecnologico e 
farmacologico. 
In studi recenti, è stato osservato che il batterio marino antartico Pseudoalteromonas 
haloplanktis TAC125 produce e secerne molecole che inibiscono il processo di 
formazione del biofilm del patogeno umano Staphylococcus epidermidis.  Inoltre, è 
stato dimostrato che i sovrarnatanti ottenuti da colture batteriche di diversi batteri 
polari appartenenti a generi Pseudoalteromonas, Psychrobacter e Psychromonas 
hanno mostrato attività anti-biofilm contro diversi ceppi patogeni. Le valutazioni 
preliminari sulla natura fisico-chimica delle molecole responsabili dell'attività anti-
biofilm ha sottolineato la loro diversa natura. Questa capacità dei batteri marini polari 
di produrre diverse molecole anti-biofilm potrebbe indicare che la capacità di evitare 
la colonizzazione e la formazione di biofilm di altri microrganismi è un vantaggio 
selettivo in questi ambienti estremi, assicurando che questi batteri possano diventare 
una fonte interessante di nuovi composti anti-biofilm. 
 
 Obiettivi 
Il mio progetto di dottorato si inserisce nell’ambito della ricerca di nuove molecole ad 
attività anti-biofilm che agiscano contro Staphylococcus epidermidis. In dettaglio, mi 
sono occupata dello studio del batterio marino antartico Pseudoalteromonas 
haloplanktis TAC125, della sua capacità di produrre molecole anti-biofilm quando 
esso stesso cresce in biofilm e, più in generale, della purificazione, identificazione e 
caratterizzazione della molecola attiva prodotta (Capitolo I). Inoltre, dato il loro 
potenziale solo parzialmente esplorato, mi sono occupata anche dello studio di altri 
batteri polari appartenenti ai generi Flavobacterium, Pseudoalteromonas, 
Pseudomonas, Psychrobacter e Psychromonas, caratterizzando la loro attività anti-
biofilm contro Staphylococcus epidermidis e mettendo a punto degli appropriati 
protocolli di purificazione per piccoli metaboliti e per molecole di natura proteica, al 
fine di identificare nuove molecole attive (Capitolo II). 
 
 Risultati 
 
Capitolo I 
E’ stato precedentemente dimostrato che il batterio marino antartico 
Pseudoalteromonas haloplanktis TAC125 è capace di produrre molecole anti-biofilm 
solo quando è coltivato in condizioni sessili, probabilmente perché le specifiche 
condizioni ambientali che prevalgono all'interno del biofilm inducono un profondo 
ricablaggio genetico e metabolico dei batteri che vivono nel biofilm, portando alla 
produzione di metaboliti biofilm-specifici. Una preliminare caratterizzazione fisico-
chimica del sovranatante di P. haloplanktis TAC125 ha dimostrato che l'attività anti-
biofilm è dovuta a una piccola molecola idrofobica, in grado di influenzare la 
formazione e la stabilità del biofilm di S. epidermidis. Il protocollo di purificazione 
inizialmente proposto ha portato all'ottenimento di una frazione arricchita della 
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molecola anti-biofilm, ma che era ancora una miscela di diversi composti. Pertanto, 
era chiaro che per la purificazione e la successiva caratterizzazione della molecola 
anti-biofilm era necessaria una produzione su larga scala. A tal proposito, è stata 
messa a punto una strategia di coltivazione di biofilm in bioreattore che ci ha 
permesso di ottenere una produzione su scala più ampia del sovranatante di P. 
haloplanktis TAC125, cresciuto in biofilm, indispensabile per la purificazione della 
molecola attiva contro il biofilm di S. epidermidis. L’ottimizzazione del protocollo di 
purificazione ha portato infine all’ottenimento di una frazione in cui erano presenti 
soltanto due molecole, il 2-tridecanone e il pentadecanale, ma data la presenza del 
chetone in una delle frazioni non attive, abbiamo concluso che l’attività fosse da 
attribuire al pentadecanale. L’ analisi dell’attività anti-biofilm del corrispondente 
prodotto commerciale ha confermato la capacità inibitoria del pentadecanale sulla 
formazione del biofilm di S. epidermidis, sia in statico che in dinamico ed in maniera 
dose-dipendente. 
Pur essendo una molecola dotata di un’interessante attività, il pentadecanale è 
un’aldeide e, come tale, potrebbe facilmente subire reazioni di ossidazione, 
polimerizzazione o idratazione, e quindi risultare chimicamente non compatibile con 
tutte le strategie anti-biofilm. Per cui, alcuni analoghi chimici del pentadecanale sono 
stati sintetizzati, purificati e saggiati per la loro capacità di inibire la formazione del 
biofilm di S. epidermidis: l’acido pentadecanoico, il pentadecanoato di metile e il 
1,1dimetossipentadecano, ovvero i corrispondenti acido, estere e acetale del 
pentadecanale. Sebbene il meccanismo molecolare dettagliato che sottende l'attività 
anti-biofilm dell'aldeide e dei suoi derivati sia ben lontano dall'essere chiarito, il loro 
effetto sulla struttura del biofilm di S. epidermidis è piuttosto evidente, poiché il 
biofilm formato in loro presenza è fortemente ridotto e caratterizzato da una struttura 
apparentemente destrutturata, contenente molti canali e spazi vuoti. Questi risultati 
hanno suggerito di esplorare l'uso dell'aldeide e dei suoi derivati in combinazione con 
antibiotici per trattare le infezioni da biofilm. Analisi di microscopia confocale hanno 
rivelato la capacità del pentadecanale e dell'acido pentadecanoico di indebolire la 
struttura del biofilm di S. epidermidis, rendendola meno compatta ed omogenea, 
consentendo così la penetrazione dell’antibiotico all’interno della matrice del biofilm, 
rendendo anche le cellule inglobate più in profondità facili da raggiungere. Questo 
potrebbe essere un grande vantaggio in caso di una ipotetica strategia terapeutica 
che preveda una combinazione di agenti antibiotici e anti-biofilm. Infine, per esplorare 
le potenzialità cliniche del pentadecanale e dei suoi analoghi, la loro biocompatibilità 
è stata studiata su fibroblasti murini e cheratinociti umani, linee cellulari eucariotiche 
che rappresentano il bersaglio delle infezioni da S. epidermidis. I dati indicano 
chiaramente che le molecole risultano biocompatibili con tutte le linee cellulari 
analizzate. 
Al fine di creare una nuova strategia anti-biofilm contro le infezioni associate a 
dispositivi medici causate da S. epidermidis, è stato sviluppato un sistema di 
rivestimento della superficie attraverso l’adsorbimento del pentadecanale e dei suoi 
analoghi su una superficie di polidimetilsilossano (PDMS), un materiale appartenente 
alla famiglia dei siliconi, frequentemente utilizzato per la fabbricazione di dispositivi 
medici come protesi fonatorie e mammarie, cateteri e valvole cardiache. In dettaglio, 
sono stati utilizzati il pentadecanale, l’acido pentadecanoico e l’esadecanale, al fine 
di capire se la lunghezza della catena alchilica e il gruppo funzionale influenzassero 
l’attività anti-biofilm del sistema di derivatizzazione proposto. La bagnabilità delle 
superfici, derivatizzate e non, è stata analizzata attraverso prove di angolo di 
contatto, dimostrando come l’adsorbimento delle molecole anti-biofilm ha modificato 
le proprietà fisicochimiche del PDMS. Inoltre, sono state effettuate analisi 
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topografiche delle superfici, derivatizzate e non,  mediante microscopio a forza 
atomica, misurando a scala nanometrica la rugosità superficiale. I dati ottenuti hanno 
rivelato una superficie quasi perfettamente piana per il PDMS non modificato e una 
rugosità molto più elevata della superficie dopo l'adsorbimento delle molecole anti-
biofilm. Successivamente, sono state analizzate le capacità antiadesive e anti-biofilm 
delle superfici derivatizzate in celle di flusso a piastre parallele, che permette di 
valutare in condizioni dinamiche l’adesione cellulare e il processo di formazione del 
biofilm su superfici di varia natura. I risultati hanno dimostrato che le superfici 
derivatizzate con le tre molecole anti-biofilm, nonostante le loro differenti 
caratteristiche, sono tutte in grado di ridurre l’adesione delle cellule di S. epidermidis 
sul PDMS e di inibire fortemente la formazione del biofilm patogeno, senza interferire 
con la vitalità cellulare. In conclusione, è possibile affermare che la strategia di 
derivatizzazione del PDMS con il pentadecanale e i suoi analoghi, attraverso 
adsorbimento fisico, è risultata vincente. 
Un’ultima parte di questo capitolo è stata dedicata allo studio del biofilm di P. 
haloplanktis TAC125, risultato una “factory” di molecole d’interesse biotecnologico. In 
dettaglio, è stata analizzata l’influenza delle condizioni di crescita, quali temperatura 
e terreno di coltura, sulla sua capacità di formare biofilm. In dettaglio, P. haloplanktis 
TAC125 è stato cresciuto in condizioni sessili in due terreni differenti, uno ricco e uno 
sintetico e definito, a due temperature, 0°C e 15°C, e la sua cinetica di formazione 
del biofilm è stata analizzata nel tempo. Una prima valutazione quantitativa, 
attraverso un saggio colorimetrico, ha fatto evincere la capacità del batterio Polare di 
rispondere a differenti temperature e livelli di abbondanza di nutrienti, producendo 
biofilm in diverse quantità e forma. Infatti, in terreno sintetico il batterio ha prodotto un 
quantitativo di biofilm superiore rispetto a quello prodotto in terreno ricco. Questo 
fenomeno è probabilmente una strategia di sopravvivenza innescata dal batterio in 
presenza di una minore disponibilità di nutrienti, il quale risponde con una maggiore 
produzione di biofilm, data la capacità della matrice di catturare sostanze nutritive. 
Inoltre, la probabile combinazione di temperatura bassa e scarsità di nutrienti ha 
indotto la colonizzazione da parte del batterio dell’interfaccia solido-liquido e la 
formazione di un biofilm sommerso, contrariamente a quanto accade nelle altre 
combinazioni di terreno e temperatura, in cui troviamo un biofilm galleggiante, 
definito pellicola, all’interfaccia aria-liquido. Probabilmente, la ridotta motilità del 
batterio cresciuto in terreno sintetico a 0°C spiega la mancata formazione di pellicole 
all’interfaccia aria-liquido, e la sovra-espressione di pili chiarifica che la formazione di 
un biofilm sommerso è anch’essa frutto di un fenomeno di adattamento non casuale. 
Analisi di microscopia confocale e microspettroscopia Raman hanno dimostrato che 
la composizione del terreno di coltura ha un ruolo chiave anche nella definizione 
della struttura del biofilm, risultando differenti in termini di contenuto di proteine, 
polisaccaridi e acidi nucleici. Lo studio del biofilm di P. haloplanktis TAC125, oltre a 
dare informazioni puramente fisiologiche in risposta a cambiamenti di condizioni 
ambientali, è da considerarsi come un approfondimento della conoscenza di un 
sistema che è in grado di produrre metaboliti bioattivi, con l’obiettivo ultimo di 
potenziarne l’utilizzo sostenibile come risorsa di composti d’interesse biotecnologico. 
Capitolo II 
Dato l’enorme potenziale dei batteri marini adattati al freddo come fonte di composti 
bioattivi utilizzabili in settori biotecnologici, industriali e clinici, una selezione di batteri 
appartenenti ai generi Flavobacterium, Pseudoalteromonas, Pseudomonas, 
Psychrobacter e Psychromonas sono stati analizzati per la loro capacità di produrre 
molecole ad attività anti-biofilm contro S. epidermidis. In dettaglio, sono state 
costruite due librerie di composti, una di piccoli metaboliti, considerando che i prodotti 
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naturali come i metaboliti secondari sono spesso coinvolti nella modulazione del 
sensing del quorum e nell'inibizione della formazione del biofilm, e una di 
proteine/peptidi, poiché è riportato in letteratura che ci sono molte molecole di natura 
proteica, come ad esempio enzimi idrolitici, capaci di degradare la matrice dei biofilm 
microbici.  
 Libreria di piccoli metaboliti. Una selezione di batteri marini Polari è stata 
analizzata per la capacità di produrre piccoli metaboliti dotati di attività anti-biofilm 
contro S. epidermidis. Gli estratti organici ottenuti dalle crescite planctoniche in 
terreno sintetico e definito sono stati saggiati e preliminarmente caratterizzati, al fine 
di identificare la provenienza intracellulare o extracellulare del composto attivo. I due 
campioni più promettenti sono risultati gli estratti intracellulari ottenuti da 
Pseudomonas sp.TAA207 e Psycrobacter sp.TAD1, attivi entrambi con effetto dose-
dipendente, ma dotati di specificità d’azione differente nei confronti dei diversi ceppi 
di S. epidermidis analizzati. I protocolli di purificazione proposti hanno portato 
all’identificazione di alcune frazioni attive. L’analisi attraverso spettroscopia NMR 
della frazione attiva identificata per Pseudomonas sp.TAA207, ha rivelato la 
presenza del pentadecanale, ovvero la molecola anti-biofilm prodotta dal batterio 
marino antartico Pseudoalteromonas haloplanktis TAC125, precedentemente 
identificata e caratterizzata. Purtroppo dall’analisi dell’attività anti-biofilm di 
Pseudomonas sp.TAA207 non è stata identificata nessuna nuova molecola attiva, 
ma è interessante notare come due batteri appartenenti a generi differenti siano in 
grado di produrre la stessa molecola. Al contrario, il protocollo di purificazione 
dell’estratto intracellulare di Psycrobacter sp.TAD1 ha portato all’ottenimento di due 
frazioni attive, contenenti molecole di natura differente, ma soprattutto, in cui non è 
stata identificata la presenza del pentadecanale. Studi futuri saranno dedicati 
all’identificazione delle molecole attive prodotte da Psycrobacter sp.TAD1. 
 Libreria di proteine/peptidi.  Una selezione di batteri marini polari è stata 
cresciuta in terreno ricco in condizioni planctoniche. I sovranatanti ottenuti dopo 
allontanamento delle cellule sono stati saggiati su S. epidermidis al fine di identificare 
i ceppi produttori di molecole anti-biofilm. Per discriminare se le molecole attive 
fossero di natura proteica, i sovranatanti sono stati sottoposti a trattamento con 
proteinasi K e saggiati nuovamente su S. epidermidis. I campioni che dopo 
trattamento con la proteasi hanno perso la loro attività anti-biofilm sono stati 
identificati come campioni proteici attivi. I due campioni più promettenti sono risultati i 
sovranatanti di Pseudoalteromonas haloplanktis TAB23, che ha mostrato la maggiore 
capacità inibente su S. epidermidis, e Pseudoalteromonas haloplanktis TAE80, 
dotato di una particolare capacità di modificare le proprietà della superficie del 
polistirene ed impedire in questo modo l’adesione delle cellule batteriche e la 
conseguente formazione del biofilm. Preliminari protocolli di purificazione attività-
guidati sono stati messi a punto al fine di identificare le molecole attive. I risultati 
ottenuti hanno evidenziato che P. haloplanktis TAB23 e P. haloplanktis TAE80 sono 
in grado di produrre proteine anti-biofilm attive contro S. epidermidis con modalità 
d’azione differenti, ma tutte dotate di una potentissima attività biologica, in quanto 
attive a concentrazioni molto basse. Purtroppo, non sono state ancora identificate le 
proteine attive, in quanto i protocolli proposti hanno portato all’ottenimento di frazioni 
sicuramente arricchite delle proteine attive, ma che risultassero ancora delle miscele 
complesse di più proteine. L’analisi in silico del genoma di P. haloplanktis TAE80 ha 
permesso l’identificazione di alcune sequenze geniche potenzialmente responsabili 
dell’espressione della/e proteina/e anti-biofilm da esso prodotta/e. La generazione di 
mutanti di delezione permetterà di capire se quelli ipotizzati risultano effettivamente 
essere i responsabili della produzione delle proteine dotate di attività anti-biofilm.
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SUMMARY 
 
Amongst marine bacteria, cold-adapted microorganisms represent an untapped 
reservoir of biodiversity endowed with an interesting chemical repertoire able to 
synthesize a broad range of potentially valuable bioactive compounds, including 
antimicrobial activity. The rapid emergence of resistant bacteria is occurring 
worldwide, endangering the efficacy of antibiotics. One of the main causes of 
antibiotic resistance is the capability of microorganisms to associate into communities 
of cells called biofilms. These complex structures provide protection from potential 
stressors, including the lack of water, high or low pH, or the presence of substances 
toxic to microorganisms such as antibiotics, antimicrobials or heavy metals. 
Therefore, coordinated efforts to implement the arsenal of novel anti-infective 
treatments are greatly needed. 
In this contest, my PhD project aimed to the sustainable exploitation of Polar marine 
biodiversity in an attempt to find viable sources of novel anti-biofilm agents, in 
particular acting against Staphylococcus epidermidis, one of the most common 
causes of infections associated with medical devices. 
In detail, during the first part of my project, I focused on the study of the Antarctic 
marine bacterium Pseudoalteromonas haloplanktis TAC125 and of its ability to 
produce anti-biofilm molecules, then, on the purification, identification and 
characterization of the active molecule produced.  By setting up of a strategy for the 
large scale biofilm cultivation of the Antarctic bacterium, the production yield of P. 
haloplanktis TAC125 anti-biofilm agent was improved, so as to allow the purification 
and the identification of the active molecule, the pentadecanal. However, as the 
pentadecanal is a chemically reactive agent, it could easily undergo oxidation 
reactions, therefore it could not be suitable for all possible anti-biofilm strategies. 
Therefore, some chemical analogues were synthesized and characterized for their 
anti-biofilm activity and their possible use in combination with antibiotics were 
investigated. Then, as a possible clinical application, an anti-biofilm coating system, 
active against S. epidermidis, was developed, by physical adsorption of pentadecanal 
and its analogues on polydimethylsiloxane (PDMS), a silicon-based material 
commonly used for the manufacturing of medical devices. Finally, some physiological 
studies were dedicated to P. haloplanktis TAC125 biofilm formation in relation with 
environmental adaptations, with the purpose to explore the potentiality of P. 
haloplanktis TAC125 in biotechnological field. 
In the second part of my PhD project, given their only partially explored potential, I 
have also studied other Polar bacteria belonging to different genera, looking for novel 
anti-biofilm agents against S. epidermidis.  
Through the screening of small metabolites and proteins/peptides libraries designed 
starting from planktonic cultures of Polar bacteria, some promising producer strains 
were identified and their anti-biofilm activities were characterized. Preliminary 
purification protocols were set up for each kind of molecules, according to their 
physico-chemical characteristics. Further studies are still ongoing to identify the 
structure of the active molecules. 
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1. Biofilms: definition, structure and development 
 
For most of the history of Microbiology, microorganisms have primarily been 
characterized as planktonic, freely suspended cells, and described on the basis of 
their growth characteristics in nutritionally rich culture media. Later there was the 
discovery of a microbiological phenomenon in which microorganisms are able to 
attach to and grow universally on exposed surfaces forming biofilms. The first 
description dates back to the 17th century, when the Dutch scientist Anthony van 
Leeuwenhoek analyzed the material scraped from his own teeth and, using his 
primitive microscope, noticed “very many small living Animals, which moved 
themselves very extravagantly”1. 
Our definition of biofilm has evolved over the last 40 years. The term biofilm was 
coined by Bill Costerton in 1978, who stated that “bacteria stick, tenaciously and 
often with exquisite specificity, to surfaces … by means of a mass of tangled fibers of 
polysaccharides, or branching sugar molecules, that extend from bacterial surface 
and form a feltlike “glycocalyx” surrounding an individual cell or a colony of cells”2. 
To date, the concept of biofilm has been widely consolidated and defined by the 
International Union of Pure and Applied Chemistry (IUPAC) as “an aggregate of 
microorganisms in which cells, that are frequently embedded within a self-produced 
matrix of extracellular polymeric substance (EPS), adhere to each other and/or to a 
surface”3. 
It is clear that microorganisms undergo profound changes during their transition from 
planktonic (free-swimming) organisms to cells that are part of a complex, surface-
attached community. These changes are reflected in the new phenotypic 
characteristics developed by biofilm bacteria and occur in response to a variety of 
environmental signals. Recent genetic and molecular approaches used to study 
microbial biofilms have identified genes and regulatory circuits important for initial 
cell-surface interactions, biofilm maturation, and the return of biofilm microorganisms 
to a planktonic mode of growth. In short, the planktonic-biofilm transition is a complex 
and highly regulated process4. Basically, the biofilm development has been 
characterized as a well-defined succession of different stages (Fig. 1). First, an 
attachment phase, regulated by electrostatic interactions, hydrophobic interactions 
and Van der Waals forces, which involves an initial and reversible attraction of 
bacterial cells to the surface, and a subsequent but more tenacious and irreversible 
adhesion of the same. Then, a maturation phase, during which cells irreversibly 
attached to surfaces begin cell division forming microcolonies, and produce EPSs 
that allows the formation of the first three-dimensional structures of biofilm, 
macrocolonies, providing the matrix structure for the biofilm. Finally, a dispersal 
phase, which involves the detachment of single cells or groups of cells that can 
colonize surrounding or remote sites and promote the origin of a new biofilm5. 
The formation and maintenance of structured multicellular microbial communities 
crucially depend on the production and quantity of EPS. The chemical features, 
abundance and three-dimensional arrangement of each component of EPS 
determine the biofilm morphology, provide mechanical stability and form a cohesive 
polymer network that interconnects and transiently immobilizes biofilm cells6. 
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Figure 1: Biofilm development stages: adhesion of the cells to a surface (attachment), cell division and EPS 
production (maturation), matrix disaggregation and cell detachment (dispersal). 
 
 
EPS compounds belong to such different classes of macromolecules as 
polysaccharides, a wide variety of proteins, glycoproteins, and glycolipids, and in 
some cases, surprising amounts of extracellular DNA (eDNA)7. 
The extracellular secreted proteins determine the microbial attachment process to 
different solid surfaces. Firstly these macromolecules are accumulated on the cell 
surface. After the secretion process to the external environment, the proteins can be 
adsorbed to contact surfaces. The formation of a protein layer on solid surface, 
named conditioning film, is conducive to the bacterial adhesion process. During more 
advanced phases of the microbial adhesion process, the in situ secretion of 
extracellular proteins leads to the intensification of the microbial attachment process 
by anchoring the single cells on the contact surface8. 
The polysaccharide component of the matrix can provide many diverse benefits to 
the cells in the biofilm, including adhesion, protection, and structure. Aggregative 
polysaccharides act as molecular glue, allowing the bacterial cells to adhere to each 
other as well as to surfaces and thus to resist physical stresses imposed by fluid 
movement that could separate the cells from a nutrient source9. Polysaccharides can 
also provide protection from a wide range of stresses and external assaults, such as 
immune responses or antibiotics10. Finally, polysaccharides can provide structure to 
biofilms, allowing stratification of the bacterial community and establishing gradients 
of nutrients and waste products11. This can be advantageous for the bacteria by 
establishing a heterogeneous population that is prepared to endure stresses created 
by the rapidly changing environments that many bacteria encounter. The diverse 
range of polysaccharide structures, properties, and roles highlight the importance of 
this matrix constituent to the successful adaptation of bacteria to nearly every 
niche12. 
Extracellular DNA has recently been described as one of a major structural 
components of the biofilm matrix13. However, the role of this extracellular molecules 
in the Gram-positive and Gram-negative biofilm development process is still unclear. 
To date, it is generally accepted that eDNA plays a role in cell surface attachment, 
cellular aggregation and even cell dispersal in the biofilm life cycle. Experiments 
demonstrating binding between eDNA and polysaccharides14, proteins15 or 
extracellular metabolites16 by different mechanisms have generated an 
understanding of the central role of DNA as a scaffold offering structural integrity to 
biofilms. 
10 
 
Nevertheless, our understanding of biofilms is still limited. Research on microbial 
biofilms is proceeding on many fronts, with particular emphasis on elucidation of the 
genes specifically expressed by biofilm-associated organisms, in order to reach a 
more complete understanding of what makes the biofilm phenotype so different from 
the planktonic phenotype. 
 
 
2. Quorum sensing, cell-cell communication in biofilms 
 
Within the biofilm community, bacteria communicate with each other by using 
chemical signal molecules in response to population density in a process that is 
called quorum sensing (QS). The cell-cell communication via QS involves the 
production, release and group-wide detection of extracellular signalling molecules, 
which are called autoinducers (AIs). AIs accumulate in the environment as the 
bacterial population density increases, and bacteria monitor this information to track 
changes in their cell numbers and to collectively alter global patterns of gene 
expression17. 
Three main QS systems can be distinguished: the acyl-homoserine lactone (AHL) 
QS system in Gram-negative bacteria, the autoinducing peptide (AIP) QS system in 
Gram-positive bacteria and the autoinducer-2 (AI-2) QS system in both Gram-
negative and -positive bacteria.  AHL-type QS systems predominately foster intra-
species cell-cell communication in Gram-negative bacteria; AHLs diffuse through the 
bacterial membrane and interact with specific cytoplasmic receptors, which can 
regulate the target genes expression acting as transcriptional activators. Because 
peptides are impermeable to biological membranes, AIP QS system in Gram-positive 
typically use secreted oligopeptides and two-component systems, which consist of 
membrane-bound receptors and cytoplasmic transcription factors that direct 
alterations in gene expression. The AI-2 QS system, shared by Gram-positive and 
Gram-negative bacteria, involves the production of a family of interconverting 
compounds synthesized by the LuxS enzyme, widely present in bacteria, leading to 
the suggestion that AI-2 is a universal language for interspecies communication18. 
These QS systems control genes that direct activities that are beneficial when 
performed by groups of bacteria acting in synchrony, including bioluminescence, 
sporulation, competence, antibiotic production, biofilm formation and virulence factor 
secretion19. Beyond controlling gene expression on a global scale, QS allows 
bacteria to communicate within and between species. In fact, high cell density and 
close proximity of diverse species of microorganisms, that are typical of life in natural 
biofilms, let the organisms get involved in complex social interactions that occur both 
within and between species and can be either competitive or cooperative20. 
Competition for nutrients and other growth parameters is certainly an important 
driving force for the development of biofilm structure. But, on the other hand, in such 
a complex organization, bacteria could benefit from division of labor, collective 
actions, and other forms of cooperative activities with their neighbors21. 
These sophisticated interactions represent good examples of microbial social 
activities in natural microbial biofilms. If from a certain point of view these social 
activities play important roles in balancing competition and coexistence of different 
organisms within a microbial community, maintaining biodiversity and homeostasis of 
microbes in the same ecosystem22, from another perspective several problems arise 
from bacterial social activities, first of all the establishment of chronic biofilm-
associated infections, such as medical device or implant infections, frequently 
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resistant to the highest deliverable levels of antibiotics23. Nowadays, the arsenal of 
therapeutics available to treat these infections are in most cases ineffective, because 
biofilms underlying these infections cannot be resolved with standard antibiotic 
treatments. Therefore, understanding bacterial social behaviours and their molecular 
mechanisms in the development of biofilms will greatly facilitate the development of 
novel strategies in the prevention and treatment of biofilm infections. 
 
 
3. Biofilm and pathogenesis 
 
Industrial pipelines, nuclear power stations, space stations, air conditioning systems, 
water distribution systems and one of the fastest technologically advancing settings, 
the hospital, are all susceptible to colonization by microorganisms growing in 
biofilms24. In clinical settings, biofilms have been implicated in a variety of human 
infections, such as endocarditis, osteomyelitis, chronic otitis media, gastrointestinal 
ulcers, urinary tract infections, chronic lung infections in cystic fibrosis patients, 
caries, and periodontitis25. Among all, the most common clinical infections associated 
with biofilm formation are medical device-related infections. Pacemakers, electrical 
dialysers, joint prosthetics, intravenous catheters, urinary catheter present high risk of 
biofilm-associated infection.  
The causative agents of biofilm-associated infections are different Gram-positive 
species of Staphylococcus, Streptococcus, and Enterococcus as well as Gram-
negative bacteria, such as Pseudomonas aeruginosa, Escherichia coli, and 
Klebsiella pneumoniae. Infections caused by biofilm-forming bacteria are often 
difficult to treat. Biofilm formation almost always leads to a large increase in 
resistance to antimicrobial agents (up to 1000-fold decrease in susceptibility) in 
comparison with planktonic cultures grown in conventional liquid media26 and to the 
triggering of evasion mechanisms of the bacteria from immune system responses of 
the host27. 
Three mechanisms have been proposed to explain the general resistance of biofilms 
to biocidal agents. The first is the barrier properties of the slime matrix28. This 
mechanism might be more relevant for reactive (bleach or superoxides), charged 
(metals) or large (immunoglobulin) antimicrobial agents that are neutralized or bound 
by the EPS and are effectively reduced to sub-lethal concentrations before they can 
reach all of the individual bacterial cells within the biofilm. The barrier properties of 
the EPS hydrogel might also protect against UV light and dehydration, and might 
localize enzymatic activity. The second protective mechanism could involve the 
physiological state of biofilm organisms. Although many antibiotics can freely 
penetrate the EPS, cells within the biofilm are often still protected. The creation of 
stationary phase dormant zones in biofilms seems to be a significant factor in the 
resistance of biofilm populations to antimicrobials29-30, particularly against antibiotics, 
such as β−lactams, which are effective against rapidly dividing Gram-positive 
bacteria by interruption of cell-wall synthesis. However, obviously all antibiotics 
require at least some degree of cellular activity to be effective, because the 
mechanism of action of most antibiotics involves disruption of a microbial process. 
Therefore, the creation of zones of cells in a biofilm in stationary phase quiescence 
might represent a general mechanism of antibiotic resistance. A third mechanism of 
protection is due to the existence of subpopulations of resistant phenotypes in the 
biofilm, which have been referred to as “persisters”31. Persister cells are highly 
multidrug-tolerant cells that constitute a small fraction of the population. They are 
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transiently refractory to killing, without having acquired resistance through genetic 
modification32. Consequently, when the antibiotic pressure drops, the cells will give 
rise to a population that is as susceptible as the original one, and that again 
possesses a similarly small proportion of persister cells. This discriminates persister 
cells from resistant mutants, which exhibit stable, inheritable drug insensitivity. 
Persisters have a significantly reduced growth rate33. Their indifference to the 
presence of antibiotics can therefore be explained by a global shutdown of processes 
essential for active growth, as the very processes that are targeted by antibiotics are 
no longer operational and hence not subject to inhibition any more. This also 
corroborates the non-specific nature of persister cell drug tolerance. So, based both 
on these findings and on modelling studies34, it was suggested that persisters may 
well represent the long-looked-for explanation for biofilm tolerance to antibiotics. 
 
 
4. Staphylococcus epidermidis, the opportunistic pathogen 
 
Coagulase-negative staphylococcal species are the predominant bacterial species 
that colonize normal human skin. In particular, Staphylococcus epidermidis is the 
most frequently isolated species from human epithelia and, as part of the human 
epithelial microflora, it usually has a benign relationship with its host35. 
Although the specific mechanisms through which skin surface microbes influence 
host function are incompletely understood, specific strains of coagulase-negative 
staphylococcal species have been shown to produce proteins that work together with 
endogenous host antimicrobial peptides to provide direct protection against infectious 
pathogens. For example, it was demonstrated that S. epidermidis produces toxins 
that can selectively kill bacterial pathogens such as S. aureus36. Further evidence 
that commensal Staphylococcus species provide host defense has come from 
observations that nasal colonization with a specific strain of S. epidermidis that 
produces a particular serine protease can inhibit nasal colonization by S. aureus37. 
Despite the evidence that the skin microbiome has an important role in promoting 
host defense, the research and the information on the non-infectious lifestyle of S. 
epidermidis are still relatively scarce, whereas, on the other hand, the interest in S. 
epidermidis infections and mechanisms by which it promotes diseases is 
continuously increasing. 
The main defined virulence factor associated with S. epidermidis is its ability to form 
biofilm and colonize biotic and abiotic surfaces. Particularly, S. epidermidis 
represents the most frequent causative agent involved with infections of any type of 
indwelling medical devices38. The onset of these infections usually start with the 
introduction of bacteria from the skin of the patient or that of health care personnel 
during device insertion and have increased in number most likely owing to the 
increased use of such devices. 
The American “Centers for Disease Control and Prevention” estimates that 2 million 
patients suffer from hospital-acquired infections every year. About 65% of these 
nosocomial infections are biofilm related and the treatment of these biofilm-
associated infections costs greater than $1 billion annually only in the United 
States39. In a recent study, the 5 most frequently occurring bacteria have been 
identified among more than 3 million clinical isolates from hospital inpatients, and S. 
epidermidis was one of the most common cause of nosocomial bacteremia in North 
America (prevalence, 11.5%), Latin America (prevalence, 13.3%) and Europe 
(prevalence, 14.6%)40. 
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S. epidermidis infections are recalcitrant to the deleterious action of antibiotics and 
impedes the host immune response, therefore, the treatment of patients with S. 
epidermidis biofilm-related infections typically involves removal of the offending 
device and subsequent replacement, causing an increase in morbidity and cost. 
Fortunately, the utilization of newer technologies enables investigators to probe 
mechanisms of virulence within S. epidermidis, particularly those factors that mediate 
biofilm formation, so as to identify new strategies to inhibit S. epidermidis colonization 
and infections. 
 
 
5. Polar marine bacteria as source of new anti-biofilm molecules 
 
Biodiversity in the seas is only partly explored, although marine organisms are 
excellent sources for many industrial products. Of the 2 million marine species on 
Earth, the total number of currently known marine species is only 230,00041-42. 
Through close cooperation between industrial and academic partners, it is possible to 
successfully collect, isolate and classify marine organisms, such as bacteria, fungi, 
micro- and macroalgae, cyanobacteria, and marine invertebrates from the oceans 
and seas globally. 
Marine organisms possess a vast diversity of metabolic capabilities, because of their 
varied adaptations to a diverse range of physical and chemical conditions of marine 
ecosystems43. In fact, the specific habitat where organism is growing has influence 
on the chemical nature of the marine primary and secondary metabolites. 
Not by chance, microorganisms that inhabit extreme environments, referred to as 
extremophiles, have an enormous potential as sources of bioactive compounds with 
applications in biotechnology and pharmaceutical industry44.  In particular, marine 
microorganisms living in Polar regions, to survive under the constant influence of low 
temperatures, strong winds, low nutrient and high UV radiation or combinations of 
these factors, require a diverse array of biochemical and physiological adaptations 
that are essential for survival. These adaptations are often accompanied by 
modifications to both gene regulation and metabolic pathways, increasing the 
possibility of finding unique functional metabolites of pharmaceutical importance45. 
One of the developed survival strategies may be represented by the production of 
molecules with anti-biofilm activity, which might be exploited to fight the biological 
competition of other bacteria.  
Several natural products were isolated from polar species, endowed with disparate 
biological activity, varying from cytotoxic, enzyme inhibitory, antioxidant, antiparasitic, 
antiviral to antibacterial46. Recently, research is focusing on the discovery of novel 
anti-biofilm agents, like quorum sensing inhibitors47 or biosurfactants48. 
The Antarctic marine bacterium Pseudoalteromonas haloplanktis TAC125 is 
considered as a model for the study of adaptation to cold marine conditions. The 
study of its exceptional genomic and metabolic features revealed the ability of the 
bacterium to grow, to a very high cell density under laboratory settings, in a wide 
range of temperatures (+20°C/-2.5°C)49, its capability to colonize biotic and abiotic 
surfaces, with a propensity to make a water/air biofilm50, and its validity either as a 
non-conventional system for production of recombinant protein49 and as a rich source 
of bioactive compounds51-52. 
Furthermore, it was observed that P. haloplanktis TAC125 is able to produce and 
secrete molecule/s inhibiting the biofilm of the human pathogen Staphylococcus 
epidermidis biofilm formation53-54. In parallel, it was demonstrated that supernatants 
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obtained from bacterial cultures of several Polar bacteria belonging to 
Pseudoalteromonas, Psychrobacter and Psychromonas genera showed anti-biofilm 
activity against different pathogenic strains55 and preliminary evaluations on the 
physicochemical nature of the molecules responsible for anti-biofilm activity 
emphasized their different nature.  
This ability of Polar marine bacteria to produce several anti-biofilm molecules could 
suggest that the capacity to avoid the colonization and biofilm formation of 
competitors is a selective advantage in this extreme environment, ensuring that these 
bacteria may become an interesting source of novel anti-biofilm compounds. 
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1. Pseudoalteromonas haloplanktis TAC125 biofilm formation: physiological 
studies and anti-biofilm agents discovery 
 
Pseudoalteromonas haloplanktis TAC125 anti-biofilm activity has been discovered 
and characterized during the last years1-2. The Antarctic bacterium is able to 
synthesize and secrete in the environment in which it lives a small anti-biofilm 
molecule, active against Staphylococcus epidermidis. In detail, it was demonstrated 
that the cell-free supernatant of P. haloplanktis TAC125 inhibits the biofilm formation 
of different S. epidermidis strains, even on the mature forms. On the basis of these 
results, in this part of my PhD project I focused my work on the identification of P. 
haloplanktis TAC125 anti-biofilm agent and its possible clinical applications. 
 
 
This chapter is organized in three paragraphs: 
 
 the first paragraph describes the set-up of a biofilm cultivation of P. 
haloplanktis TAC125 in automatic bioreactor, for a large scale production of 
the anti-biofilm molecule, and the subsequent characterization and 
identification of the active compound; 
 the second paragraph describes the design of new anti-biofilm compounds, 
based on the chemical structure of the identified P. haloplanktis TAC125 anti-
biofilm molecule, but endowed with different physicochemical properties, and 
their possible clinical application as anti-biofilm coating for medical devices; 
 the third paragraph describes some physiological studies on P. haloplanktis 
TAC125 biofilm formation in relation with environmental adaptations, with the 
purpose to explore the potentiality of P. haloplanktis TAC125 in 
biotechnological field. 
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1.1. Characterization and identification of Pseudoalteromonas haloplanktis 
TAC125 anti-biofilm agent 
 
From a previous study1, P. haloplanktis TAC125 has been shown to produce the anti-
biofilm molecule only when it is grown in sessile condition, probably because the 
specific environmental conditions prevailing within the biofilm may induce profound 
genetic and metabolic rewiring of the biofilm-dwelling bacteria3, and this could led to 
the production of biofilm-specific metabolites. A preliminary physicochemical 
characterization of the supernatant of P. haloplanktis TAC125 demonstrated that the 
anti-biofilm activity is due to a small hydrophobic molecule, able to affect S. 
epidermidis biofilm formation and stability. The purification protocol initially proposed 
led to the obtainment of a fraction enriched in the anti-biofilm molecule, but which 
was still a mixture of several compounds2. Therefore, it was clear that for the 
purification and the subsequent characterization of the anti-biofilm molecule a large-
scale production was necessary. 
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anti-biofilm molecule and paved the way to study differ-
ences between P. haloplanktis TAC125 cells grown in bio-
film and in planktonic conditions. In particular, the modifi-
cations occurring in the lipopolysaccharide of cells grown 
in biofilm were investigated.
Keywords Biofilm cultivation · Pseudoalteromonas 
haloplanktis TAC125 · Anti-biofilm · Bacterial biofilm 
phenotype
Introduction
Biofilm is a structured aggregation of microorganisms 
associated with a surface and it is the predominant mode 
of growth for bacteria in most environments. The transition 
from the planktonic state to biofilm growth occurs as a con-
sequence of environmental changes that trigger the activa-
tion of multiple regulatory networks (Hall-Stoodley et al. 
2004; de la Fuente-Núñez et al. 2013). Thus, upon sensing 
a proper signal, free-living (planktonic) cells will initiate 
attachment to a surface, which will lead to the formation 
of a biofilm that has a greater ability to withstand environ-
mental challenges. Bacteria possess a biofilm genetic pro-
gram that could be triggered by stressful conditions, aim-
ing at the adaptation to transiently hostile environments (de 
la Fuente-Núñez et al. 2013). This program involves the 
switch on of regulatory circuits that cause transient genetic 
alterations rather than permanent. Proteomic and transcrip-
tomic studies have shown a global shift in metabolism 
when growth switches from planktonic to biofilm (de la 
Fuente-Núñez et al. 2013).
Although bacterial biofilm has drawn increasing atten-
tion due to many detrimental effects on human health (Per-
cival et al. 2015), it can be used in many biotechnological 
Abstract Microbial biofilms are mainly studied due to 
detrimental effects on human health but they are also well 
established in industrial biotechnology for the produc-
tion of chemicals. Moreover, biofilm can be considered 
as a source of novel drugs since the conditions prevailing 
within biofilm can allow the production of specific metabo-
lites. Antarctic bacterium Pseudoalteromonas haloplank-
tis TAC125 when grown in biofilm condition produces 
an anti-biofilm molecule able to inhibit the biofilm of the 
opportunistic pathogen Staphylococcus epidermidis. In this 
paper we set up a P. haloplanktis TAC125 biofilm cultiva-
tion methodology in automatic bioreactor. The biofilm cul-
tivation was designated to obtain two goals: (1) the scale 
up of cell-free supernatant production in an amount nec-
essary for the anti-biofilm molecule/s purification; (2) the 
recovery of P. haloplanktis TAC125 cells grown in biofilm 
for physiological studies. We set up a fluidized-bed reac-
tor fermentation in which floating polystyrene supports 
were homogeneously mixed, exposing an optimal air–liq-
uid interface to let bacterium biofilm formation. The pro-
posed methodology allowed a large-scale production of 
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applications (Rosche et al. 2009). Indeed, the specific envi-
ronmental conditions prevailing within biofilms induce 
profound genetic and metabolic rewiring of the biofilm-
dwelling bacteria that can allow the production of metabo-
lites different from those obtained in planktonic condition. 
From this point of view, the biofilm could be considered 
as a source of novel drugs. Furthermore, many bacterial 
biofilms secrete molecules such as quorum sensing sig-
nals, surfactants, enzymes, and polysaccharides that act by 
regulating biofilm architecture or mediating the release of 
cells from biofilms during the dispersal stage of the biofilm 
life cycle (Valle et al. 2006; Qin et al. 2009; Ni et al. 2009; 
Kiran et al. 2010; Papa et al. 2015). While understanding 
of these aspects of biofilms has increased, further work is 
needed, especially in the field of in vitro systems develop-
ment for growing and studying microbial biofilms.
Two major biofilm models are studied in the laboratory, 
biofilms grown without a continuous flow of fresh medium 
and biofilms grown with a continuous flow of fresh 
medium. These systems generally provide a surface that 
can be removed and examined once it is colonized to assess 
biofilm formation. Along with the development of these 
systems for biofilm physiology studies at small scale, the 
biotechnological applications of microbial biofilm, such as 
water purification and wastewater treatment and enhanced 
production of added-value fermentation products (Pongtha-
rangku and Demirci 2007, Cheng et al. 2010) fostered the 
set-up of biofilm reactors for large-scale industrial produc-
tion. Biofilm reactors have been proven quite effective in 
enhancing productions of added-value products, such as 
bioethanol, organic acids, enzymes, antibiotics, and poly-
saccharides as they can generate increased volumetric pro-
ductivity rates by maintaining high biomass concentration 
in the bioreactors (Cheng et al. 2010).
In general, biofilm reactors can be categorized into two 
groups: fixed-bed and expanded-bed reactors. Fixed-bed 
reactors include all processes in which the biofilm develops 
on static media (Cheng et al. 2010; Szilágyi et al. 2013). 
Expanded-bed reactors include biofilm with continuously 
moving media driven by high air or liquid velocity, or by 
mechanical stirring (Cheng et al. 2010). A great variety of 
solid supports have been developed and designed to increase 
the specific surface area per volume of reactor to obtain 
higher efficiency and compactness (Cheng et al. 2010).
We previously (Papa et al. 2013b; Parrilli et al. 2015) 
demonstrated that the cell-free supernatant of Antarctic 
bacterium Pseudoalteromonas haloplanktis TAC125 (P. 
haloplanktis TAC125) inhibits Staphylococcus epidermidis 
(S. epidermidis) biofilm formation. Interestingly P. halo-
planktis TAC125 shows this activity only when it is grown 
in sessile condition (Papa et al. 2013b). Recent investiga-
tion (Parrilli et al. 2015) on chemical nature of P. halo-
planktis TAC125 anti-biofilm molecule demonstrated that 
the anti-biofilm activity is due to small hydrophobic mol-
ecule that likely works as signal. These results are highly 
suggestive of actual differences in P. haloplanktis TAC125 
cells physiology when sessile rather than planktonic life-
style is adopted, and pave the way to several open questions 
about the biofilm-specific pathway involved in the anti-
biofilm molecule synthesis. To answer these questions it is 
necessary to have a methodology to investigate the charac-
teristics of P. haloplanktis TAC125 cell grown in biofilm. 
Moreover, the previously proposed purification protocol 
(Parrilli et al. 2015), even if it allowed to obtain an active 
fraction enriched in anti-biofilm compound, is character-
ized by a poor purification yield. Therefore, the purification 
and characterization of the anti-biofilm molecule requires a 
larger scale production.
In this paper, we set up a biofilm cultivation methodol-
ogy of P. haloplanktis TAC125 in automatic bioreactor. 
The Gram-negative psychrotolerant marine bacterium P. 
haloplanktis TAC125 is one of the best-studied cultivable 
representatives of the marine bacterioplankton and it is 
considered a model organism of bacterial cold-adaptation 
(Medigue et al. 2005). Indeed, in the last few years the 
increasing interest in P. haloplanktis TAC125 has led to the 
accumulation of different data types, including its complete 
genome sequence (Medigue et al. 2005), its intracellular 
and extracellular proteome (Piette et al. 2010, 2011; Papa 
et al. 2006), detailed growth phenotypes (Wilmes et al. 
2010; Giuliani et al. 2011), and a genome-scale metabolic 
model (Fondi et al. 2015). A fermentation scheme to up-
scale P. haloplanktis TAC125 growth in automatic biore-
actors, at a laboratory scale, was developed and used for 
batch (Giuliani et al. 2011), chemostat cultivation (Giuliani 
et al. 2011) and fed-batch fermentation (Wilmes et al. 
2010). However, no strategy was established to obtain a 
biofilm cultivation of P. haloplanktis TAC125 in bioreactor.
In this paper, we proposed a biofilm cultivation of P. 
haloplanktis TAC125 in automatic bioreactor aimed at a 
larger scale production of P. haloplanktis TAC125 super-
natant grown in biofilm condition, indispensable for the 
purification of the molecule active against S. epider-
midis biofilm. The set up process also allowed a consist-
ent enhancement of the recovery yield of P. haloplanktis 
TAC125 biomass, making now possible to carry out com-
parative physiologic studies of Antarctic bacterial cells 
grown in biofilm and in planktonic conditions.
Materials and methods
Bacterial strains and culture conditions
Bacterial strains used in this work were: S. epidermidis 
O-47 isolated from clinical septic arthritis and kindly 
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provided by Prof. Gotz (Heilmann et al. 1996); P. halo-
planktis TAC125 (Medigue et al. 2005) collected in 1992 
from seawater near French Antarctic Station Dumont 
d’Urville. Bacteria were grown in Brain Heart Infusion 
broth (BHI, Oxoid, UK). Biofilm formation was assessed in 
static condition while planktonic cultures were performed 
under vigorous agitation (180 rpm). All strains were main-
tained at −80 °C in cryovials with 15 % of glycerol.
Biofilm formation of P. haloplanktis TAC125 
on supports in flask
Polystyrene supports were hand made using pieces of 
expanded polystyrene with two different shapes. The mean 
length of the outer side is 2 cm, the mean thickness is 1 cm 
and the mean surface exposed area is 12 cm2 in case of 
support A. Type B are characterized by a mean thickness 
of 1 cm, a mean diameter of 0.5 cm and a mean surface 
exposed area of 2.1 cm2.
The supports were placed in water and sterilized in auto-
clave at 121 °C for 20 min. After sterilization, the polysty-
rene supports were added to cell cultures. In detail, 250 ml 
glass wide-neck flasks were filled with 25 ml of BHI 
medium and an appropriate dilution of Antarctic bacterial 
culture in exponential growth phase (about 0.1 OD 600 nm) 
was added into each flask. Several replicates of autoclaved 
polystyrene supports were separately placed onto the sur-
face of the broth with a sterile forceps to allow a homo-
geneous soaking of the surfaces and to enable biofilm for-
mation at air–liquid interface. In detail, four replicates of 
support A (Fig. 1) and 24 replicates of support B (Fig. 1) 
were added in each flask, respectively. P. haloplanktis 
TAC125 cultures were incubated at 15 and at 4 °C for 96 h 
in static condition. After incubation, supernatants were 
separated from polystyrene supports and sterilized by filtra-
tion through membranes with a pore diameter of 0.22 µm, 
and stored at 4 °C until use. Supports were recovered and 
rinsed twice with 40 ml of PBS. Then adhered cells on sup-
ports were stained with 0.1 % crystal violet, rinsed twice 
with double-distilled water, and thoroughly dried. The dye 
bound to adherent cells on supports was solubilized with 
20 ml of 20 % (v/v) glacial acetic acid and 80 % (v/v) etha-
nol and the absorbance at 590 nm was measured.
Recovery of attached cells by sonication
250 ml glass wide-neck flasks were filled with 25 ml of 
BHI medium and an appropriate dilution of Antarctic bac-
terial culture in exponential growth phase (about 0.1 OD 
600 nm) was added into each flask. Then four replicates 
of support A and 24 replicates of support B were added in 
each flask, respectively. P. haloplanktis TAC125 cultures 
were incubated at 4 °C for 96 h in static condition, after 
incubation supports were transferred with a sterile forceps 
to a 50 ml Falcon tube filled with 10 ml of BHI broth, with 
the supports completely immersed into the broth. In detail, 
one single support A and six supports B in each Falcon tube 
were transferred, respectively. Samples were sonicated at 
three different exposure times (5, 10 and 15 min). Sonica-
tion was performed by using an ultrasound bath (Elmasonic 
S 30/H) at a constant ultrasound frequency of 37 kHz. The 
supports floated to the top of the liquid level while the 
detached biomass settled. Sonication fluid obtained after 
three different exposure times was transferred to 10 ml 
Falcon tubes, respectively. Samples were centrifuged at 
13,000 rpm, supernatant was discarded and cell pellets 
were resuspended in a small volume of fresh broth. Cell 
suspensions were transferred in 2 ml microcentrifuge tubes 
and centrifuged at 13,000 rpm. Then supernatant was dis-
carded and cell pellets were dried in an oven at 55 °C for 
24 h. Dry weight of recovered cell pellets was measured by 
using an analytical balance.
Anti‑biofilm compound/s production in automatic 
bioreactor
P. haloplanktis TAC125 bacterial culture was grown in BHI 
medium in a Stirred Tank Reactor 3 L fermenter (Applikon) 
connected to an ADI-1030 Bio Controller (Applikon) with 
a working volume of 1 L. The bioreactor was equipped 
with the standard pH-, pO2-, level- and temperature sensors 
for the bioprocess monitoring. To allow the biofilm forma-
tion, autoclaved solid polystyrene supports A were added 
into the bioreactor (33 supports in 1 L). The culture was 
carried out at 15 °C for 48 h, or at 4 °C for 96 h, in aer-
obic conditions using an airflow of 6 L h−1, without stir-
ring. Supernatant was recovered and separated from sup-
ports and cells by a centrifugation at 13,000 rpm. Then, it 
was sterilized by filtration through membranes with a pore 
Fig. 1  Autoclaved polystyrene supports. a Support A: the mean 
length of the outer side is 2 cm, the mean thickness is 1 cm and the 
mean surface exposed area is 12 cm2. b Support B: the mean thick-
ness is 1 cm, the mean diameter is 0.5 cm and the mean surface 
exposed area is 2.1 cm2
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diameter of 0.22 µm, and stored at 4 °C until use. Supports 
were recovered and subjected to biofilm detachment proce-
dure previously described.
Biofilm formation of staphylococci
Quantification of in vitro biofilm production was based on 
the method described by Christensen with slight modifi-
cations (Papa et al. 2013a; Artini et al. 2013). Briefly, the 
wells of a sterile 48-well flat-bottomed polystyrene plate 
were filled with 400 µl of BHI medium. 1/100 Dilution of 
overnight bacterial cultures was added into each well (about 
5.0 OD 600 nm). The first row contained the untreated bac-
teria, while each of the remaining rows contained serial 
dilutions of supernatant (SN) starting from 1:2. The plates 
were incubated aerobically for 24 h at 37 °C.
Biofilm formation was measured using crystal vio-
let staining. After treatment, planktonic cells were gently 
removed; each well was washed three times with PBS and 
patted dry with a piece of paper towel in an inverted posi-
tion. To quantify biofilm formation, each well was stained 
with 0.1 % crystal violet and incubated for 15 min at room 
temperature, rinsed twice with double-distilled water, and 
thoroughly dried. The dye bound to adherent cells was sol-
ubilized with 20 % (v/v) glacial acetic acid and 80 % (v/v) 
ethanol. After 30 min of incubation at room temperature, 
OD 590 nm was measured to quantify the total biomass of 
biofilm formed in each well. Each data point is composed 
of three independent experiments each performed at least 
in 3-replicates.
LPS extraction and characterization
P. haloplanktis TAC125 cells were grown in planktonic and 
in biofilm conditions at 15 and 4 °C, respectively. Then 
the cells were extracted by phenol/chloroform/light petro-
leum ether (PCP) method to isolate the lipopolysaccharide 
(LPS) fractions (Galanos et al. 1969) and visualized by 
electrophoresis. For the extraction of LPS from P. halo-
planktis TAC125 grown in planktonic conditions, bacterial 
cells were treated as already reported (Corsaro et al. 2001). 
PAGE was performed using the system of Laemmli et al. 
(1970) with sodium deoxycholate (DOC) as detergent. 
The separating gel contained final concentrations of 16 % 
acrylamide, 0.1 % DOC, and 375 mM Tris/HCl pH 8.8; the 
stacking gel contained 4 % acrylamide, 0.1 % DOC, and 
125 mM Tris/HCl pH 6.8. LOS samples were prepared at 
a concentration of 0.05 % in the sample buffer (2 % DOC 
and 60 mM Tris/HCl pH 6.8 25 % glycerol, 14.4 mM 
2-mercaptoethanol, and 0.1 % bromophenol blue). All con-
centrations are expressed as mass/volume percentage. The 
electrode buffer was composed of SDS (1 g L−1), glycine 
(14.4 g L−1), and Tris (3.0 g L−1). Electrophoresis was 
performed at constant amperage of 30 mA. Gels were fixed 
in an aqueous solution of 40 % ethanol and 5 % acetic acid. 
LOS bands were visualized by silver staining (Tsai and 
Frasch 1982).
Monosaccharides were analyzed as acetylated methyl 
glycosides. The LPS samples (1 mg) were treated with HCl/
CH3OH (1.25 M, 1 mL) and the methanolysis was per-
formed as reported (Carillo et al. 2015). After acetylation the 
samples were analyzed on an Agilent Technologies gas chro-
matograph 6850A equipped with a mass selective detector 
5973 N and a Zebron ZB-5 capillary column (Phenomenex, 
30 m × 0.25 mm i.d., flow rate 1 ml min−1, He as carrier 
gas), accordingly with the following temperature program: 
140 °C for 3 min, 140 °C → 240 °C at 3 °C min−1.
Results and discussion
Polystyrene supports selection
As previously reported (Papa et al. 2013b; Parrilli et al. 
2015), P. haloplanktis TAC125 can be efficiently grown in 
biofilm condition using sterile 24-well flat-bottomed poly-
styrene plates. Therefore, the first step to assess a proper 
strategy to scale up the biofilm growth condition was the 
identification of suitable polystyrene supports for bio-
film formation. P. haloplanktis TAC125 biofilm formation 
mostly occurs at air–liquid interface (Medigue et al. 2005), 
therefore we selected supports able to float and character-
ized by a large surface area per volume unit to promote 
microorganism adhesion. Two types of polystyrene sup-
ports were tested (Fig. 1).
To assess the ability of P. haloplanktis TAC125 to form 
biofilm on selected polystyrene supports, Antarctic bac-
terium was grown in BHI medium using glass wide-neck 
flasks in the presence of the supports A or B, at 15 and 
4 °C in static condition for 96 h. P. haloplanktis TAC125 
resulted to be able to form biofilm on both types of poly-
styrene supports and a qualitative measurement of formed 
biofilm was performed as described in “Materials and 
methods”. The amount of biofilm formed on 5 type A sup-
ports or on 30 type B supports resulted to be almost the 
same (data not shown). This result is not surprising as type 
A supports have a mean exposed surface area of 12 cm2, 
about six times higher than that of type B supports (mean 
exposed surface area 2.1 cm2).
Moreover, supernatants of P. haloplanktis TAC125 
grown in the presence of tested supports were found to be 
able to inhibit S. epidermidis O-47 biofilm formation (data 
not shown).
In view of a possible characterization of cells in bio-
film, supports were treated with ultrasounds for three dif-
ferent exposure times (5, 10 and 15 min) to allow biofilm 
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detaching and biomass recovery. Sonication was performed 
using an ultrasound bath at a constant ultrasound frequency 
of 37 kHz. After treatments, a qualitative analysis of resid-
ual biofilm biomass was determined using crystal violet 
staining (Fig. 2a).
For a quantitative evaluation, the dry weight of cell pel-
lets recovered after sonication of the supports was deter-
mined (Fig. 2b). As shown in Fig. 2, both supports were 
suitable for biofilm formation, but support A allowed a 
better biofilm detachment and cell recovery after sonica-
tion. Therefore, we selected the support A for the set-up 
of biofilm cultivation of Antarctic bacterium in automatic 
bioreactor.
Set up of P. haloplanktis TAC125 biofilm cultivation 
in automatic bioreactor
To develop a scalable process for P. haloplanktis TAC125 
growth in biofilm, Antarctic bacterium was grown in 
bioreactor in the presence of supports A, without stirring 
and keeping a low air inflow (see “Materials and meth-
ods”). The experimental conditions were chosen to obtain 
a sort of fluidized-bed reactor, in which the supports were 
homogeneously mixed and properly exposed to air–liquid 
interface, where P. haloplanktis TAC125 biofilm formation 
mostly occurs. Moreover, all parameter were selected to 
avoid the shearing detachment of biofilm. To attain these 
aims, several airflow conditions and ratios between medium 
volume and number of added supports were tested (data not 
shown). The best results were obtained using 33 supports A 
in 1 L of BHI medium using an airflow of 6 L h−1 without 
stirring.
To evaluate the molecule/s anti-biofilm production in 
the selected conditions, Antarctic bacterium was grown in 
BHI in a 3L-stirred tank reactor (Applikon ADI 1030) at 
two different temperatures (4 and 15 °C) in the presence 
of supports A. Corresponding supernatants were recov-
ered for each condition after 24, 48, 72 and 96 h at 4 °C 
and after 24, 48 and 72 h at 15 °C, respectively, and their 
effect on S. epidermidis strain O-47 biofilm was evalu-
ated (Fig. 3). Anti-biofilm effect is reported as percentage 
of residual biofilm after treatment in comparison with bio-
film formation by untreated bacteria. As shown in Fig. 3, 
the anti-biofilm compound was produced at both tested 
temperatures and in all tested conditions. In particular, at 
15 °C the greatest production occurs at 72 h of cultivation, 
while at lower temperature (4 °C) 96 h of incubation are 
needed to achieve the best anti-biofilm compound produc-
tion (Fig. 3). This result is in perfect agreement with previ-
ously reported production conditions (Parrilli et al. 2015) 
where sterile 24-well flat-bottomed polystyrene devices 
were used. Therefore the proposed P. haloplanktis TAC125 
biofilm cultivation is suitable for a larger scale production 
of anti-biofilm molecule and it allows to obtain an amount 
of cell-free supernatant sufficient for the future purification.
Comparison between P. haloplanktis TAC125 
lipopolysaccharide extracted from planktonic 
and biofilm associated cells
It is widely accepted that the choice of biofilm lifestyle 
imposes profound physiological, metabolic, and morpho-
logical changes to planktonic growing bacteria. It is very 
likely that also Antarctic marine bacteria do not escape 
this general rule. However, only very limited informa-
tion, essentially coming from the study of P. haloplanktis 
TAC125, are available on cold-adapted bacteria grown in 
sessile conditions. Therefore, the second—but not less 
important—aim of this work was to demonstrate that the 
optimized fermentation process allowed the easy recovery 
of P. haloplanktis TAC125 biomass grown in biofilm, ready 
to be used in comparative structural analyses with respect to 
Fig. 2  Evaluation of P. haloplanktis TAC125 biofilm removal from 
polystyrene supports by sonication. Data reported are referred to 
treatment of five supports A (white bar) and 30 supports B (gray bar). 
a Crystal violet staining: supports A and B stained before (NS) and 
after sonication for biofilm mass evaluation. b Dry weight of cell pel-
lets recovered from supports A and B after sonication
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cells grown in planktonic conditions. Amongst the cellular 
components that were structurally characterized in plank-
tonic P. haloplanktis TAC125 cells, LPS was the object of 
the comparative analysis. LPS is the major constituent of 
all Gram-negative outer membranes, and although their 
structure varies in response to certain environmental stimuli 
(Raetz and Whitfield 2002), few studies have investigated 
changes in structure of LPSs extracted from cells grown in 
biofilms (Hansen et al. 2007; Ciornei et al. 2010; Chala-
baev et al. 2014). In particular, reversible loss of lipopoly-
saccharide O-antigen and alteration of lipid A have been 
observed in some Pseudomonas aeruginosa strains when 
grown in biofilm (Ciornei et al. 2010). Recently, Chalabaev 
and coworkers demonstrated that Escherichia coli LPS 
displays some modifications, in particular occurring in the 
lipid A moiety, when the molecules extracted from the two 
growth conditions were compared (Chalabaev et al. 2014). 
Here, we compared P. haloplanktis TAC125 LPS obtained 
during biofilm growth at 15 °C (LPSb15) and 4 °C (LPSb4) 
with previously characterized LPS extracted by planktonic 
bacteria grown at 15 °C (LPSp15) (Corsaro et al. 2001). 
Dried cells embedded in the biofilm were extracted by PCP 
procedure to isolate the crude LPS. The purified samples 
were analyzed by DOC-PAGE electrophoresis and visual-
ized with silver nitrate staining (Fig. 4).
Electrophoresis analysis revealed that all the samples 
contain bands at low molecular masses indicating the rough 
nature of LPS. This latter revealed that P. haloplanktis 
TAC125, grown in static condition, produced a lipopoly-
saccharide with the same nature of the LPS previously 
described for planktonic condition (Corsaro et al. 2001). 
Nevertheless, a difference was observed between the sam-
ples grown in sessile (Fig. 4, lanes b and c) and planktonic 
conditions (Fig. 4, lane d). Indeed, while the planktonic 
LPS showed only one band, two bands were clearly detect-
able for LPS molecules extracted from cells grown in bio-
film. A glycosyl analysis was then performed on the three 
different LPS samples (LPSb15, LPSb4 and LPSp15) to 
assess if this difference could be due to a modification in 
the sugar composition.
The analysis was carried out by GC–MS of the acety-
lated methyl glycosides and revealed for all the samples 
the presence of galactose (Gal), 2-amino-2-deoxymannose 
(ManN), 2-amino-2-deoxyglucose (GlcN) and heptose 
(Fig. S1-S3). Since all these monosaccharides were already 
Fig. 3  S. epidermidis biofilm formation in the presence of P. halo-
planktis TAC125 cell-free supernatants. P. haloplanktis TAC125 was 
grown in an automatic bioreactors in the presence of supports A at 
4 °C and at 15 °C. Corresponding supernatants recovered at differ-
ent times were tested. Data are reported as percentage of residual bio-
film after the treatment. Each data point represents the mean ± SD of 
three independent experiments each performed at least in 3-replicates 
of three independent samples
Fig. 4  16 % DOC-PAGE analysis of Escherichia coli O55:B5 LPS 
used as standard (a), P. haloplanktis TAC125, LPSb4 (b), LPSb15 
(c), and P. haloplanktis TAC125 LPSp15 (d). The arrows indicate the 
LPS bands extracted from cells grown in biofilm
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described to be the components of P. haloplanktis TAC125 
LPS (Corsaro et al. 2001), it can be deduced that the gly-
cosyl composition of LPSb15 and LPSb4 is the same of 
LPSp15 (Fig. S1–S3). Then, the detection of an additional 
band in LPS molecules extracted from cells grown in bio-
film conditions suggests that the modification could be 
present in the lipid A moiety (Ciornei et al. 2010; Chala-
baev et al. 2014). Further characterization of LPS from P. 
haloplanktis TAC125 biofilm cells by NMR and mass spec-
trometry will help in the identification of the punctual dif-
ferences with respect to planktonic bacteria.
Conclusions
Cold-adapted marine bacteria represent an untapped res-
ervoir of biodiversity endowed with an interesting chemi-
cal repertoire. A preliminary characterization of molecules 
isolated from cold-adapted bacteria revealed that these 
compounds display antimicrobial, anti-fouling and various 
pharmaceutically relevant activities (Bowman et al. 2005). 
P. haloplanktis TAC125 is considered to be one of the 
model organisms of cold-adapted bacteria and it resulted 
to be a source of bioactive metabolites of biotechnologi-
cal relevance, such as anti-biofilm molecules (Papa et al. 
2013b, Parrilli et al. 2015). In particular P. haloplanktis 
TAC125 produces this activity only when it is grown in ses-
sile condition (Papa et al. 2013b), confirming that the study 
of biofilm lifestyle allows to analyze a different associated 
chemical diversity. The proposed strategy for a biofilm cul-
tivation of the Antarctic bacterium in automatic bioreactor 
makes also possible the isolation of bioactive compounds 
produced at very low amount. Beside this “drug discovery” 
aspect, this paper reports for the first time the possibility to 
recover Antarctic bacteria biomass grown in biofilm, pav-
ing the way to study the features of a cold-adapted biofilm.
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Staphylococcus epidermidis is a harmless human skin colonizer responsible for∼20% of
orthopedic device-related infections due to its capability to form biofilm. Nowadays there
is an interest in the development of anti-biofilm molecules. Marine bacteria represent a
still underexploited source of biodiversity able to synthesize a broad range of bioactive
compounds, including anti-biofilm molecules. Previous results have demonstrated that
the culture supernatant of Antarctic marine bacterium Pseudoalteromonas haloplanktis
TAC125 impairs the formation of S. epidermidis biofilm. Further, evidence supports the
hydrophobic nature of the active molecule, which has been suggested to act as a signal
molecule. In this paper we describe an efficient activity-guided purification protocol which
allowed us to purify this anti-biofilm molecule and structurally characterize it by NMR
and mass spectrometry analyses. Our results demonstrate that the anti-biofilm molecule
is pentadecanal, a long-chain fatty aldehyde, whose anti-S. epidermidis biofilm activity
has been assessed using both static and dynamic biofilm assays. The specificity of its
action on S. epidermidis biofilm has been demonstrated by testing chemical analogs
of pentadecanal differing either in the length of the aliphatic chain or in their functional
group properties. Further, indications of the mode of action of pentadecanal have been
collected by studying the bioluminescence of a Vibrio harveyi reporter strain for the
detection of autoinducer AI-2 like activities. The data collected suggest that pentadecanal
acts as an AI-2 signal. Moreover, the aldehyde metabolic role and synthesis in the
Antarctic source strain has been investigated. To the best of our knowledge, this is the first
report on the identification of an anti-biofilm molecule form from cold-adapted bacteria
and on the action of a long-chain fatty aldehyde acting as an anti-biofilmmolecule against
S. epidermidis.
Keywords: anti-biofilm, Staphylococcus epidermidis, long fatty acid aldehyde, quorum sensing,
Pseudoalteromonas haloplanktis TAC125
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INTRODUCTION
Staphylococcus epidermidis (S. epidermidis) is now being
recognized as an important opportunistic pathogen that can
cause significant problems when breaching the epithelial barrier,
especially during the biofilm-associated infection of indwelling
medical devices (Otto, 2008; Arciola et al., 2012). Most diseases
caused by S. epidermidis are of a chronic character and occur
as device-related infections (such as intravascular catheter or
prosthetic joint infections) and/or their complications (Dohar
et al., 2009; Artini et al., 2013). Implantations of medical devices
are steadily increasing and thus heightening the relevance of S.
epidermidis as a human pathogen. The ability of S. epidermidis
to adhere on both eukaryotic cells and abiotic surfaces and to
form biofilm is an essential virulence factor that contributes to
the chronicization of infections particularly difficult to eradicate.
Biofilms are sticky, surface-attached agglomerations of bacteria
that are embedded in an extracellular matrix and provide
protection for single cells from antibiotics and mechanisms of
host defense (Epstein et al., 2012).
S. epidermidis infections are estimated to reach 250,000 cases
per year in the USA with a mortality rate of up to 25%.
The interest in the development of innovative approaches for
the prevention and treatment of staphylococcal adhesion and
biofilm formation capabilities has therefore increased. A viable
approach should target the staphylococcal adhesive properties
without affecting the bacterial viability in order to avoid the rapid
appearance of escape mutants (Papa et al., 2015).
From another point of view, biofilm could be considered
as a source of novel drugs. Indeed, the specific environmental
conditions prevailing within biofilms may induce a profound
genetic and metabolic rewiring of biofilm-dwelling bacteria and
therefore may allow the production of metabolites different
from those obtained in the planktonic condition. Indeed, many
bacterial biofilms secrete molecules such as quorum sensing
signals (Ni et al., 2009), surfactants (Kiran et al., 2010), enzymes
(Kaplan, 2010), and polysaccharides (Valle et al., 2006; Qin et al.,
2009) that act by regulating the biofilm architecture or mediating
the release of cells from biofilms during the dispersal stage of the
biofilm life cycle (Kaplan, 2010). Furthermore, the production
of extracellular molecules that degrade adhesive components in
the biofilm matrix is a basic mechanism used in the biological
competition between phylogenetically different bacteria (Kaplan,
2010).
Starting from the idea that the production of an anti-biofilm
compound might result from the selective pressure exerted on
bacteria living in oligotrophic and extreme environments like
Antarctica, cold-adapted marine bacteria have been investigated
as a possible source of anti-biofilm molecules. Previous papers
(Klein et al., 2011; Papa et al., 2013b, 2015; Parrilli et al., 2015,
2016; Sun et al., 2015) have confirmed that cold adapted bacteria
represent an untapped reservoir of biodiversity able to synthesize
a broad range of potentially valuable bioactive compounds (Klein
et al., 2011), including anti-biofilm molecules (Papa et al., 2013b;
Parrilli et al., 2015, 2016).
In particular, the Antarctic bacterium Pseudoalteromonas
haloplanktis TAC125 (P. haloplanktis TAC125), when grown with
a sessile life-style, proved to be able to secrete an anti-biofilm
molecule capable of inhibiting S. epidermidis biofilm formation
(Papa et al., 2013b; Parrilli et al., 2015, 2016). This anti-biofilm
compound impairs biofilm development and disaggregates the
mature biofilm of S. epidermidis, even in dynamic conditions,
without affecting the bacterial viability, showing that its action
is specifically directed against biofilm (Papa et al., 2013b; Parrilli
et al., 2015, 2016).
In this research study the anti-biofilm molecule produced by
P. haloplanktis TAC125 has been purified and characterized. In
detail, a P. haloplanktis TAC125 biofilm cultivation in automatic
bioreactor (Parrilli et al., 2016) has been used to obtain a cell-
free supernatant in a sufficient amount to purify and characterize
the anti-biofilm molecule. A suitable purification protocol was
developed using an activity-guided fractionation strategy. The
structure of the purified molecule, obtained by NMR and mass
spectrometry, corresponded to pentadecanal, a long chain fatty
aldehyde. Several experiments were performed to assess the
chemical features responsible for its activity, by testing chemical
analogs differing in the length of the aliphatic chain and in their
functional group properties. Therefore, the anti-biofilm activity
of different long chain alcohols and aldehydes on S. epidermidis
biofilm was evaluated. As for the anti-biofilm mode of action,
the results reported demonstrated that the long-chain fatty
aldehyde works as an AI-2 signal, suggesting that it may interfere
with the S. epidermidis quorum sensing system. Moreover, in
this paper we have investigated the role of pentadecanal in
the metabolism of the source strain, in order to clarify if the
molecule regulates biofilm development also in the Antarctic
bacterium.
MATERIALS AND METHODS
Bacterial Strains and Culture Conditions
Bacterial strains used in this work were: S. epidermidis O-47
isolated from clinical septic arthritis and kindly provided by
Prof. Gotz (Heilmann et al., 1996); S. epidermidis RP62A
reference strain isolated from infected catheter (ATCC collection
no. 35984); P. haloplanktis TAC125 (Médigue et al., 2005)
collected in 1992 from seawater near French Antarctic Station
Dumont d’Urville. Bacteria were grown in Brain Heart Infusion
broth (BHI, Oxoid, UK) and in Tryptic Soy Broth (TSB,
Oxoid, UK). Biofilm formation was assessed in static condition
while planktonic cultures were performed under vigorous
agitation (180 rpm).
Vibrio harveyi BB170 (luxN::Tn5kan) (ATCC R©BAA-1117TM)
was grown as suggested by suppliers, cultivated in the
Autoinducer Bioassay (AB) Medium (Taga, 2005) and incubated
aerobically on a rotary shaker at 30◦C under vigorous
agitation (180 rpm).
All strains were maintained at −80◦C in cryovials with 15%
of glycerol.
Bioluminescence Assay
To screen the ability of the compounds to interfere with QS, the
test products were serially diluted in the ABmedium using sterile,
black, clear-bottom 96-well microtiter plates (Greiner Bio-one
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#655090) as assay platform. An overnight culture of V. harveyi
BB170 was diluted 1:100 in fresh AB medium and incubated
at 30◦C up to a visible increase in basal bioluminescence. 100
µl of the diluted culture were dispensed inside each well in
the microtiter plate starting from a cellular density of about
0.05 (OD)600nm; 100 µl of opportune dilutions of pentadecanal
in AB medium were added into each well. Luminescence and
(OD)600nm were monitored every 15 min over 18 h with a
high-performance multimode plate reader (GloMax R© Discover
System, Promega) in order to correlate the effects of the products
on both the growth and bioluminescence kinetics. Data are
reported as light units (LU).
Large Scale Biofilm Cultivation of
P. haloplanktis TAC125 in Automatic
Bioreactor for the Anti-Biofilm
Compound/s Production
P. haloplanktis TAC125 bacterial culture was grown in BHI
medium in a Stirred Tank Reactor 3 L fermenter (Applikon)
connected to an ADI-1030 Bio Controller (Applikon) with a
working volume of 1 L. The bioreactor was equipped with
the standard pH-, pO2-, level-, and temperature sensors for
the bioprocess monitoring. To allow the biofilm formation,
autoclaved solid polystyrene supports were added into the
bioreactor (33 supports in 1 L). The culture was carried out at
15◦C for 48 h, or at 4◦C for 96 h, in aerobic conditions using
airflow of 6 L/h, without stirring. After incubation, supports
were removed from the supernatant and the adherent cells were
recovered by sonication as previously described (Parrilli et al.,
2016). In parallel the supernatant was recovered and further
separated from cells by centrifugation at 13,000 rpm, sterilized by
filtration through membranes with a pore diameter of 0.22 µm
and stored at 4◦C until use.
P. haloplanktis TAC125 Growth in
Aerobiosis and Microaerobiosis
Batch cultivations were performed in a computer-controlled
bioreactor (Sixfors System, Infors) equipped with control units
for pH and temperature, an oxygen sensing electrode measuring
the solution oxygen pressure, and mechanical stirring (200
rpm) at 4◦C. Each fermentation unit, filled with medium and
sterilized by autoclaving, was equilibrated at process temperature.
In order to allow oxygenation of the medium, the stirring
speed was set up at the maximum value to be used during
the fermentation, and then sterile air supply was switched
on. The system was left to stabilize for at least 30 min to
guarantee the saturation of the medium with air. In these
conditions 100% of measured oxygen pressure was assigned.
The zero-point set calibration was performed by saturating the
medium with sterile nitrogen gas. Under aerobiosis conditions,
measured oxygen pressure was maintained always above 20% by
modifying stirring speed and aeration rate. In microaerobiosis
(measured oxygen pressure always below 5% saturation) air
supply was stopped after inoculum. For each strain, the growth
kinetics were followed in triplicate in at least two independent
experiments.
Molecular Methods and Reagents
Suppliers
Standard methods were employed for DNA manipulation
and isolation, amplification by PCR, and DNA sequencing.
Restriction enzymes, T4 DNA ligase, alkaline phosphatase, T4
polynucleotide kinase, Klenow fragment, Taq DNA polymerase
were supplied from Boehringer-Roche, Amersham-Pharmacia
Biotech, Promega, and New England Biolabs. DNA fragment
purification was carried out with the QUIAEX II kit from Qiagen
GmbH.
Vector pVSb0219 and P. haloplanktis
TAC125-b0219 Mutant Construction
PCR was employed to amplify a DNA fragment of PSHAb0219
gene. P. haloplanktis TAC125 genomic DNA was used as
PCR template and two primers were designed to amplify
a 275 bp-long region of the PHSAb0219 gene and to
introduce an EcoRI and a SphI site (Oligo b0219EcoRIfw
5′-CTATGAATTCAAGAAGATATTTACGAGC-3′ and Oligo
b0219SphIrv 5′-AATACCCGCATGCCGTTGGTGCC-3′). The
amplified DNA fragment was digested by EcoRI and SphI,
and inserted into the pVS plasmid (Giuliani et al., 2012)
corresponding site, thus obtaining the pVSb0219 vector.
The vector was mobilized by intergeneric conjugation into
P. haloplanktis TAC125 cells and insertion mutants were
screened on plates at 4◦C containing carbenicillin (30 µg/ml) as
selection agent.
RNA Preparation and RT-PCR
Total RNA was isolated from 500 µl aliquots of P. haloplanktis
TAC125 cells recovered from both planktonic growth and,
after sonication of supports, biofilm growth as reported in
literature (Rippa et al., 2012). RNA was reverse transcribed
using SuperScript II RNase H- reverse transcriptase (Invitrogen)
according to the manufacturer’s instructions. PHSAb0219 was
reverse transcribed starting from total RNA (∼5 µg) using as
primer-specific oligonucleotide designed on the 3′ region of
the gene (RT-PCR-Rev 5′-AATACCCGCATGCCGTTGGTGCC-
3′′). The reaction mix was denatured at 65◦C for 5 min
and reverse transcribed at 45◦C for 50 min. cDNA (275
bp), the cDNA was amplified using primers Oligo b0219
EcoRIfw 5′-CTATGAATTCAAGAAGATATTTACGAGC-3′ and
Oligo b0219 SphIrv 5′-AATACCCGCATGCCGTTGGTGCC-3′,
and Taq polymerase (Promega, Madison, WI, USA) according to
the manufacturer’s instructions. The reaction mix was amplified
(denaturation at 95◦C for 45 s; annealing at 58◦C for 45 s;
extension at 72◦C for 1 min, 35 cycles). For each reverse
transcriptase amplification, an additional PCR reaction on DNA-
free total RNAwas performed as control, in order to exclude false
positive signals (Figure S3).
Determination of Minimal Inhibitory
Concentration (MIC)
MIC was performed according to the guidelines of Clinical
Laboratory Standards Institute. Pentadecanal was added directly
from mother stock and solutions were prepared by two-fold
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serial dilutions. A total of 5 concentrations were used
within the 1.6–0.1µg/ml range. Experiments were performed
in quadruplicate. The MIC was determined as the lowest
concentration at which the observable bacterial growth was
inhibited. No inhibition of the bacterial growth was evidenced
at testedconcentrations.
BIOFILM FORMATION OF
STAPHYLOCOCCI
Static Biofilm Assay
The quantification of in vitro biofilm production was based on
the method described by Christensen with slight modifications
(Artini et al., 2013; Papa et al., 2013a). Briefly, the wells of a sterile
48-well flat-bottomed polystyrene plate were filled with 400 µl
of BHI or TSB medium. 1/100 Dilution of overnight bacterial
cultures was added into each well. The first row contained the
untreated bacteria, while each of the remaining rows contained
serial dilutions of the supernatant (SN) starting from 1:2. The
plates were incubated aerobically for 24 h at 37◦C.
The biofilm formation was measured using crystal violet
staining. After treatment, planktonic cells were gently removed;
each well was washed three times with PBS and patted dry with
a piece of paper towel in an inverted position. To quantify the
biofilm formation, each well was stained with 0.1% crystal violet
and incubated for 15 min at room temperature, rinsed twice
with double-distilled water, and thoroughly dried. The dye bound
to adherent cells was solubilized with 20% (v/v) glacial acetic
acid and 80% (v/v) ethanol. After 30 min of incubation at room
temperature, (OD) was measured at 590 nm to quantify the
total biomass of biofilm formed in each well. Each data point is
composed of three independent experiments, each performed at
least in 3-replicates.
Dynamic Biofilm Assay
To continuously monitor the biofilm development in dynamic
condition, we utilized a BioFlux 2,000 microfluidic system
(Fluxion Biosciences Inc., San Francisco, CA), which allows
the acquisition of microscopic images over time using the
experimental protocol previously set up (Iebba et al., 2014). Each
flow channel connects to an input well (inlet) and an output
well (outlet) on the plate. To grow the biofilm in the BioFlux
system, the channels were first primed. We have filled the outlet
with 100 µl of sterile distilled water and set the flow at a share
setting of 1 dyne/cm2 for 2min. Coating with 100 µl of 10 µg/ml
fibronectin was made for 2 min at 1 dyne/cm2. The fibronectin
binding was performed for 30 min without flow. After priming,
fibronectin was aspirated from the output wells and replaced with
100 µl of fresh overnight cultures diluted to an (OD)600 of 0.8.
The channels were seeded by pumping from the output wells
to the input wells at 2.0 dyne/cm2 for 4 sec. Bacterial adhesion
was performed for 30 min at 37◦C without flow. 2.0 mL of BHI
was added to the input well and pumped at 1 dyne/cm2 for 12
h. We used two inlet wells; in the first well we added only BHI.
In the second well we added pentadecanal at a concentration of
120 µg/ml. Bright-field images were taken at 40X magnification
at 1-min intervals for a total of 720 time points.
Anti-Biofilm Molecule Purification and
Identification
As reported in the previous paper (Parrilli et al., 2016),
P. haloplanktis TAC125 supernatant deriving from sessile growth
was dialyzed, and the permeated water (2 g) was then purified on
a gel-filtration column (Biorad, Biogel P-2) eluted with MilliQ
water. The active fractions were collected and fractionated
on a C18 reverse phase column (Sigma, 30 mL, 40 × 0.5 cm,
fraction volume 4mL), eluted with CH3CN:H2O ranging from
10 to 95% of CH3CN. The fraction resulted to be active (S) was
analyzed on a Agilent Technologies gas chromatograph 6850A
equipped with a mass selective detector 5973N and a Zebron
ZB-5 capillary column (Phenomenex, 30m × 0.25 mmi.d.,
flow rate 1 cm3/min, He as carrier gas), by using the following
temperature program: 150◦C for 3 min, from 150 to 300◦C at
15◦C/min, at 300◦C for 5min.
NMR Spectroscopy
NMR spectra were performed by using a Bruker Avance-DRX
600 MHz spectrometer equipped with a cryoprobe. 1H-1HDQF-
COSY, 1H-1HTOCSY, 1H-13CDEPT-HSQC, and 1H-13CHMBC
experiments were recorded at 298K in CDCl3. The mixing time
for TOCSY experiment was 100 ms.
Fatty Aldehydes Chemical Synthesis
C14-C16 aldheydes were purchased from TCI. All the
other tested compounds were synthesized starting from the
corresponding alcohols (Sigma). 1- heptadecanol (30 mg, 0.12
mmol) was charged into a 10 mL round-bottom flask equipped
with a magnetic stir bar. The solid was then dissolved in toluene
(2 mL) at 20◦C, and an aqueous solution of sodium bicarbonate
(0.2 g, 2.38 mmol in 2 mL of deionized water) was prepared
and charged into the toluene slurry. Solid iodine (2.0 eq., 60
mg, 0.24 mmol) was then charged to the alcohol followed by
solid TEMPO (0.1 eq., 1.87 mg, 12.0 µmol; Miller and Hoerrner,
2003). The reaction mixture was then left under stirring for 16 h
at 20◦C. The batch was cooled to 5◦C, diluted with ethyl acetate
(2 mL), and quenched at 5◦C by adding an aqueous solution of
sodium sulfite 10% (312mg sodium sulfite in 2 mL of deionized
water). The quenched reaction mixture was transferred into
a separatory funnel, rinsed with additional ethyl acetate (10
mL) and deionized water (10 mL), and the aqueous layer was
cut away. The organic layer was then washed with 10 mL of
saturated aqueous sodium bicarbonate, followed by 10 mL of
brine. The organic layer was then dried over sodium sulfate,
filtrated, and concentrated in vacuum to a volume of 4 mL. Then,
the solution was completely dried under a stream of argon, to
give the aldehyde with a 95% yield.
The same procedure was then utilized for the alcohols 1-
octadecanol, 1-nonadecanol, and 1-eicosanol for the obtainment
of the corresponding aldehydes.
Statistics and Reproducibility of Results
The data reported were statistically validated using the Student’s
t-test comparing the mean absorbance of treated and untreated
samples. The significance of differences between the mean
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absorbance values was calculated using a two-tailed Student’s
t-test. A p < 0.05 was considered significant.
Bacterial Viability and Biofilm Thickness
Determined by Confocal Laser Scanning
Microscopy
For confocal microscopy biofilms were formed on Nunc
TM
Lab-Tek R© 8-well Chamber Slides (n◦ 177445; Thermo
Scientific, Ottawa, ON, Canada). Briefly, overnight cultures
of S. epidermidis O-47 and RP62A grown in BHI were diluted
and inoculated into each well of the chamber slide to a cell
concentration of about 0.001 (OD)600nm. The bacterial cultures
were incubated at 37◦C for 20 h in presence of pentadecanal (100
µg/ml) in order to assess its anti-biofilm activity and its influence
on cell viability.
The biofilm cell viability was determined with the
FilmTracerTM LIVE/DEAD R© Biofilm Viability Kit (Molecular
Probes, Invitrogen, Carlsbad, California) following the
manufacturer’s instructions. After rinsing with filter-sterilized
PBS, each well of the chamber slide were filled with 300 µl of
working solution of fluorescent stains, containing the SYTO R©
9 green fluorescent nucleic acid stain (10 µM) and Propidium
iodide, the red-fluorescent nucleic acid stain (60 µM), and
incubated for 20–30 min at room temperature, protected from
light. All excess stain was removed by rinsing gently with
filter-sterilized PBS.
All microscopic observations and image acquisitions were
performed with a confocal laser scanning microscope (CLSM;
LSM700-Zeiss, Germany) equipped with an Ar laser (488 nm),
and a He-Ne laser (555 nm). Images were obtained using a
20X/0.8 objective. The excitation/emission maxima for these
dyes are ∼480/500 nm for SYTO R© 9 stain and 490/635 nm
for propidium iodide. Z-stacks were obtained by driving the
microscope to a point just out of focus on both the top and
bottom of the biofilms. Images were recorded as a series of.tif files
with a file-depth of 16 bits. For each condition, two independent
biofilm samples were used.
RESULTS
Anti-Biofilm Production and Purification
We have previously (Papa et al., 2013b; Parrilli et al., 2015)
demonstrated that the cell-free supernatant of the Antarctic
bacterium P. haloplanktis TAC125 inhibits S. epidermidis biofilm
formation and that the bacterium produces the active molecule
only when it is grown in a sessile condition (Papa et al., 2013b). To
obtain a sufficient amount of cell-free supernatant, we adopted
a recently described (Parrilli et al., 2016) biofilm cultivation
strategy for P. haloplanktis TAC125. This consists in a fluidized-
bed reactor fermentation in the presence of floating polystyrene
supports used to increase the biofilm formation (Parrilli et al.,
2016). In this work the Antarctic bacterium has been grown
in the presence of floating polystyrene supports in BHI in a 3
L tank reactor at 4◦C without stirring, using an airflow of 6 L
h−1 (see materials and Methods Section). The obtained cell-free
supernatant was recovered after 96 h and separated from the
floating polystyrene supports and the cells by a centrifugation
at 13,000 rpm. Subsequently the supernatant was sterilized by
filtration through membranes with a pore diameter of 0.22 µm,
and then underwent dialysis treatment using a semipermeable
membrane with a cut-off of 3.5 KDa. The permeate product
after lyophilization was fractionated on a Biogel P-2 column and
the anti-biofilm activity of each fraction was evaluated (data not
shown). The fraction endowed with anti-biofilm activity on S.
epidermidis O-47 was further purified on a C18 reverse phase
column eluted with acetonitrile/water. Several fractions (A–S)
were collected, and the anti-biofilm activity of each fraction
was tested as reported in Figure 1A. Fraction S, eluted with
95% acetonitrile, showed the highest inhibitory activity on S.
epidermidis biofilm. The analysis of the 1H NMR spectrum of
this fraction revealed a signal at δ 9.77 ppm, which immediately
suggested the presence of an aldehyde (MOLBASE.COM CAS.
No. 2765-11-9). This was believed to be aliphatic, due to the
presence of intense signals in the range between δ 0.1–2.5 ppm
(data not shown). To confirm this hypothesis, and to check
the purity of the sample, a GC-MS analysis was performed
(Figure 1B). The chromatogram clearly indicated two different
compounds, named A and B, the EI mass spectra of which are
reported (Figures 1C,D). Both spectra showed signals at m/z 43,
57, 71, and 85, that are typical of a straight chain hydrocarbon
backbone, thus confirming the aliphatic character of the two
molecules. As this type of fragmentation can be attributed to a
broad range of compounds, a research in the NIST library was
required. The results indicated with a high score a 2-tridecanone
and a pentadecanal for A and B, respectively. As the inactive
fraction Qmainly contains the ketone whereas fraction S shows a
higher content of the pentadecanal, we concluded that the activity
should be assigned to the aldehyde. To exclude the possibility
that the mass spectrum of B could belong to an aldehyde with
a short difference in the carbon chain length, we injected into
the gas chromatograph commercial C14-C16 aldehydes. The
retention time of compound B proved to correspond to that of
pentadecanal.
To confirm the data obtained from GC-MS, the S fraction
was analyzed by 2D-NMR spectroscopy. In particular,
two-dimensional 1H-1H DQF-COSY (double quantum-
filtered correlation spectroscopy), 1H-1H TOCSY (total
correlation spectroscopy), 1H-13C DEPT-HSQC (distortionless
enhancement by polarization transfer-heteronuclear single
quantum coherence), and 1H-13C HMBC (heteronuclear
multiple bond correlation) experiments were performed. The
proton at δ 9.79 ppm, that clearly indicated an aldehyde
functional group on the molecule, displayed a correlation with
a carbon at δ 203.1 ppm (Figure 2A; data not shown). In turn,
this carbon showed a long range scalar connectivity with protons
at δ 2.43 ppm (CH2,C2; Figure 2B). Starting from this proton
signal, the correlations revealed in the COSY and TOCSY spectra
allowed us to attribute all the CH2(C3-C14) that constitute the
aliphatic chain. The last signal, attributable to the CH2C14 (δH/C
1.36/22.9), showed a long-range cross-peak, with the methyl
group at δH/C 0.9/13.6 ppm (Figure 2C).
A confirmation of the correct assignment of the pentadecanal
structure was obtained by testing the commercial product on
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FIGURE 1 | Anti-biofilm assay and identification by GC-MS analysis. (A) The anti-biofilm activity of different fractions obtained from reverse phase C18 column.
The fraction S eluted with 95% acetonitrile showed the highest inhibition activity. (B) GC-MS chromatogram of the fraction S. (C) Mass spectrum of compound A, and
(D) compound B.
FIGURE 2 | Relevant sections of 1H-13C HSQC spectrum, recorded in CDCl3 at 298K at 600MHz. (A) The correlation at δ 9.79/203.1 ppm, clearly indicated
the aldehydic functional group of the molecule. (B) The carbon signal at δ 203.1 ppm is in turn correlated in the HMBC experiment (data not shown), with the protons
at δ 2.43 ppm (CH2 C2). (C) The attribution of the aliphatic chain (C3–C15).
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S. epidermidis biofilm, that was found to be active (Figure 3A).
Consequently, commercial pentadecanal was used for all further
experiments.
Anti-Biofilm Activity and Specificity of
Pentadecanal on S. epidermidis Biofilm
Once the structure of the anti-biofilm molecule had been
identified, the first step was to confirm the absence of any
antimicrobial activity of pentadecanal on the staphylococcal
reference strains by determining the minimum inhibitory
concentration. The data obtained indicated no bacteriostatic
and no bactericidal activity within the range of concentrations
explored (the highest concentration explored was 1,6 mg/ml).
Preliminary experiments were also carried out to assess the effects
of the molecule on the planktonic growth rate of S. epidermidis.
The results obtained showed that pentadecanal did not affect
the staphylococcal duplication rate. Bacterial growth curves were
superimposable both in the presence and absence of pentadecanal
(data not shown).
The pentadecanal activity on biofilm formation was assessed
on two different S. epidermidis strains (Figure 3A), according
to previously reported data that demonstrated the cell-free
FIGURE 3 | Pentadecanal anti-biofilm activity on S. epidermidis biofilm formation. (A) The effect of pentadecanal at different concentrations on biofilm
formation of S. epidermidis O-47 and S. epidermidis RP62A. The data are reported as percentages of residual biofilm. Each data point is composed of three
independent samples. (B) Biofilm formation of S. epidermidis O-47 in a BioFlux system in the presence of pentadecanal. Each image contains two channels: the
bottom channel is the pentadecanal-treated sample and the top channel is the control. Bright-field microscopic images were collected at 1-min intervals. The images
presented were taken from the complete set of 720 images taken at 40x magnification.
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supernatant activity of P. haloplanktisTAC125 against the
S. epidermidis O-47 and S. epidermidis RP62A biofilms (Papa
et al., 2013b). As expected, the pentadecanal inhibitory effect was
clearly dose-dependent with an efficacy higher than 50% already
at 60µg/ml (50.9% residual biofilm for S. epidermidis O-47 and
21.8% for S. epidermidis RP62A, respectively). All previously
described experiments were performed in BHI medium. The
pentadecanal anti-biofilm activity was also tested in TSBmedium
to verify its effectiveness in function of growth medium
composition. The results demonstrated that this latter did not
influence the anti-biofilm ability of pentadecanal (untreated
bacteria 0.761± 0.137; treated bacteria 0.152± 0.020).
The pentadecanal anti-biofilm efficacy was also tested in
dynamic conditions with the BioFlux system, a microfluidic
device that precisely controls the flow of growthmedium between
two interconnected wells of a microtiter plate. By positioning
the channel connecting the two wells over a window accessible
for viewing by microscopy, biofilm growth can be monitored
in a time-course assay in which images are collected at 1-min
intervals. In Figure 3B selected images of the BioFlux analysis
are reported, showing the biofilm development of S. epidermidis
O-47 at different times, in the absence or in the presence of
pentadecanal (top and bottom lanes of each panel, respectively).
The bacteria were seeded in both channels visible in each frame
and after 30 min the flow was applied. The images collected
showed an initial rapid growth of the bacteria, resulting in
a confluent “lawn” of cells that was followed by a period of
detachment. Pentadecanal clearly impaired the biofilm formation
confirming the results obtained in the static system.
The pentadecanal effect on S. epidermidis O-47 biofilm
was further investigated by confocal laser scanning microscopy
(Figures 4A–D). CLSM was used to analyse the biofilm structure
and viability, as shown in Figures 4B,D. In the presence
of pentadecanal, as expected, the biofilm thickness decreased
significantly with a notable alteration in the architecture. This
effect was evident both on S. epidermidis O-47 biofilm and on
S. epidermidis RP62A biofilm. Moreover, the viability of cells
encapsulated in the biofilm in the presence and in the absence
of pentadecanal was evaluated by live/dead staining. As shown
in Figure 4C, cells exposed to pentadecanal were alive (green
indicates viable cells while red indicates dead cells) confirming
that the long-chain fatty aldehyde had no bactericidal activity on
the S. epidermidis cells living in the biofilm.
In order to investigate the chemical features (the length of
the chain and the functional group nature) that are essential
for the anti-biofilm activity, the effect of similar aldehydes and
corresponding alcohols, characterized by different lengths of the
aliphatic chain in the range fromC-14 to C-20, were analyzed and
the results are summarized in Figure 5. The data are reported as
percentages of residual biofilm after the treatment in comparison
FIGURE 5 | Anti-biofilm activity of different aldehydes and alcohols on
S. epidermidis O-47. The anti-biofilm activity of different long-chain aldehydes
and alcohols on S. epidermidis O-47. The data are reported as percentages of
residual biofilm. Each data point is composed of four independent samples.
FIGURE 4 | CLSM of S. epidermidis O-47 and S. epidermidis RP62A biofilms in the presence and absence of pentadecanal. (A) CLSM of S. epidermidis
O-47 and S. epidermidis RP62A biofilms in BHI medium without pentadecanal and (C) with pentadecanal 100 µg/ml. The bacteria were grown in chamber slides for
20 h and then stained with LIVE/DEAD reagents. The green fluorescence (SYTO9) indicates viable cells PI and the red fluorescence (PI) indicates dead cells. (B)
Z-stack analysis of S. epidermidis O-47 and RP62A biofilms without pentadecanal. (D) Z-stack analysis of S. epidermidis O-47 and RP62A biofilms treated with 100
µg/ml pentadecanal.
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with the untreated biofilm of S. epidermidis O-47. Our results
clearly showed that, except for a partial reduction observed after
treatment with the alcohol at the C-14 chain, the anti-biofilm
activity was limited to pentadecanal.
Pentadecanal As an AI-2 Signaling
Molecule in the LuxS/AI-2 QS System
To test whether the anti-biofilm activity displayed by
pentadecanal is correlated with a modulation/activation of
the AI-2 quorum sensing system, the effect of pentadecanal
was investigated on a V. harveyi BB170 strain (luxN::tn5Kan), a
mutant sensor strain that responds only to AI-2 autoinducers.
TheV. harveyiBB170 bioluminescence wasmonitored (Figure 6)
after adding two different concentrations of pentadecanal. At
a low concentration (12.5 µg/ml) the pentadecanal was
able to increase the V. harveyi bioluminescence (Figure 6),
indicating that the V. harveyi LuxS/AI-2 QS system responds
to pentadecanal. At a higher concentration (200 µg/ml)
pentadecanal reduced the bioluminescence (Figure 6). In
this condition, pentadecanal probably inhibits the V. harveyi
luciferase. Since the V. harveyi luciferase physiological substrate
is tetradecanal (Ulitzur and Hastings, 1979), the bioluminescence
inV. harveyiBB170 was alsomonitored after adding two different
concentrations of tetradecanal (Figure S1). As expected, a higher
concentration (200µg/ml) of tetradecanal reduced theV. harveyi
bioluminescence due to the luciferase substrate inhibition, at
low concentrations tetradecanal had no effect on the V. harveyi
bioluminescence (Figure S1).
The Role of Pentadecanal in the
P. haloplanktisTAC125 Physiology
To assess the role of pentadecanal in the P. haloplanktisTAC125
physiology, we investigated the conditions necessary for
pentadecanal production and the possible synthetic pathway
involved.
The in silico analysis of the P. haloplanktisTAC125 genome
(EMBL under accession nos. CR954246 and CR954247).
did not allow us to identify the genes coding for enzymes
known to be able to synthesize fatty aldehydes, like fatty acid
reductase (EC 1.2.1.50 (Gahan, 2012) or fatty acid peroxidase
(EC1.11.1.3, Martin and Stumpf, 1959). However, the analysis
allowed the identification of a gene (PSHAb0219) coding for an
aldehyde dehydrogenase B (EC1.2.1.3), an enzyme annotated
as a reversible aldehyde oxidoreductase NAD(P)+-dependent
with a wide specificity (http://www.genoscope.cns.fr/agc/
microscope/mage/viewer.php). The aldehyde oxidoreductase,
in specific conditions, could be able to produce pentadecanal
by reducing the corresponding fatty acid. To assess if this was
a correct hypothesis, we first investigated the presence of the
pentadecanoic acid in P. haloplanktis TAC125 cells. A GC-MS
analysis of fatty acid methyl esters from P. haloplanktis TAC 125
cells, grown either in sessile or in planktonic conditions, revealed
the presence of pentadecanoic acid (Figure S2).
Once the presence of the possible substrate had been
verified, both in sessile and in planktonic conditions, a RT
PCR analysis of the PSHAb0219 gene was performed to
assess if the gene transcription is growth condition-dependent.
P. haloplanktis TAC125 cells were cultured in planktonic or
in sessile conditions and total RNA was extracted from the
two different samples. The PSHAb0219 gene amplification was
obtained with specific oligonucleotide pairs (see Material and
Methods Section). The results of the RT-PCR experiments
(Figure S3) showed that a PSHAb0219 gene transcription
was clearly detected in the RNA samples extracted from
P. haloplanktis TAC125 cells grown in both conditions. Several
experiments were then attempted to delete the PSHAb0219 gene
by using genetic tools for the creation of insertion/deletion
FIGURE 6 | V. harveyi LuxS/AI-2 QS system responds to the presence of pentadecanal. Bioluminescence (solid lines) and growth curves (dotted lines) of the
V. harveyi BB170 strain incubated for 20 h in the presence of only the AB medium (green lines), 12.5 µg/mL pentadecanal (black lines) and 200 µg/mL pentadecanal
concentrations (red lines).
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mutants already available (Parrilli et al., 2010). However, these
experiments were not successful probably due to the fact
that PSHAb0219, in tested conditions, is likely to be an
essential gene.
Since the pentadecanoic acid was produced in both sessile and
planktonic conditions and the PSHAb0219 gene was transcribed
in both settings, a possible explanation of the presence of
pentadecanal only in the supernatant of the sessile form could
be that the aldehyde oxidoreductase catalyses the reduction of
the acid to aldehyde only in the biofilm condition. In particular,
in oxygen limitation, a condition occurring in biofilm (Wessel
et al., 2014), bacterial cells could reduce the fatty acids in
order to obtain the oxidized cofactor (NAD(P)+) necessary
for cell metabolism. To verify this hypothesis P. haloplanktis
TAC125 cells were grown, in an automatic bioreactor, at 4◦C
in microaerobiosis under agitation, a condition where the
measured oxygen pressure is kept constantly below 5% saturation
(measured oxygen pressure <5%)(see Materials and Methods
Section). The anti-biofilm activity of the cell-free supernatant
of P. haloplanktis TAC125 grown in microaerobiosis (SN-M)
was tested on S. epidermidis biofilm. The SN-M proved to
be able to inhibit the S. epidermidis O-47 biofilm formation
(Figure 7), thus indicating that the pentadecanal production
occurs also in microaerobiosis. This experiment demonstrates
that oxygen availability is a crucial parameter for pentadecanal
synthesis and proves to be the main difference between sessile
and planktonic conditions, so determining the anti-biofilm
production.
Although pentadecanal could be not defined as a strictly
biofilm-specific metabolite, its effect on P. haloplanktis
TAC125 biofilm formation and development was tested.
The aldehyde presence proved to have no effect (Figure
S4) on the Antarctic bacterium biofilm development.
Moreover, pentadecanal proved to be inactive against
the mature biofilm of P. haloplanktis TAC125 (data
not shown).
FIGURE 7 | The cell-free supernatant of P. haloplanktis TAC125 grown
in microaerobiosis has an anti-biofilm activity S. epidermidis O-47 biofilm
formation after incubation with P. haloplanktis TAC125 cell-free supernatants
obtained from sessile (SN-S) and planktonic growths (SN-P) and from
microaerobiosis growth (SN-M). The data are reported as percentages of
residual biofilm. Each data point represents the mean ± SD of at least three
independent samples.
DISCUSSION
The emergence of Staphylococcus epidermidis as an opportunistic
pathogen is closely related to the biofilm forming capability of
this bacterial species, especially during the biofilm-associated
infection of indwelling medical devices. The increasing use
of implanted medical devices heightens the importance of S.
epidermidis as a human pathogen. Our research has been aimed
at discovering anti-biofilm molecules from natural sources, such
as marine microbiota, since we are convinced that this approach
will lead to the discovery of novel and unforeseen compounds.
Cold-adapted marine bacteria represent a still underexploited
source of biodiversity able to synthesize a broad range of bioactive
compounds, including anti-biofilm molecules. Previous results
(Papa et al., 2013b; Parrilli et al., 2015) have demonstrated
that the culture supernatant of Antarctic marine bacterium
P. haloplanktis TAC125 impairs the formation of S. epidermidis
biofilm.
In this paper we applied a P. haloplanktis TAC125 biofilm
cultivation strategy in automatic bioreactor (Parrilli et al., 2016)
and an efficient activity-guided purification protocol to produce
and purify the anti-biofilm molecule. The structure of the anti-
biofilm molecule, obtained by NMR and mass spectrometry,
corresponds to pentadecanal, a long-chain fatty aldehyde.
The pentadecanal activity on biofilm formation was confirmed
on two different S. epidermidis strains in static condition and,
by the BioFlux system, also in dynamic conditions. BioFlux
can reproduce environmental or physiological conditions by
precisely controlling shear flow, bridging the gap between in
vitro and in vivo assays. In Bioflux conditions bacteria progress
through a series of developmental steps, ultimately forming a
multicellular structure containing differentiated cell populations.
The observation of the growing biofilm at various time-points
throughout this process provides a glimpse of the temporal
changes that occur. Flow biofilm is more closely related to
natural biofilms and can differ from static biofilms in terms of
the hydrodynamic influences on cell signaling. The finding that
pentadecanal is active also in dynamic conditions demonstrates
that this molecule shows great promise in terms of its use in vivo
systems.
It is interesting to note that most of the known anti-biofilm
molecules also display an antibacterial activity (bactericidal or
bacteriostatic). In contrast, pentadecanal lacks any antibacterial
activity against free-living bacteria and against bacteria entrapped
in biofilm matrix. Indeed as demonstrated by CLSM analysis the
presence of pentadecanal reduces the biofilm thickness without
affecting the viability of S. epidermidis cells living in the biofilm.
Therefore, pentadecanal targets the adhesive properties without
affecting the bacterial viability, a type of behavior which should
prevent the development of escape mutants. This property makes
pentadecanal particularly interesting and suggests its possible use
in combination with conventional antibiotic therapy.
The specificity of pentadecanal action on S. epidermidis
biofilm has been demonstrated by testing chemical analogs
differing either in the length of the aliphatic chain or in their
functional group properties. The results reported demonstrate
that both the length of the aliphatic chain and the functional
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group properties are essential for the pentadecanal activity
against S. epidermidis biofilm.
With regard to the anti-biofilm mode of action, several
observations prompted us to explore the idea that the action
of pentadecanal on S. epidermidis biofilm could be related to
its possible interference in the quorum sensing system. The
most important and best-characterized quorum-sensing system
in staphylococci is the accessory gene regulator (agr) system.
Remarkably, the P. haloplanktis TAC125 anti-biofilm molecule is
active on the clinical isolate O-47, which is a naturally occurring
agr mutant (Vuong et al., 2003); therefore a possible effect
mediated by quorum sensing should be directed at the LuxS/AI-
2 quorum sensing system (Xu et al., 2006; Li et al., 2008), the
second quorum sensing system present in S. epidermidis. The role
of the LuxS/AI-2 QS system in S. epidermidis biofilm regulation
is under debate. Xu and co-authors have suggested that the
autoinducer 2 (AI-2) negatively regulates the expression of the ica
gene [ica operon encodes enzymes responsible for the production
of polysaccharide intercellular adhesion PIA (Otto, 2008)] at
the transcriptional level, reducing the PIA synthesis and biofilm
formation (Xu et al., 2006). In contrast, a recent paper of Xue
et al. (2015) has reported that AI-2 increased biofilm formation
in S. epidermidis RP62A by enhancing the transcription of the
ica operon. Moreover, in a paper (Li et al., 2008) concerning
AI-2 dependent gene regulation in S. epidermidis, it has been
demonstrated that AI-2 controls also the levels of phenol-
soluble modulins (PSMs), key molecules able to lead to biofilm
detachment of S. epidermidis biofilm in vivo e in vitro (Otto,
2013). In any case, the crucial role of the LuxS/AI-2 QS system
in S. epidermidis biofilm formation is evident, while its role in
Staphylococcus aureus biofilm formation is less clear; indeed,
several studies suggest that the LuxS/AI-2 quorum sensing
system has no role in S. aureus biofilm formation (Doherty et al.,
2006; Cluzel et al., 2010). The differences in the involvement of
AI-2 molecules in biofilm formation between S. aureus and S.
epidermidis could explain why the P. haloplanktis TAC125 anti-
biofilm compound is effective against the S. epidermidis biofilm
but is not able to inhibit the S. aureus biofilm (Papa et al.,
2013b). To test whether the anti-biofilm activity displayed by
pentadecanal is correlated with a modulation/activation of the
AI-2 quorum sensing system, the effect of pentadecanal was
investigated on a V. harveyi mutant sensor strain that responds
only to the AI-2 autoinducers.
The results reported demonstrate that at low concentration
the pentadecanal is able to increase the V. harveyi
bioluminescence, indicating that the V. harveyi LuxS/AI-2
QS system responds to pentadecanal, at a higher concentration
it reduces the bioluminescence. In this condition, pentadecanal
probably inhibits the V. harveyi luciferase. The key reaction
in bacterial bioluminescence is the oxidation of the luciferase-
catalyzed FMNH2 and the long chain aliphatic aldehyde (Byers
et al., 1988), and, consequently, the bacterial luciferase, that can
utilize fatty aldehydes of varying chain lengths, is inhibited by
the high levels of aldehydes (Francisco et al., 1993). Therefore,
it is reasonable to assume that also pentadecanal could be
an inhibitor of the V. harveyi luciferase. Since the V. harveyi
luciferase physiological substrate is tetradecanal (Ulitzur and
Hastings, 1979), the bioluminescence in V. harveyi mutant was
also monitored in presence of tetradecanal, and, as expected, a
higher concentration reduced the V. harveyi bioluminescence
due to the luciferase substrate inhibition. It is interesting to note
that at low concentrations tetradecanal had no effect on the
V. harveyi bioluminescence.
The results reported demonstrate that theV. harveyi LuxS/AI-
2 QS system responds to pentadecanal. These data suggest
that the pentadecanal anti-biofilm activity in S. epidermidis
could be due to an interference in the AI-2 quorum sensing
system. Although several studies will be necessary to clarify the
molecular details of the pentadecanal action on S. epidermidis
biofilm formation, this is the first report on the action of
a long-chain fatty aldehyde as an anti-biofilm molecule that
works as a signaling molecule in an AI-2 QS system. Further
investigations will be necessary to clarify if this modulation
occurs also in the S. epidermidis AI-2 quorum sensing
system.
Besides the characterization of pentadecanal anti-biofilm
activity on S. epidermidis biofilm, we have investigated the
metabolic role and synthesis of this long fatty compound in
the Antarctic source strain. In a previous work we examined
the anti-biofilm activity of cell-free supernatants obtained from
the P. haloplanktis TAC125 grown in sessile or in planktonic
conditions on different staphylococci (Papa et al., 2013b). Our
results demonstrated that only when P. haloplanktisTAC125
is grown in sessile condition the cell-free supernatant inhibit
the biofilm formation of S. epidermidis. This latter result was
explained by considering that biofilm specific environmental
conditions may induce a profound genetic and metabolic
rewiring allowing the production of biofilm-specific metabolites
(Beloin and Ghigo, 2005). To evaluate if pentadecanal can
be considered a biofilm-specific metabolite, we investigated
the conditions necessary for pentadecanal production and
the possible synthetic pathway involved. The results reported
strongly suggest that a P. haloplanktisTAC125 reversible
aldehyde oxidoreductase NAD(P)+-dependent catalyses, in
oxygen limitation, the reduction of the pentadecaonic acid to
aldehyde to obtain the oxidized cofactor (NAD(P)+) necessary
for cell metabolism. Therefore, the pentadecanal production
occurs in the biofilm condition and in microaerobiosis due to the
reduced oxygen availability that characterizes these two growth
conditions. The oxygen availability results a crucial parameter
for pentadecanal synthesis and proves to be the main difference
between sessile and planktonic conditions, so determining the
anti-biofilm production. Moreover, the results described in this
paper indicate that the long-chain fatty aldehyde is not involved
in the control/modulation of the Antarctic bacterium biofilm
development.
In conclusion, this is the first report both on the action of a
long chain fatty aldehyde as an anti-biofilm molecule and on an
aldehyde working as a signaling molecule in the AI-2 QS system.
We believe that this paper endorses the potential of cold-adapted
marine bacteria as a source of bioactive compounds of interest,
and contributes to the development of innovative approaches for
the prevention and treatment of S. epidermidis biofilm-associated
infections.
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1.2. Pentadecanal inspired anti-biofilm molecules: from the synthesis 
towards the clinical applications 
 
A large-scale production and an optimization of the purification protocol have been 
decisive for the identification of the P. haloplanktis TAC125 anti-biofilm molecule, the 
pentadecanal. It was demonstrated that pentadecanal interferes with the S. 
epidermidis quorum sensing system and reduces the biofilm formation without 
affecting bacterial viability4. This capability of preventing the biofilm formation could 
be exploited for the development of new materials, or surface coatings, which avoid 
the adhesion of viable bacteria. However, as the pentadecanal is an aldehyde, and 
thus a chemically reactive agent, it could easily undergo oxidation reactions, 
therefore it could be not suitable for all the possible anti-biofilm strategies. One of the 
aims of this work was the design of some pentadecanal derivatives, in order to enrich 
the arsenal of weapons to fight the biofilms, and, with these molecules, the 
development of a valid anti-biofilm strategy. 
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ABSTRACT
Staphylococcus epidermidis, a harmless human skin colonizer, is a significant nosocomial
pathogen in predisposed hosts because of its capability to form a biofilm on indwelling medical
devices. In a recent paper, the purification and identification of the pentadecanal produced by
the Antarctic bacterium Pseudoalteromonas haloplanktis TAC125, able to impair S. epidermidis bio-
film formation, were reported. Here the authors report on the chemical synthesis of pentadecanal
derivatives, their anti-biofilm activity on S. epidermidis, and their action in combination with
antibiotics. The results clearly indicate that the pentadecanal derivatives were able to prevent, to
a different extent, biofilm formation and that pentadecanoic acid positively modulated the
antimicrobial activity of the vancomycin. The cytotoxicity of these new anti-biofilm molecules was
tested on two different immortalized eukaryotic cell lines in view of their potential applications.
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Introduction
Although Staphylococcus epidermidis is a harmless
human skin colonizer, it has emerged as an important
opportunistic pathogen in infections associated
with medical devices (such as urinary and intra-
vascular catheters, orthopaedic implants), causing
approximately 30–43% of joint prosthesis infections
(Valour et al. 2013) and fracture fixation infections
(Morgenstern et al. 2016). The capability of S. epider-
midis to adhere on both eukaryotic cells and abiotic
surfaces and to form biofilm is an essential virulence
factor (Otto 2012) that contributes to the chroniciza-
tion of infections caused by this bacterium as particu-
larly difficult to eradicate. S. epidermidis can migrate
from the skin along the surface of the device into the
body, forming a highly organized bacterial community
known as biofilm. A biofilm is a microbially derived
sessile community, characterized by cells attached
either to a substratum, or to an interface, or to each
other, embedded in a self-produced matrix of extra-
cellular polymeric substance, which exhibit an altered
phenotype with regard to growth, gene expression and
protein production (Donlan and Costerton 2002).
In a biofilm, cells are embedded and protected
from external assaults and in this condition bacteria
have been found to be more resistant to conventional
antibiotic treatments, thus resulting in recalcitrant
biofilm-associated infections (Koo et al. 2017).
Biofilm resistance to antimicrobials is a complex phe-
nomenon, not only correlated merely with the genetic
resistance that arises from mutations, although the
increased microbial cell density may help the transfer
of resistance genes. Indeed, other mechanisms are
involved, such as: (1) the low penetration of the
antimicrobial agent due to the barrier function
performed by the biofilm matrix; (2) the presence of
persister cells exhibiting a high multidrug tolerance;
and (3) a reduced susceptibility to antibiotics as
a consequence of stress adaptive responses or changes
in the chemical biofilm microenvironment (Satpathy
et al. 2016). Accordingly, the strategies adopted to
treat these challenging infections are rapidly changing,
according to the increasing understanding of the
structure and functions of the biofilm. Nonetheless,
the prevention of biofilm formation and the treatment
of existing biofilms is currently a difficult challenge
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and therefore the discovery of new multi-targeted or
combinatorial therapies is increasingly urgent (Koo
et al. 2017).
In recent years, several authors working in this
field have focused their studies on the search for
anti-biofilm molecules in extreme environments, such
as Antarctica, since it has been reported that cold-
adapted bacteria represent an unexploited source of
chemical biodiversity, able to produce a wide range of
high added-value compounds (Papaleo et al. 2013;
Sun et al. 2015; De Santi et al. 2016, Sannino et al.
2017; Sannino et al. 2018), including anti-biofilm
molecules (Papa et al. 2015).
In a recent paper, it was demonstrated that
Antarctic bacterium Pseudoalteromonas haloplanktis
TAC125 produces a long-chain fatty aldehyde, the
pentadecanal (Casillo et al. 2017), endowed with a
strong anti-biofilm activity against S. epidermidis
(Papa et al. 2013, Parrilli et al. 2015). The pentadeca-
nal interferes with the quorum sensing system of S.
epidermidis and reduces biofilm formation without
affecting bacterial viability (Casillo et al. 2017). It is
interesting to note that the pentadecanal is also found
in the essential oils of different plant species (Gao
et al. 2017). This mechanism of action should prevent
the development of escape mutants, making the
pentadecanal a good candidate for combined therapies
with conventional antibiotics. Moreover, the pentade-
canal’s capability of preventing biofilm formation
could be exploited for the development of new
materials, or surface coatings, which avoid the adhe-
sion of viable bacteria. In the literature, the incorpor-
ation of an antibiotic or biocide within a ’reservoir’
coating is being studied as a possible approach
to inhibit bacterial adhesion and biofilm formation
(Busscher et al. 2012). An ideal anti-biofilm molecule
must be endowed with several characteristics
described by Batoni et al. (2016); amongst the other
things it should interfere with the bacterial cell com-
munication machinery, penetrate the extracellular
matrix and/or interfere with its production, and
synergize with other conventional and unconventional
antimicrobial compounds. Moreover, an anti-biofilm
molecule, to have a concrete therapeutic application,
should be active following its incorporation within
a ’reservoir’ coating and, in any case, the coating
should not alter the biocompatibility of devices or
delivery systems. However, as the pentadecanal is an
aldehyde (a chemically reactive agent), it could easily
undergo oxidation reactions, therefore it may not be
suitable for all possible anti-biofilm strategies. One of
the aims of this work was the design of some
pentadecanal derivatives to enrich the arsenal of
weapons to fight biofilm development. With the pur-
pose of obtaining new anti-biofilm molecules
endowed with different physico-chemical properties,
the dimethyl acetal of the pentadecanal, the pentade-
canoic acid, and its methyl ester, were synthesized.
The capability of the pentadecanal derivatives to
prevent biofilm formation by S. epidermidis and their
possible use in combination with antibiotics was
investigated. Finally, to explore the possible clinical
applications, their biocompatibility on eukaryotic cells
was analysed on two different immortalized cell lines.
Materials and methods
Bacterial strains and culture conditions
The bacterial strains used in this work were: S. epider-
midis RP62A, a reference strain isolated from an
infected catheter (ATCC collection no. 35984); and S.
epidermidis O-47, a strong biofilm producer (Figure
S1 in Supplemental material) agr-mutant, isolated
from clinical septic arthritis and kindly provided by
Prof. Gotz (Heilmann et al. 1996). Bacteria were
grown in brain heart infusion broth (BHI, Oxoid,
Q1UK). Biofilm formation was assessed in static condi-
tions at 37 C, whereas planktonic cultures were per-
formed under vigorous agitation (180 rpm) at 37 C.
All strains were maintained at –80 C in cryovials
with 15% glycerol.
Derivatives design and synthesis and purification
To generate new anti-biofilm molecules endowed with
physico-chemical properties different from those of
pentadecanal, pentadecanoic acid (carboxylic acid),
pentadecanoic acid methyl ester (ester), and 1,1-dime-
thoxypentadecane (acetal) were synthesized. The
choice of these derivatives was mainly suggested by
the well-known reactivity of an aldehyde, which is
able to be oxidized by oxygen in the air, even in the
presence of a catalytic amount of Fe3þ (Carey and
Sundberg 2000; Farquhar 1961; Jiang et al. 2018).
Pentadecanoic acid was purchased from Sigma
( Q4Sigma-Aldrich, Inc., # 2018 Merck KGaA,
Darmstadt, Germany).
The acetal was obtained by treating the pentadeca-
nal (50mg) by reaction with 6ml of 1.25M HCl/
CH3OH at 80 C for 16 h. After overnight reaction,
the reaction was quenched with anionic exchange
resin (HCO3
– form), and the product recovered with
a yield of 98%.
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To obtain the methyl ester, 50mg of pentadecanoic
acid were treated with 5ml of 1.25M HCl/CH3OH
at 80 C for 16 h. The methanol layer was extracted
three times with hexane to recover the methyl ester
with a yield of 99%. The mixture was then treated
with Dowex 1X8 resin (Sigma, HCO3
– form) and
dried under argon flow. As for the methyl ester, the
recovery of the acetal was 98%.
All the synthesized compounds were characterized
by 1H-NMR spectroscopy and gas chromatography-
mass spectrometry (GC-MS). Furthermore, the purity
of the synthesized derivatives was confirmed by
GC-MS analysis (Figure S2). All the compounds were
analysed on an Agilent 7820A GC System-5977B
MSD spectrometer equipped with the automatic
injector 7693Aand a Zebron ZB-5 capillary column
(Phenomenex, Toornace, CA, USA; flow rate
1ml min–1; He as carrier gas), using the following
temperature program: 150 C for 3min, 150 C!
300 C at 15 C/min, 300 C for 5min. As for the 1H
NMR experiments, each sample was dissolved in
0.55ml of dimethyl sulfoxide-d6 (DMSO-d6), and the
spectra were recorded at 298K using a Bruker Avance
600MHz spectrometer equipped with a cryoprobe
(Bruker Italia, Milano, Italy).
Biofilm formation by staphylococci
Static biofilm assay
The quantification of in vitro biofilm production was
based on the method described by Christensen with
slight modifications (Papa et al. 2013).
Briefly, the wells of a sterile 96-well flat-bottomed
polystyrene plate (tissue culture treated by vacuum
gas plasma, FalconQ3 ) were filled with S. epidermidis
RP62A or S. epidermidis O-47 cultures in exponential
growth phase diluted in BHI with a final concentra-
tion of about 0.1 and 0.001 OD600nm respectively. The
derivatives were added at different concentrations and
the final volume was 200 ml.
The first row contained the untreated bacterial
cells, while each of the remaining rows contained dif-
ferent concentrations (from 12.5 lg ml1 to 100 lg
ml1) of the derivatives samples. Dried derivatives
were first re-solubilized in DMSO and a working
solution of each derivative to be tested was diluted in
BHI (0.8% DMSO final concentration at the maximal
concentration used). From this stock solution,
serial two-fold dilutions in BHI broth were carried
out in 96-well plates over the concentration range
100–12.5 lg ml1. A control using BHI broth with
0.8% DMSO was also included in each experiment.
The plates were incubated aerobically for 24 h at
37 C. After the incubation, planktonic cells were gen-
tly removed; each well was washed three times with
double-distilled water and patted dry with a piece of
paper towel in an inverted position. To quantify the
biofilm formation, each well was stained with 0.1%
(w v–1) crystal violet and incubated for 15min at
room temperature, rinsed twice with double-distilled
water, and thoroughly dried. The dye bound to
adherent cells was solubilized with 20% (v v–1) glacial
acetic acid and 80% (v v–1) ethanol. After incubation
at room temperature for 30min, the OD was
measured at 590 nm to quantify the total biomass
of biofilm formed in each well. Each data point is
composed of three independent experiments, each
performed in six replicates. The data reported were
statistically validated using the Student’s t-test com-
paring the mean absorbance of treated and untreated
samples. The significance of differences between the
mean absorbance values was calculated using a two-
tailed Student’s t-test. A p-value of <0.05 was consid-
ered significant.
CLSM analysis and COMSTAT
For confocal microscope analysis, biofilms were
formed on NuncTM Lab-TekVR 8-well Chamber Slides
(n 177445; Thermo Scientific, Ottawa, Canada).
Briefly, the wells of the chamber slide were filled with
S. epidermidis RP62A or S. epidermidis O-47 cultures
in exponential growth phase diluted in BHI at a final
concentration of 0.1 and 0.001 OD600nm respectively
and incubated in the presence of derivatives (100 lg
ml1 – 0.8% DMSO). The final volume was 300ml.
The bacterial cultures were incubated at 37 C for
20 h in the presence and absence of derivatives in
order to assess their anti-biofilm activity and their
influence on cell viability. The biofilm cell viability
was determined by the FilmTracerTM LIVE/DEADVR
Biofilm Viability Kit (Molecular Probes, Invitrogen,
Carlsbad, CA, USA) following the manufacturer’s
instructions. After rinsing with filter-sterilized PBS,
each well of the chamber slide was filled with 300 ll
of a working solution of fluorescent stains, containing
the SYTOVR 9 green fluorescent nucleic acid stain
(10 lM) and propidium iodide, and the red-fluores-
cent nucleic acid stain (60 lM), and incubated for
20–30min at room temperature, protected from light.
Excess stain was removed by gently rinsing with fil-
ter-sterilized PBS. All microscopic observations and
image acquisitions were performed with a confocal
laser scanning microscope (CLSM; LSM700-Zeiss, Q2
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Germany) equipped with an Ar laser (488 nm), and
a He-Ne laser (555 nm). Images were obtained using
a 20/0.8 objective. The excitation/emission maxima
for these dyes are 480/500 nm for SYTOVR 9 stain
and 490/635 nm for propidium iodide. Z-stacks were
obtained by driving the microscope to a point just
out of focus on both the top and bottom of the
biofilms. Images were recorded as a series of .tif files
with a file-depth of 16 bits. A COMSTAT software
package was used to determine biomasses (lm3
lm2), average thicknesses (lm) and roughness coef-
ficient (Ra). For each condition, two independent
biofilm samples were used.
MIC and MBC of vancomycin determination
The conventional MIC of vancomycin was deter-
mined for S. epidermidis RP62A in duplicate, by two-
fold serial dilution (CLSI 2017)Q8 . Briefly, an overnight
culture was diluted at 0.5 McFarland and 90 ll of this
dilution were added to each well of a 96-well micro-
titre dish. Ten ll vancomycin previously diluted to
the desired final concentration were added to the
wells. Ten ll water were added for the control lane.
The microtitre plate was incubated at 37 C for 24 h.
After the incubation the MIC was determined.
Furthermore, the minimal bactericidal concentration
(MBC) of vancomycin was determined as reported.
Using the replica plater for 96-well plate (Sigma
Aldrich) 3 ll of planktonic culture from each well
of the microtitre plate were transferred to the surface
of a BHI agar plate. Plates were incubated for 16 h at
37 C. The MBC was determined by identifying the
cut off for bacterial growth.
MBIC and MBEC of vancomycin determinations
The minimum biofilm inhibitory concentration
(MBIC) and the minimum biofilm eradication concen-
tration (MBEC) of vancomycin for S. epidermidis
RP62A were determined. Briefly, the wells of a sterile
96-well flat-bottomed polystyrene plate (Falcon) were
filled with 100ll of BHI with an appropriate dilution
of overnight cultures of S. epidermidis RP62A (0.1
OD600nm) and incubated overnight at 37 C without
shaking, to allow bacterial attachment. Non-adherent
cells were removed by gentle washing three times with
sterile PBS. The plates were left to air dry for 15min.
Serial twofold dilutions of vancomycin (initial concen-
tration 240lg ml1) in cation-adjusted Mueller–
Hinton broth (CAMHB) were added to the microplates
followed by incubation at 37 C for 24h. The MBIC
was defined as the minimal antimicrobial concentra-
tion at which there was no observable bacterial growth
in wells containing adherent microcolonies, ie the
minimal concentration that inhibited the release of
planktonic bacteria from the biofilm (Reiter et al. 2013).
After MBIC measurement, the content of each well
was spotted on an agar plate using a replica plater for
96-well plate (Sigma-Aldrich). The agar plate was
incubated for 24 h at 37 C. The MBEC was defined
as the minimal antimicrobial concentration at which
bacteria fail to regrow after antimicrobial exposure, ie
the minimal concentration required for eradicating
the biofilm (Reiter et al. 2013). All the determinations
were performed in duplicate.
Synergy testing by checkerboard assay
Synergism between the pentadecanoic acid or the
pentadecanal and vancomycin was assessed by the
so-called ‘checkerboard’ assay against S. epidermidis
RP62A. Twofold serial dilutions of pentadecanoic
acid or the pentadecanal and vancomycin were tested
in combination. To do this, the pentadecanoic acid
and the pentadecanal were tested at concentrations
ranging from 250 to 31.25lg ml1 and vancomycin
at concentrations ranging from 240 to 7.5 lg ml1,
respectively. All the determinations were performed
in duplicate.
MBIC and MBEC experiments were performed as
previously described.
Synergy testing by CLSM analysis
For synergy evaluation between the anti-biofilm mole-
cules and vancomycin by confocal microscopy, bio-
film formation was assessed as previously described.
Briefly, an overnight culture of S. epidermidis RP62A
grown in BHI was diluted and inoculated into each
well of an eight-well chamber slide at an appropriate
cell concentration, 0.1 OD600nm. The bacterial cul-
tures were incubated at 37 C for 2 h in presence of
120 lg ml1 of vancomycin, with or without the anti-
biofilm molecules, pentadecanal and pentadecanoic
acid (250 lg ml1), in order to assess whether the
anti-biofilm molecules were able to improve the anti-
microbial activity of vancomycin. The biofilm cell viabil-
ity was determined by the FilmTracerTM LIVE/DEADVR
Biofilm Viability Kit (Molecular Probes, Invitrogen) as
previously described (Casillo et al. 2017).
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Cytotoxicity assay
Immortalized human keratinocyte cells (HaCaT), and
mouse fibroblasts (BALB/c3T3) were from ATCC.
These cell lines are commonly used for biocompatibil-
ity and cytotoxicity assay, as reported by Wiegand
and Hipler (2009), and are particularly appropriate
cell lines for use in cytotoxicity and tolerance tests
concerning the skin because they represent dermal
fibroblasts and epidermal keratinocytes, both targets
of S. epidermidis. Cells were cultured in Dulbecco’s
modified Eagle’s medium (Sigma-Aldrich), supple-
mented with 10% foetal bovine serum (HyClone,
Logan, UT, USA), 2mM L-glutamine and antibiotics.
Cells were grown in a 5% CO2 humidified atmos-
phere at 37 C. To test the biocompatibility of the
molecules, cells were seeded in 96-well plates at a
density of 2.5 103 well1. Twenty-four hours after
seeding, cells were incubated with increasing amounts
of the molecule under test (from 10 to 100 lg ml1)
for 24, 48 and 72 h. At the end of incubation, cell via-
bility was assessed by the MTT assay as previously
described (Arciello et al. 2011). Cell survival was
expressed as a percentage of viable cells in the pres-
ence of the analysed molecule, with respect to the
control cells. Control cells were represented by cells
grown in the absence of the molecule and by cells
supplemented with identical volumes of DMSO. Two-
way ANOVA was performed as a statistical analysis.
Results
Anti-biofilm activity of derivatives
To evaluate the anti-biofilm activity of pentadecanal
derivatives, molecules were tested at different concen-
trations against the reference strain S. epidermidis
RP62A and against S. epidermidis O-47, a strong bio-
film producer agr-mutant (Heilmann et al. 1996). As
shown in Figure 1, all the molecules reduced biofilm
formation by the reference strain S. epidermidis
RP62A and, surprisingly, the carboxylic acid, at low
concentrations (25 lg ml1 and 12.5 lg ml1), was
more active than the pentadecanal. Besides the penta-
decanal, the most effective derivatives on S. epidermi-
dis O-47 biofilm was the ester and then the acetal.
It is interesting to note that the acid was not able
to induce a significant reduction in the S. epidermidis
O-47 biofilm, contrary to what found on S. epidermidis
RP62A. The anti-biofilm activity of pentadecanal
derivatives was further confirmed by CLSM. CLSM
analysis of S. epidermidis O-47 and RP62A biofilms
were performed after 24 h incubation in the presence
and absence of the derivatives, respectively. The
LIVE/DEAD staining was used to analyse the biofilm
structure and cell viability. As shown in Figure 2A,
cells exposed to derivatives were alive (green indicates
viable cells and red indicates dead cells), confirming
that the new molecules, exactly like the pentadecanal
(Casillo et al. 2017), had no bactericidal activity on
either of the S. epidermidis bacterial strains living in
the biofilm. To obtain more detailed information on
the biofilm structure, the collected three-dimensional
files were analysed using the COMSTAT image
analysis software package (Heydorn et al. 2000).
The results demonstrated that biofilms formed in the
presence of the derivatives were characterized by
a lower biomass (Figure 2B) and this effect was
clearly evident in both the S. epidermidis strains using
all the derivatives. It is interesting to note that the
carboxylic acid by CLSM and COMSTAT analysis
was active, contrary to what was demonstrated when
its anti-biofilm activity was evaluated by crystal violet
assay (Figure 1). As shown in Figure 2C and D, the
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Figure 1. The anti-biofilm activity of pentadecanal and its
derivatives on S. epidermidis biofilm formation. The anti-biofilm
effect was evaluated on biofilm formation of S. epidermidis
O-47 and S. epidermidis RP62A using different concentrations
of the tested molecules. The data are reported as percentages
of residual biofilm. Each data point represents the mean± the
SD of three independent samples; the mean values were com-
pared to the untreated control and considered significant
when p< 0.05 (p< 0.05, p< 0.01, p< 0.001) according
to the Student t-test. Change. Q6
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biofilms obtained in the presence of the derivatives
were quite similar in terms of thickness, but the rough-
ness coefficient indicated significant differences. In par-
ticular, an increase in the roughness coefficient was
observed. This dimensionless factor provides a measure
of how much the thickness of a biofilm varies, and it is
thus used as a direct indicator of biofilm heterogeneity.
The same reported trend was observed also for biofilm
obtained in presence of the pentadecanal (Figure S3).
The synergy of derivatives with vancomycin by
checkerboard assay
The pentadecanal or its synthetic derivatives were
tested in combination with an antibiotic on mature
biofilm in order to assess whether the anti-biofilm
activity could modulate the antibiotic activity by weak-
ening the S. epidermidis biofilm structure, making
it less compact and rougher, and thus allowing the
penetration of the antimicrobial agent. These experi-
ments were performed using vancomycin as antibiotic
and S. epidermidis RP62A as the target strain.
To exclude any interference between the anti-
biofilm molecules and the vancomycin, the MBC of
this antibiotic on S. epidermidis RP62A was calculated
in the presence and in the absence of anti-biofilm
compounds (up to 250lg ml1). The MBC value was
evaluated for the vancomycin on S. epidermidis RP62A
planktonic cells according to CLSI (2017) (Table 1)
and, in all the tested conditions, the vancomycin
efficacy was not affected by the presence of the
anti-biofilm molecules (data not shown). Measurement
of the MBIC and of the MBEC was used to evaluate
the vancomycin antimicrobial activity against the
mature biofilms (Reiter et al. 2013). The S. epidermidis
RP62A 24h mature biofilm was subjected to anti-
microbial exposure and, as expected, the MBEC and
MBIC values were extremely high when compared to
the MBC value. The MBIC and MBEC were equivalent
and significantly higher than the value obtained for the
MBC on planktonic growth (Table 1). The possible
synergistic effect of anti-biofilm molecules and vanco-
mycin was evaluated on 24h mature biofilm using the
pentadecanoic acid or the pentadecanal as only these
two molecules showed a slight, but significant effect on
mature S. epidermidis RP62A biofilm (data not shown).
The synergy was evaluated by using the checkboard
method, as described in the Materials and methods
section. The results are reported in Table 1. The
addition of pentadecanal did not prompt a reduction
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Figure 2. Analysis of the effect of pentadecanal derivatives on S. epidermidis O-47 and S. epidermidis RP62A biofilm structure.
(A) CLSM analysis of S. epidermidis O-47 and S. epidermidis RP62A biofilms were performed after 24 h incubation at 37 C in the
presence and in absence of the derivatives. Three-dimensional biofilm structures were obtained using the LIVE/DEADVR Biofilm
Viability Kit. COMSTAT quantitative analysis of (B) biomassQ7 , (C) average thickness and (D) roughness coefficient of S. epidermidis O-47
and S. epidermidis RP62A biofilms were performed for all the tested conditions.
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in the MBIC or MBEC values of vancomycin on
S. epidermidis RP62A. On the contraryQ5 , the pentadeca-
noic acid modulated the antimicrobial activity of
the vancomycin. In particular, the MBIC and MBEC
values, obtained after 24h incubation, were reduced
twofold in combination with 125lg ml1 and 250lg
ml1 of pentadecanoic acid, respectively.
In order to collect information on the mechanism
of action of the pentadecanoic acid in combination
with the vancomycin and to understand the reasons
for the inefficiency of pentadecanal, a CLSM analysis
of S. epidermidis RP62A mature biofilm treated with
vancomycin in the absence or in the presence of either
pentadecanal or pentadecanoic acid was performed.
In detail, 24h mature biofilm of S. epidermidis RP62A
was incubated for 2h in the presence of 120lg ml1 of
vancomycin and in the presence or absence of 250lg
ml1 of the pentadecanal or the pentadecanoic acid.
As shown in Figure 3, the vancomycin led to a
slight reduction in the biofilm biomass, but it was
not able to kill the cells embedded in the biofilm
matrix. Whereas, when the vancomycin was com-
bined with either the pentadecanal or the carboxylic
acid, it was able to penetrate the biofilm structure,
showing a substantial bactericidal activity even
against the deepest cells in the biofilm structure
(Figure 3, red signal).
Effect of pentadecanal derivatives on eukaryotic
cell viability
The biocompatibility of the pentadecanal and its
derivatives was investigated on keratinocytes and
fibroblasts. These two cell lines were chosen as they
represent the skin, in which keratinocytes are the
outer part of the skin and cover the fibroblasts layer
and are a target for S. epidermidis infections.
As shown in Figure 4, after 24 h incubation, in
the case of keratinocytes, all the analysed molecules
were fully biocompatible, as no toxicity was
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Table 1. Antimicrobial activities of vancomycin and vancomycin in the presence of pentadecanoic acid and pentadecanal against
S. epidermidis RP62A in planktonic and biofilm growth.
Vancomycin
Vancomycinþ
pentadecanoic
acid 250 mg ml–1
Vancomycinþ
pentadecanoic
acid 125 mg ml–1
Vancomycinþ
pentadecanal
250 mg ml–1
Vancomycinþ
pentadecanal
125 mg ml–1
MBC (mg ml–1) 7.5 7.5 7.5 7.5 7.5
MBIC (mg ml–1) 60 15 15 60 60
MBEC (mg ml–1) 60 15 15 60 60
Figure 3. Analysis of the synergistic effect of derivatives with vancomycin on S. epidermidis RP62A biofilm structure. CLSM analysis
of S. epidermidis RP62A biofilms was performed on mature biofilms after 2h incubation at 37 C in the presence and absence
of derivatives and vancomycin. Three-dimensional biofilm structures were obtained using the LIVE/DEADVR Biofilm Viability Kit.
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observed, except for the pentadecanal, which was
biocompatible up to 50 mg ml1. After 48–72 h the
ester and acetal were safe for HaCaT cells up to
50 mg ml1, whereas a toxicity was observed for
the acid (after 72 h incubation). The pentadecanal
was fully biocompatible when used at concentra-
tions up to 50 mg ml1. These results were similar
also in the case of BALB/c-3T3 cells.
Altogether, these data clearly indicate that the
ester derivative is fully biocompatible, followed
by acetal.
Discussion
Recently, the identification of the pentadecanal as
a new anti-biofilm molecule against S. epidermidis
was reported (Casillo et al. 2017). This molecule,
produced by the Antarctic bacterium P. haloplanktis
TAC125, is a very promising anti-biofilm molecule.
Nonetheless, the pentadecanal is a chemically
reactive agent which could easily undergo reactions
of oxidation, polymerization, and/or hydration, and
therefore it could be not chemically compatible with
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Figure 4. Effect of pentadecanal and its derivatives on immortalized cell lines. Dose-response plot of cells after 24, 48 and 72 h
incubation with increasing concentrations (10–100mg ml1) of molecules. Cell viability was assessed by the MTT assay
and expressed as described in the Materials and methods section. Values are given as means± SD (n 3); a indicates p< 0.05,
b indicates p< 0.01, c indicates p< 0.005, d indicates p< 0.001, with respect to control cells.
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all anti-biofilm strategies. Therefore, the aim of this
work was to produce and characterize novel pentadeca-
nal derivatives to be used in anti-biofilm applications.
In a previous paper, the specificity of the pentade-
canal action on S. epidermidis biofilm was explored
by testing chemical analogues differing either in the
length of the aliphatic chain or in their functional
group properties (Casillo et al. 2017). In particular,
similar aldehydes and corresponding alcohols, charac-
terized by different lengths of the aliphatic chain (C-
14/C-20), were analysed, and the results demonstrated
that both the length of the aliphatic chain and the
functional group properties were important for the
pentadecanal activity against S. epidermidis biofilm
(Casillo et al. 2017). Since the hexadecanal and the
tetradecanal did not show anti-biofilm activity
(Casillo et al. 2017), whereas the pentadecanol showed
a slight but significant activity, the new anti-biofilm
molecules were designed preserving the length of the
aliphatic chain and modifying the functional group.
The pentadecanal derivatives synthesized were:
pentadecanoic acid, the pentadecanoic acid methyl
ester and 1,1-dimethoxypentadecane. In particular,
the acetal could offer the opportunity to generate the
aldehyde when treated with an electrophilic agent.
Therefore, the acetal could be a good choice in treat-
ing in vivo infections, especially those close to the
implant surface, where the bacterial metabolic activity
generates a local acidic pH (4–5) (Vroom et al. 1999;
Wang et al. 2014). The ester and the carboxylic acid
were selected since both are less reactive than alde-
hyde in oxidation and polymerization reactions.
All the synthesized molecules were tested for their
anti-biofilm activity and, unexpectedly, all of them
showed that they were able to prevent, to a different
extent, biofilm formation by S. epidermidis RP62A.
This result clearly demonstrates that the functional
group has a key role in the anti-biofilm activity, even
if they are not strictly related. Casillo et al. (2017)
demonstrated that the pentadecanal interfered in the
AI-2 quorum sensing system of S. epidermidis. It is
interesting to note that the AI-2 quorum sensing
molecular pathway in Gram-positive bacteria is not
completely clarified, and a putative receptor for AI-2
molecules has not yet been identified (Ma et al. 2017).
Thus, it is not clear how AI-2 signals are detected, or
which functions are regulated by them in many luxS-
containing bacteria. Moreover, in S. epidermidis, no
potential AI-2 receptors have been found. Therefore, it
is not possible to exclude the possibility that the penta-
decanal and its derivatives cross the bacterial cell wall
by diffusion since their physico-chemical properties are
compatible with this mechanism.
Moreover, the AI-2 mechanism of action in S. epider-
midis has not yet been thoroughly characterized, and
probably, this unexpected result will be clarified when
all the details of the AI-2 quorum sensing molecular
mechanism in S. epidermidis have been explained.
The efficacy of the pentadecanoic acid addition on
S. epidermidis RP62A and S. epidermidis O-47 biofilm
formation was different. Indeed, S. epidermidis O-47
biofilm formation was poorly affected by the carbox-
ylic acid addition, compared to the strong effect
shown on the reference strain.
S. epidermidis O-47 is a naturally occurring agr
mutant (Vuong et al. 2003). As previously reported
(Vuong et al. 2003; Kohler et al. 2014), the agr-nega-
tive genotype enhanced biofilm formation on polymer
surfaces by increasing expression of the surface pro-
tein AtlE, a bifunctional adhesin/autolysin abundant
in the cell wall of S. epidermidis. The amount of
AtlE present in the cell envelope is one of the
reported differences between the S. epidermidis
RP62A and S. epidermidis O-47 (Vuong et al. 2003).
It is possible to speculate that the overexpression of
AtlE renders the S. epidermidis O-47 cell envelope
less permeable, compared to RP62A, to a hypothetical
diffusion of charged molecules, such as the pentadeca-
noic acid, the only charged molecule tested here.
Moreover, AtlE induces significant changes in the
hydrophobicity of the bacterial surface (B€uttner et al.
2015); this effect could explain the inefficacy of the
pentadecanoic acid, that is less hydrophobic compared
to the pentadecanal. Nevertheless, the S. epidermidis
O-47 genome sequence is not available, and this
information will be instrumental in understanding the
observed difference.
Although the detailed molecular mechanism that
underpins the anti-biofilm activity of aldehyde deriva-
tives is far from being elucidated, their effect on the
S. epidermidis biofilm structure is quite evident, as the
biofilm formed in their presence is strongly reduced
and characterized by a porous structure containing
many channels and voids. These results suggested
exploring the use of the aldehyde and its derivatives
in combination with antibiotics to treat biofilm
infections. S. epidermidis RP62A is a strongly adher-
ent, slime-producing pathogenic strain isolated from
a patient with intravascular catheter-associated sepsis
and, for this reason, it represents the ideal candidate
for these experiments since it is a reference biofilm
positive/ica-positive strain and methicillin-resistant
(Qin et al. 2007). As for the antibiotic, the
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glycopeptide vancomycin was chosen since it is con-
sidered one of the most reliable therapeutic agents
against infections caused by multidrug-resistant staph-
ylococci (Qin et al. 2007). Moreover, it is the primary
antibiotic used to cure infections caused by coagulase-
negative staphylococci and is used to treat prosthetic
valve endocarditis caused by S. epidermidis (Nailor
and Sobel 2009). On the other hand, vancomycin dis-
plays a reduced penetration into the biofilm matrix
and a low microbicidal effect on S. epidermidis within
the biofilm (Zhang et al. 2015).
To investigate a possible synergy between the pen-
tadecanal or the pentadecanoic acid and vancomycin,
the MBEC and the MBIC in the presence of the anti-
biofilm molecules were evaluated, since these method-
ologies have been suggested as a laboratory assay to
evaluate antimicrobial activity against mature biofilm
(Reiter et al. 2013). The results demonstrated that the
pentadecanoic acid modulated the antimicrobial activ-
ity of vancomycin, with a twofold reduction in MBIC
and MBEC values at a concentration of anti-biofilm
molecules of 125lg ml1, whereas no effect was
detected using the aldehyde. As the MBIC and MBEC
assays were usually performed on mature biofilm
treated with the anti-biofilm and antibiotic for 24 h,
this condition could not be optimal for a chemically
reactive agent such as the pentadecanal. Therefore,
CLSM analyses of mature biofilm of S. epidermidis
RP62A treated with vancomycin and pentadecanal
were performed, selecting experimental conditions
which allowed the detection of a possible effect in
a short incubation time. The results obtained revealed
the capacity of the pentadecanal and the carboxylic acid
to weaken the S. epidermidis biofilm structure, making
it less compact and homogeneous, and thus allowing
the penetration of the vancomycin into the structure of
the biofilm, making cells deeply embedded into the
matrix easier to reach. This could be a great advantage
in the case of a possible therapeutic strategy providing
an antibiotic/anti-biofilm combination.
To explore the clinical potential of pentadecanal
and its derivatives, their biocompatibility was
investigated on fibroblasts and keratinocytes, eukaryotic
cell lines which represent the target of S. epidermidis
infections. The data clearly indicate that the pentadeca-
nal derivatives are biocompatible with all the cell lines
analysed at all the concentrations tested, while the
aldehyde is fully biocompatible when used at concen-
trations lower than 50mg ml1.
In conclusion, this work endorses pentadecanal
and its derivatives as useful molecules for the devel-
opment of innovative approaches mainly aimed at the
prevention of biofilm formation. Nevertheless, these
molecules could also be useful to fight established
infections in combination with an opportune anti-
biotic therapy, thus suggesting that the use of penta-
decanoic acid in combination with vancomycin could
improve the efficacy of therapy for the treatment of
S. epidermidis biofilm-associated infections.
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1.3. Physiological studies of Pseudoalteromonas haloplanktis TAC125 
biofilm for biotechnological applications 
 
The biofilm mode of growth of Pseudoalteromonas haloplanktis TAC125 resulted to 
be the crucial variable for the production of the pentadecanal, underlying the 
hypothesis that the specific environmental conditions prevailing within biofilms could 
induce profound genetic and metabolic rewiring of the biofilm-associated bacteria, 
which might allow the production of metabolites different from those obtained in 
planktonic condition. 
From this point of view, microbial biofilms could be considered as cell factories. In 
fact, many biofilm-secreted molecules, such as surfactants5, enzymes6, 
polysaccharides7, may be of biotechnological utility for, among others, the cosmetics, 
food, and pharmaceutical industries. 
These considerations strongly suggest the existence of differences in P. haloplanktis 
TAC125 cells physiology between the sessile and the planktonic lifestyle and pave 
the way to several open questions about the biofilm-specific pathway involved in the 
pentadecanal synthesis. Therefore, to better understand the mechanisms undergoing 
the anti-biofilm production, and, especially, to explore the potentiality of P. 
haloplanktis TAC125 in other biotechnological fields, the structural characterization of 
the biofilm of the Antarctic bacterium, produced in response to different nutrient 
abundance and temperatures, was investigated. 
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A B S T R A C T
Biofilms are the most widely distributed and successful microbial modes of life. The capacity of bacteria to
colonize surfaces provides stability in the growth environment, allows the capturing of nutrients and affords
protection from a range of environmental challenges and stress. Bacteria living in cold environments, like
Antarctica, can be found as biofilms, even though the mechanisms of how this lifestyle is related to their en-
vironmental adaptation have been poorly investigated. In this paper, the biofilm of Pseudoalteromonas halo-
planktis TAC125, one of the model organisms of cold-adapted bacteria, has been characterized in terms of biofilm
typology and matrix composition. The characterization was performed on biofilms produced by the bacterium in
response to different nutrient abundance and temperatures; in particular, this is the first report describing the
structure of a biofilm formed at 0 °C. The results reported demonstrate that PhTAC125 produces biofilms in
different amount and endowed with different physico-chemical properties, like hydrophobicity and roughness,
by modulating the relative amount of the different macromolecules present in the biofilm matrix. The capability
of PhTAC125 to adopt different biofilm structures in response to environment changes appears to be an inter-
esting adaptation strategy and gives the first hints about the biofilm formation in cold environments.
1. Introduction
Bacteria in nature are most often found associated with surfaces in
communities known as biofilms (Hall-Stoodley et al., 2004). Biofilm has
been defined as an aggregate of microorganisms in which the cells are
surrounded by a self-produced matrix constituted of extracellular
polymeric substances (EPS) and adhere to each other and/or to a sur-
face. The intermolecular interactions between the EPS molecules de-
termine the mechanical properties of the matrix, and the physiological
activity of the organisms in the biofilm (Flemming and Wingender,
2010). Although the precise chemical and physical composition of the
EPS varies according to the species and the growth conditions, the main
biofilm matrix building blocks are bacterial proteins, extracellular DNA
(eDNA) (Whitchurch et al., 2002), lipids and polysaccharides
(Flemming and Wingender, 2010). The eDNA is a critical component of
the biofilm matrix of several bacteria (Whitchurch et al., 2002; Seper
et al., 2011), and its amount in the biofilms varies greatly from strain to
strain. It has multiple functions in biofilm formation (Okshevsky et al.,
2015) and influences the three-dimensional biofilm architecture and
stability by acting as a cell-cell interaction polymer (Allesen-Holm
et al., 2006).
The importance of proteins in the biofilm structure and function is
increasingly being recognized. Matrix proteins include not only the
outer membrane proteins and the secreted proteins, but also particular
classes of proteins, such as the adhesins, or motility organelles, such as
curli or type IV pili proteins (Flemming and Wingender, 2010; Johnson
et al., 2014).
Extracellular polysaccharides are important structural components
of the biofilm matrix. Most of the exopolysaccharides of the matrix are
very long, with a molecular weight range of 500–2000 kDa; they can be
homopolymers, such as cellulose, curdlan, and dextran, or hetero-
polymers, such as alginate, emulsan, gellan, and xanthan (Yildiz et al.,
2014).
Biofilm architectures are highly variable, ranging from open struc-
tures, containing channels and columns of bacteria, to structures with
no obvious pores and densely packed regions of cells (Wimpenny et al.,
2000; Doghri et al., 2015). To date, most attention has been focused on
biofilms arising from the colonization of solid-liquid (S–L) interfaces
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(i.e. submerged biofilms), but several other kinds of interface, as the air-
liquid (A–L), also provide ecological opportunities for bacterial colo-
nization. The biofilms formed on the surface of static liquids are usually
referred to as pellicles or floating biofilms (Wimpenny et al., 2000).
Irrespective of the interface where the bacteria aggregate, the bio-
film formation consists of several stages and involves numerous con-
served and/or species-specific factors (Hall-Stoodley et al., 2004). In
any case, the biofilm formation can be described as a developmental
process with distinct stages: an ‘initial adhesion’, in which the micro-
organisms adhere to biotic or abiotic surfaces; an ‘early biofilm for-
mation’, during which the microorganisms begin to produce extra-
cellular polymeric substances (EPS); a ‘biofilm maturation’, involving
the development of three-dimensional structures where the EPS com-
ponent provides a multifunctional and protective scaffold; and finally a
‘dispersal’, whereby the cells leave the biofilm to reenter the planktonic
phase (Sauer et al., 2002). This is a dynamic and complex process and
requires a considerable energetic cost (Saville et al., 2011); however,
this cost may be evolutionarily acceptable due to the structural and
physico-chemical advantages deriving from the biofilm formation. First,
the capacity to colonize a surface provides a high level of stability in the
growth environment. Secondly, the matrix enables the biofilm to cap-
ture resources such as the nutrients that are present in the environment
or that are associated with the substratum on which the biofilm is
growing (Flemming and Wingender, 2010). Thirdly, the biofilm for-
mation affords protection from a wide range of environmental chal-
lenges (Flemming et al., 2016). Moreover, the spatial organization of
the cells in biofilms allows a high degree of biodiversity and complex,
dynamic and synergistic interactions, including cell-to-cell commu-
nication and enhanced horizontal gene transfer (Flemming et al., 2016).
Therefore, the ability to form biofilm is a selective advantage for bac-
teria.
Correspondingly, bacteria living in extreme environments, like
Antarctica, can be found as biofilms and this ability is believed to aid
their adaptation and survival in the environment (Liao et al., 2016).
The capability of cold-adapted bacteria to live and proliferate at low
temperatures is the result of a wide range of adaptive features
(Margesin and Feller, 2010; Carillo et al., 2015; Casillo et al., 2017) but
how and if the capability to form biofilm can be included into these
features is poorly investigated (Smith et al., 2016; Liao et al., 2016).
In this paper, our attention has been focused on the biofilm struc-
ture of Pseudoalteromonas haloplanktis TAC125 (PhTAC125) (Médigue
et al., 2005). Pseudoalteromonas strains played a significant role in
marine ecosystems and they have been frequently isolated from natural
biofilms or surfaces of eukaryote (Holmström and Kjelleberg, 1999).
They are also known to produce a wide array of compounds with
pharmaceutical and antifouling potential (Isnansetyo and Kamei, 2003;
Klein et al., 2011). Moreover, PhTAC125 is one of the model organisms
of cold-adaptation and is one of the most intensively investigated psy-
chrophilic bacteria. The increasing interest in PhTAC125 has led to the
accumulation of different data types for this bacterium in the last few
years, including its complete genome sequence (Médigue et al., 2005),
its proteome (Piette et al., 2011), its growth phenotypes description in
different conditions (Giuliani et al., 2011; Sannino et al., 2017; Wilmes
et al., 2010) and the construction of a genome-scale metabolic model
(Fondi et al., 2015).
The main aim of this paper was the characterization of PhTAC125
biofilm in different environmental conditions to asses if and how the
PhTAC125 biofilm structure is shaped by the environment. In detail, the
response to different temperatures (15 °C vs 0 °C) and nutrient abun-
dance (rich medium vs synthetic medium) has been analyzed. The
PhTAC125 biofilm has been characterized in terms of biofilm typology
and matrix composition by means of several classic experimental ap-
proaches, such as confocal laser scanning microscopy, and Raman
Microspectroscopy a technique recently used to provide molecular de-
tails of the chemical composition of bacterial biofilms (Carey et al.,
2017; Henry et al., 2017; Takahashi et al., 2017).
2. Materials and methods
2.1. Bacterial strains and culture conditions
Pseudoalteromonas haloplanktis TAC125 was isolated in 1992 from
an Antarctic coastal seawater sample collected near the French
Antarctic station Dumont d'Urville, Terre Adélie (66°40′ S; 140° 01′ E).
It was grown in Brain Heart Infusion broth (BHI, Oxoid, UK) and the
synthetic medium GG (10 g/L D-Gluconic acid sodium, 10 g/L glutamic
acid, SCHATZ salt mixture) (Sannino et al., 2017). The biofilm forma-
tion was assessed in the static condition in the BHI medium and GG
medium at 15 °C and 0 °C at different times (24 h, 48 h, 72 h, and 96 h).
2.2. Biofilm formation and assays
The quantification of the in vitro biofilm production was based on
the method described by Christensen with slight modifications
(Christensen et al., 1985). Briefly, the wells of a sterile 24-well flat-
bottomed polystyrene plate were filled with 1mL of a medium with a
suitable dilution of the Antarctic bacterial culture in the exponential
growth phase (about 0.1 OD 600 nm). The plates were incubated at
15 °C and 0 °C for different times (24 h, 48 h, 72 h, and 96 h). After
rinsing with PBS, the adherent cells were stained with 0.1% (w/v)
crystal violet, rinsed twice with double-distilled water, and thoroughly
dried. To analyze the typology of the biofilm formed at the different
tested conditions, the stained biofilms were photographed by a camera
from the top (the submerged biofilms) and from the front (the pellicles)
of the plates. Subsequently, the dye bound to the adherent cells was
solubilized with 20% (v/v) acetone and 80% (v/v) ethanol. After
10min of incubation at room temperature, the OD 590 nm was mea-
sured to quantify the total biomass of biofilm formed in each well; the
OD590 values reported was obtained by subtracting the OD590 value of
the control obtained in absence of bacteria. Each data point was com-
posed of six independent samples.
2.3. Biofilm recovery
Pellicles. The biofilm formation assay was performed in BHI
medium and GG medium at 15 °C, since in these conditions the biofilm
formation occurred at the air-liquid interface. Briefly, the wells of a
sterile 24-well flat-bottomed polystyrene plate were filled with 1mL of
a medium with a suitable dilution of a PhTAC125 culture in the ex-
ponential growth phase (about 0.1 OD600 nm). Plates were incubated
at 15 °C for 96 h to allow the formation of compact and resistant pel-
licles at the air-liquid interface. After incubation, the pellicles were
recovered using a pipette and stored at −20 °C. The samples were
freeze-dried for further analysis.
Submerged biofilm. The biofilm formation assay was performed in
the GG medium at 0 °C, since in this condition the biofilm formation
occurred at the solid-liquid interface. Briefly, sterile plastic Petri dishes
(90×15mm) were filled with 25mL of the GG medium with a suitable
dilution of a PhTAC125 culture in the exponential growth phase (about
0.1 OD 600 nm). The plates were incubated at 0 °C for 48 h to allow a
strong biofilm formation at the solid-liquid interface on the bottom of
the plates. After incubation, the supernatant and the cells were dis-
carded, and the plates were rinsed twice with filter-sterilized PBS. The
submerged biofilm was recovered by scraping with a sterile cell scraper,
centrifuged to remove the supernatant and stored at −20 °C. The
samples were freeze-dried for further analysis.
2.4. Microbial adhesion to hydrocarbons (MATH) assay
Solution chemistry and cleaning procedure. Analytical reagent
grade chemicals were used throughout and Milli-Q deionized (DI) water
was used to prepare all the solutions. The electrolyte solutions were
prepared with 200mM NaCl. All the experiments were performed at
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room temperature (20 ± 1 °C). The cleaning procedure for the glass-
ware was rinsed with acetone, washing with DI water, acid-washing
with 12M HCl and finally rinsing repeatedly with DI water.
Preparation of bacteria. The PhTAC125 biofilm formation was per-
formed in the BHI medium and GG medium at 15 °C. After 96 h in-
cubation, the biofilms (pellicles) were recovered, separated from the
supernatant by centrifugation and then resuspended in a 0.2 M NaCl
electrolyte solution. To remove traces of the growth medium, the bio-
films were centrifuged and resuspended in a fresh electrolyte solution
three times to obtain a final bacterial suspension suitable for use.
Hydrocarbons. Three different hydrocarbons were chosen: n-hex-
adecane (97–99%, Sigma), n-dodecane (≥99%, Sigma), and toluene
(99.8%, Sigma). The partition coefficients were: n-hexadecane, log
Kow=8.20; n-dodecane, log Kow=6.10; and toluene, log
Kow=2.73.
MATH assay. The cell surface hydrophobicity (CSH) of the biofilms
(pellicles), recovered in the BHI medium and GG medium as previously
described, was determined through the Microbial Adhesion to
Hydrocarbons (MATH) assay, as a measure of their hydrophobic ad-
herence, by following the method of (Rosenberg et al., 1980) with slight
modifications. The bacterial suspension was adjusted to an absorbance
(A0) of 0.6 at 600 nm. In a clean borosilicate round-bottom glass tube
(16× 150mm), 1mL of the test hydrocarbon was added to 4mL of the
bacterial suspension. The tube was vortexed for 2min and set aside to
rest for 30min to allow for the phase separation. Next, a sample of the
bacterial suspension was retrieved with a clean Pasteur pipette, with
great care taken to avoid allowing the hydrocarbon layer to enter the
pipette. The sample was then transferred to a cuvette for the final ab-
sorbance measurement (Af) at 600 nm. The adhesion of the bacteria to
the hydrocarbons was evaluated as the fraction partitioned in the hy-
drocarbon phase, FPC. This was calculated as (FPC=1 − Af /A0).
2.5. Motility assay
For the swarming motility assay, BHI and GG soft agar plates (0.3%
agar) were used. An appropriate volume of a saturated cell culture
(about 50 μL) of PhTAC125, grown in the BHI medium and GG medium,
was spotted on autoclaved circular pieces of Whatman Filter Paper with
an average diameter of approx. 1.5 cm. Once the cells had been ab-
sorbed, the filters were placed in the center of the BHI and GG soft-agar
plates and then the plates were incubated at 15 °C and at 0 °C, in par-
allel. To evaluate the ability of PhTAC125 to swarm into a semi-solid
medium, the cell spots were measured every 24 h in terms of distance
from the filter. In this work, the motility is expressed as the length of
the path per unit of time (mm/h).
2.6. Mannose effect on the biofilm formation
To test whether the presence of mannose affects the ability of
PhTAC125 to form a biofilm, a static biofilm formation assay was
performed in the GG medium for 24 h at 0 °C in the presence of man-
nose. In detail, 200 μL of the medium with a suitable dilution of a
PhTAC125 culture in the exponential growth phase (about 0.1 OD
600 nm) were added into each well of a sterile 96-well flat-bottomed
polystyrene plate in the absence and presence of 200mM D-mannose
(Merck KGaA) and 200mM D-galactose (VWR International) as a con-
trol. After the incubation, the biofilm quantification was performed by
means of the crystal violet method, as previously described.
2.7. Confocal laser scanning microscopy
For the confocal microscopy analysis, the biofilm formation was
performed on Nunc™ Lab-Tek® 8-well Chamber Slides (n° 177445;
Thermo Scientific, Ottawa, ON, Canada) in the BHI medium and GG
medium at 15 °C and 0 °C for 24 h. All the microscopic observations and
image acquisitions were performed with a confocal laser scanning
microscope (CLSM) (LSM700-Zeiss, Germany) equipped with an Ar
laser (488 nm), and a He-Ne laser (555 nm).
Bacterial Viability and Biofilm Thickness Determination. The bio-
film cell viability was determined by the FilmTracer™ LIVE/DEAD®
Biofilm Viability Kit (Molecular Probes, Invitrogen) following the
manufacturer’s instructions. Briefly, 300 μL of the medium with a sui-
table dilution of a PhTAC125 culture in the exponential growth phase
(about 0.1 OD 600 nm) were added to each well of a sterile Chamber
Slide. After 24 h incubation, the plates were rinsed with filter-sterilized
PBS. Then each well of the chamber slide was filled with 300 μL of a
working solution of fluorescent stains, containing the SYTO® 9 green
fluorescent nucleic acid stain (10 μM) and Propidium iodide, the red-
fluorescent nucleic acid stain (60 μM), and incubated for 20–30min. at
room temperature, protected from light. All the excess staining was
removed by rinsing gently with filter-sterilized PBS. The images were
obtained using a 20X/0.8 objective. The excitation/emission maxima
for these dyes are approximately 480/500 nm for the SYTO® 9 stain and
490/635 nm for propidium iodide. Z-stacks were obtained by driving
the microscope to a point just out of focus on both the top and bottom of
the biofilms. The images were recorded as a series of. tif files with a file-
depth of 16 bits. The COMSTAT software package(Heydorn et al., 2000)
was used to determine the biovolume (μm3/μm2), mean thickness (μm)
and roughness coefficient (Ra*). Biovolume was defined as the number
of biomass pixels in all images of a stack, multiplied by the voxel size
and divided by the substratum area of the image stack. Biovolume re-
presents the overall volume of the biofilm, and also provides an esti-
mate of the biomass in the biofilm. Average thickness of biofilm pro-
vided a measure of the space size of the biofilm and is the most common
variable in biofilm literature. Roughness coefficient is calculated from
the thickness distribution of the biofilm and provides a measure of how
much the thickness of the biofilm varies and is an indicator of biofilm
heterogeneity. For each condition, two independent biofilm samples
were used and at least two Z-stacks were performed.
2.8. Raman microspectroscopy
Raman is a technique appropriate for the investigation of biopo-
lymer compositions in media containing high concentrations, such as in
biopolymer crystals (Vergara et al., 2013, 2005) or cells. Indeed, bio-
film media and substrates have been investigated by Raman micro-
spectroscopy in order to describe the chemical composition of bacterial
biofilms (Henry et al., 2017; Carey et al., 2017). A confocal Raman
microscope (Jasco, NRS-3100) was used to obtain the Raman spectra.
The 514 nm line of an air-cooled Ar+ laser (Melles Griot, 35 LAP431
220) was injected into an integrated Olympus microscope and focused
to a spot diameter of approximately 1 μm by a 100x objective with a
final 6mW power at the sample. A holographic notch filter was used to
reject the excitation laser line. The Raman backscattering was collected
using a diffraction lattice of 1200 grooves/mm and 0.1mm slits. Typi-
cally, it took 60 s to collect a complete data set by means of a Peltier-
cooled 1024×128 pixel CCD photon detector (Andor DU401BVI). The
Raman measurements were at least triplicated for reasons of reprodu-
cibility for each spot sampled. The wavelength calibration was per-
formed by using cyclohexane as standard.
2.9. DOC-PAGE
PAGE was performed using the system of Laemmli (Laemmli, 1970)
with sodium deoxycholate (DOC) as the detergent. The separating gel
contained final concentrations of 14% acrylamide, 0.1% DOC, and
375mM Tris/HCl (pH 8.8); the stacking gel contained 4% acrylamide,
0.1% DOC, and 125mM Tris/HCl (pH 6.8). The biofilm samples were
prepared at a concentration of 0.05% in the sample buffer (2% DOC and
60mM Tris/HCl [pH 6.8], 25% glycerol, 14.4mM 2-mercaptoethanol,
and 0.1% bromophenol blue). All the concentrations are expressed as
the mass/vol percentage. The electrode buffer was composed of SDS
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(1 g/L), glycine (14.4 g/L), and Tris (3.0 g/L). The electrophoresis was
performed at a constant amperage of 30mA. The gels were fixed in an
aqueous solution of 40% ethanol and 5% acetic acid. The biofilm
sample bands were visualized by silver staining as previously described
(Tsai and Frasch, 1982).
2.10. Sugar analysis
The glycosyl analysis was performed as already reported (Carillo
et al., 2014). Briefly, biofilm samples (0.5 mg) were mixed with 1mL of
HCl/CH3OH, subjected to methanolysis for 16 h at 80 °C and then
acetylated. Fatty acids were extracted twice with hexane and the me-
thanol layer was dried and acetylated. Both the acetylated methyl
glycosides and methyl esters of the fatty acids were injected into the
GC–MS. All the sample derivatives were analyzed on an Agilent Tech-
nologies gas chromatograph 6850 A equipped with a mass selective
detector 5973 N and a Zebron ZB-5 capillary column (Phenomenex,
30 m×0.25mm i.d., flow rate 1mL/min, He as carrier gas). The
acetylated methyl glycosides were analyzed using the following tem-
perature program: 140 °C for 3min, and 140 °C → 240 °C at 3 °C/min.
The acetylated alditols were analyzed using the following temperature
program: 150 °C for 3min, and 150 °C → 330 °C at 3 °C/min.
2.11. Calcofluor binding assay
The cellulose production was detected by growing bacteria on GG or
BHI agar supplemented with 200 μg/ml Calcofluor (Sigma, Milan). The
plates were incubated at 0 °C or 15 C for 96 h. The colonies were vi-
sualized under a 366 nm light source.
2.12. Cellulase assay
20mg of each sample was incubated with 0.4 mL of acetic acid
0.05M, 0.1 mL of water, and 0.1mL of cellulase from Trichoderma reesei
ATCC 26921, at 37 °C for 2 h. The reaction was quenched by transfer-
ring the tube into an ice bath and centrifuged at 4 °C, 3000 rpm, 10min.
The supernatant was freeze-dried and analyzed as acetylated alditols, as
reported (Pieretti et al., 2010).
2.13. DNase I and proteinase K treatment on biofilm formation
To understand if DNase I and proteinase K are able to affect the
PhTAC125 biofilm formation process, a static biofilm assay was per-
formed in the presence of DNase I or proteinase K. The biofilm for-
mation was assessed in the BHI medium and GG medium at 15 °C and
0 °C for 24 h. In detail, 200 μL of the medium with a suitable dilution of
a PhTAC125 culture in the exponential growth phase (about 0.1 OD
600 nm) were added into each well of a sterile 96-well flat-bottomed
polystyrene plate in the absence and presence of DNase I or proteinase
K at 100 μL/mL. After incubation, biofilm quantification was performed
by means of the crystal violet method, as previously described
(Christensen et al., 1985).
3. Results
3.1. Characterization of PhTAC125 biofilm obtained in different culture
conditions
To investigate the capability of PhTAC125 to form biofilm at dif-
ferent growth temperatures, the bacterium was grown in BHI, a rich
culture medium, or in GG, a synthetic minimum medium, at 15 °C and
0 °C in static conditions, and the biofilm was evaluated at different
incubation times. As shown in Fig. 1, the Antarctic bacterium was able
to form biofilm in all the tested conditions and the amount of the
biofilm formed in the diverse conditions was different (statistically
significative shown Table S1); in the synthetic medium GG, the amount
of biofilm produced by the bacterium was higher than that produced in
the rich medium BHI both at 15 °C and at 0 °C (Fig. 1). Moreover, the
kinetics of the biofilm formation proved to be slightly different in the
analyzed conditions, considering that, at 15 °C in GG the amount of
biofilm increased over time while at 0 °C decreased (Fig. 1), suggesting
that the temperature strongly influences the kinetics of the biofilm
formation.
Furthermore, as shown in Fig. 1 the PhTAC125 biofilm accumulated
mainly at the air-liquid interface forming pellicles at 15 °C in both BHI
and GG media and at 0 °C only in BHI, while, interestingly, it formed
biofilm mainly at the solid-liquid interface at 0 °C in the GG medium.
3.2. MATH assay on pellicles obtained in different culture conditions
The macroscopic inspection of the pellicles deriving from A–L bio-
films obtained when PhTAC125 was grown in BHI or GG medium was
suggestive of changes in their respective structural features. In fact,
pellicles from the bacterial growth in BHI medium at 15 °C after 96 h
incubation proved to be stickier and slimier than those obtained in the
GG in the same conditions, which, in contrast, presented more compact.
Therefore, the microbial adhesion to hydrocarbons (MATH) assay was
performed to assess the hydrophobicity of the PhTAC125 pellicles by
examining their solubility in three different solvents: toluene, n-dode-
cane, and n-hexadecane. As shown in Fig. 2, the PhTAC125 pellicles
obtained in GG medium exhibited a significant degree of solubility in all
the hydrocarbon solvents examined. In contrast, the PhTAC125 pellicles
formed in BHI medium demonstrated negative partitioning fractions in
the tested solvents, indicating that the PhTAC125 GG-grown pellicles
exhibited a higher hydrophobicity with respect to the PhTAC125 BHI-
grown ones.
3.3. Motility assay in different culture conditions
The different motility of the PhTAC125 cells in the four studied
conditions was evaluated (Table 1) by means of an LB soft agar motility
assay (Liu et al., 2010) and was expressed as the length of the path
travelled on the BHI and GG soft-agar plates per unit of time. The re-
duction of the flagellar motility at low temperatures has previously
been reported (De Maayer et al., 2014), and indeed, as expected, at 0 °C
the bacterium displayed a lower ability to move in a semi-solid medium
than at 15 °C.
3.4. CLSM analysis of biofilm obtained in different culture conditions
The biofilms produced by PhTAC125 in the diverse conditions were
further investigated by confocal laser scanning microscopy (CLSM) to
analyze the biofilm structure and the biomass distribution by means of
three-dimensional biofilm images. Live/dead staining was used to vi-
sualize the PhTAC125 cells encapsulated in the biofilm matrix (Figs. 3a
and S1) (green indicates viable cells and red indicates damaged cells).
Although the four images were clearly different, it is difficult to obtain
detailed and accurate descriptions of the differences among the four
biofilms, based on visual inspection only. Therefore, all the CLSM image
stack data were further analyzed using the COMSTAT image analysis
software package (Heydorn et al., 2000) to evaluate the different
variables describing the biofilm structure. As expected, the values of the
biomass and the average thickness of the biofilm obtained in the rich
medium BHI were significantly lower if compared to those of the bio-
film produced by PhTAC125 in the GG medium at the same temperature
(Fig. 3b). The analysis revealed that in the GG medium the biofilm
proved to be more compact, both at 15 °C and at 0 °C, as indicated by a
lower roughness coefficient (Fig. 3b). This dimensionless factor pro-
vides a measure of how much the thickness of a biofilm varies, and it is
thus used as a direct indicator of biofilm heterogeneity, suggesting that
the medium composition has a key role in the definition of this char-
acteristic of the biofilm structure (Toyofuku et al., 2016; Bester et al.,
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2011; Shrout et al., 2006).
3.5. Raman microspectroscopy of PhTAC125 biofilms
High-quality Raman spectra were collected for biofilms grown at
0 °C in the GG and BHI media (spectra a and b in Fig. 4). Eventual
signals coming from growth medium and/or the polystyrene supports
were explored by recording the Raman spectra of the uninoculated
media and of polystyrene, from which the GG-grown biofilm at 0 °C was
scraped. As shown in Fig. 4, the GG medium presented several Raman
bands in the 800-1500 cm−1 region (spectrum c in Fig. 4) that can be
mainly assigned to carbohydrate-related vibrations. BHI medium was
instead not active at Raman analysis (spectrum d in Fig. 4). The ob-
served Raman bands recorded in the reference experiments were taken
into consideration and not mentioned during the following analysis of
microbial biofilms.
Both biofilms grown at 0 °C in the GG and BHI media showed
Raman bands assignable to proteins, nucleic acids, and carbohydrates
(Henry et al., 2017; Carey et al., 2017). The visual inspection of the
obtained Raman spectra indicated that they were significantly different.
Therefore, these spectral changes do indeed reflect the different che-
mical composition of the PhTAC125 biofilms. For the purpose of a
quantitative comparison, the spectra of the biofilms in Fig. 4 were
normalized with respect to the amide I band (∼ 1665 cm−1). There-
fore, the following comparison between the biofilms refers to the re-
lative content of nucleic acids or carbohydrates with respect to the
protein content (Henry et al., 2017).
The strongest evidence was the presence of Raman bands at
Fig. 1. Analysis of the effect of temperature and growth medium on the PhTAC125 biofilm formation at different times. PhTAC125 biofilm obtained at 15 °C or 0 °C in
the BHI medium or in the GG medium. The biofilms were analyzed at 24 h, 48 h, 72 h, and 96 h with the crystal violet assay. Each data point was composed of six
independent samples. (Top) Stained biofilms: the top view of wells allows a better vision of the submerged biofilms at the solid/liquid interface, (Lateral) whereas the
lateral view is more useful to see the biofilms at the air/liquid interface.
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674 cm−1 (the guanine–ring mode), 786 cm−1 (mostly the DNA phos-
phodiester backbone mode), and 815 cm−1 (mostly the RNA phos-
phodiester backbone mode) only in the sample grown in the GG
medium. These bands, which represent important nucleic acid finger-
prints (Carey et al., 2017), were, on the contrary, not detectable in the
biofilm obtained in the BHI. Other nucleic acid-related bands can be
compared between the two samples, consistently indicating a much
higher nucleic acid relative content in the GG-grown biofilms. Indeed,
the Raman bands at 1588 cm−1 (the adenine/guanine ring) and at
1178 cm−1 (the guanine-ring) presented a higher intensity in the latter
sample. Moreover, the band at 1488 cm−1 (the adenine/guanine ring),
after normalization to amide I (1665 cm−1), was∼5 times higher in the
GG- than in the BHI- grown biofilms.
The relative content of carbohydrates can be estimated by the ratio
I1130/I1007, related to the carbohydrate and Phe-ring bands, respec-
tively (Carey et al., 2017; Henry et al., 2017). Other carbohydrate-re-
lated Raman bands were located at 1366 and 1400 cm−1. All these
markers consistently indicated a slightly higher carbohydrate/protein
content in the biofilms grown in the GG medium compared to those
obtained in the BHI medium.
Concerning the analysis of biofilms grown at 15 °C, as a high
fluorescence was observed for biofilms grown in both media, a further
washing step was carried out to get rid of this interference.
Unfortunately, a Raman spectrum of modest quality was collected only
for the sample grown in the GG medium (data not shown). Despite its
modest quality, the Raman spectrum recorded allowed us to see at least
detectable nucleic acid-related Raman bands at 674 cm−1, 786 cm−1,
and 815 cm−1 with a relative nucleic acid/protein Raman intensity si-
milar to that observed for the biofilms grown at 0 °C, indicating that the
specific growth temperature did not influence the relative nucleic/
protein ratio.
3.6. Sugar analysis of PhTAC125 biofilms
In order to obtain information on the polysaccharides present in the
different PhTAC125 biofilm, samples were analyzed by 14% DOC-PAGE
and visualized by using the silver nitrate method (Tsai and Frasch,
1982) (Fig. S2). The silver nitrate showed the presence in all the sam-
ples of one band at low molecular masses, corresponding to LPS, the
Fig. 2. MATH assay of PhTAC125 A–L biofilms. The fraction of the biofilms
partitioned in the hydrocarbon phase measured by means of MATH assay. The
bacterial suspensions are contacted with toluene, n-dodecane, and n-hex-
adecane. The cells were suspended in 200mM NaCl for all the measurements.
Each data point represents the mean ± SD of four independent samples.
Table 1
Motility of PhTAC125 in different conditions. Analysis of the ability of
PhTAC125 to swarm into a semi-solid medium. The motility was expressed as
the length of the path travelled on the BHI and GG soft-agar plates per unit of
time (mm/h). The data are reported as the mean ± SD of three independent
experiments.
MOTILITY (mm/h)
0 °C 15 °C
BHI 0.092 ± 0.008 0.375 ± 0.02
GG 0.016 ± 0.002 0.104 ± 0.003
Fig. 3. CLSM analysis of PhTAC125 biofilms. Analysis of the effect of temperature and growth medium on the PhTAC125 biofilm structure. (a) CLSM analysis of
PhTAC125 biofilm grown in chamber slides at 15 °C and 0 °C in the BHI medium and GG medium for 24 h. The three-dimensional biofilm structures were obtained
using the LIVE/DEAD® Biofilm Viability Kit. (b) COMSTAT quantitative analysis of the biomass, average thickness and roughness coefficient of the PhTAC125
biofilms at all the tested conditions. (For interpretation of the references to colour in the text, the reader is referred to the web version of this article).
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structure of which had already been characterized (Michela Corsaro
et al., 2001). In addition, samples corresponding to GG-grown biofilm
and the BHI-grown biofilm, both developed at 0 °C, showed several
bands attributable to nucleic acids (Fig. S2 lanes a and b). Glycosyl
analysis performed on the PhTAC125 biofilms confirmed the presence
of sugars attributable to the lipopolysaccharide (Michela Corsaro et al.,
2001) like galactose, glucosamine, heptose, and traces of mannosamine;
indeed, in the biofilm a lot of biomass is constituted by cells. Moreover,
N-Acetyl-muramic acid (MurNAc, NAM), ribose and glucose were found
(Table 2). The presence of ribose confirmed the occurrence of nucleic
acids in the samples.
The presence of cellulose in PhTAC125 biofilm was preliminarily
investigated by staining cells, grown on GG or BHI agar plates, with the
Calcofluor (Fig. S3). Although it is routinely used for this purpose
(Zogaj et al., 2001), Calcofluor is not absolutely specific for cellulose (it
is known to bind also β[1–4] and β[1–3]-linked glucosyl polymers).
Therefore, to confirm the presence of cellulose, the samples of the
PhTAC125 biofilms were treated with a cellulase, an enzyme which has
the capability to specifically hydrolyze cellulose, leading to free glucose
formation. The released glucose was revealed as acetylated alditol,
demonstrating the presence of cellulose in all the tested samples (Fig.
S4).
3.7. DNase I and proteinase K effect on biofilm formation in different
environmental conditions
The role of proteins and eDNA in the ‘initial adhesion’ and ‘early
biofilm formation’ steps was studied to collect more information on
molecular mechanisms involved in PhTAC125 biofilm formation in the
four explored conditions. PhTAC125 was grown in the BHI and GG
media at 15 °C and 0 °C in static conditions, in the presence of either
DNase I or proteinase K, and a quantification of the formed biofilm was
performed by means of crystal violet staining (Fig. 5). The results ob-
tained revealed that the treatment with DNase I did not lead to any
reduction in the biofilm development but, interestingly, in the GG at
0 °C the nuclease addition led to an increase in the biofilm biomass. The
proteinase K treatment, on the other hand, strongly affected the Ant-
arctic bacterium biofilm formation in the BHI medium, whereas the
protease addition did not have a great impact on the biofilm formation
in the GG medium (Fig. 5).
4. Discussion
The ability of bacteria to form biofilms in many environments is
undoubtedly related to the selective advantage that the surface asso-
ciation offers. As previously reported the Antarctic bacterium
PhTAC125 is able to form biofilm at 4 °C in BHI and in GG broths and in
these conditions, the biofilm formation generally occurs at the air-li-
quid interface (Papa et al., 2013; Parrilli et al., 2015).
In this paper, the structural characterization of the biofilm of the
Antarctic bacterium PhTAC125, produced in response to different nu-
trient abundance and temperatures, was investigated. In particular, the
capability of PhTAC125 to form biofilm was investigated at 15 °C and
0 °C in BHI and GG media.
Fig. 4. Raman analysis of PhTAC125 biofilms.
Raman spectra (500–1800 cm-1) collected with
514 nm laser, 60 s exposure, and 1 μm spot
size: (a) GG-grown biofilm at 0 °C, (b) BHI-
grown biofilm at 0 °C, (c) GG medium, (d) BHI
medium, and (e) polystyrene substrate. The
spectra a and b are normalized with respect to
the amide I band (1665 cm−1).
Table 2
Biofilm sugar analysis profile. Monosaccharides percentage calculated for each
biofilm growth condition referred to the relative abundance of each component
compared to the total sugars.
Carbohydrate PhTAC125
S-L Biofilm
0 °C GG
PhTAC125
A-L Biofilm
0 °C BHI
PhTAC125
A-L Biofilm
15 °C BHI
PhTAC125
A-L Biofilm
15 °C GG
Ribose 37.6% 3.4% – 22.5%
Mannose – 1.1% 1.8% 1.2%
Galactose 13.1% 36.1% 36.2% 15.7%
Glucose 4.9% 5.3% 4.5% 7.4%
GlcN 18.1% 18.2% 19.3% 24.6%
Heptose 22.8% 35% 37.5% 22.7%
NAM 3.5% 0.9% 0.7% 5.9%
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The Antarctic bacterium resulted to be able to form biofilm and the
majority of cells unbudded in the matrix resulted vital (Fig. S1) in all
the tested conditions. This result is not surprising since its genomic and
metabolic features indicate that this bacterium is adapted to periodic
changes in temperature and nutrient availability (Médigue et al., 2005).
Data described demonstrating that the cold-adapted bacterium re-
sponds to different temperatures (15 °C vs 0 °C) and levels of nutrients
abundance (rich medium vs synthetic medium) producing different
amount of biofilm, indeed in the synthetic medium, the biofilm quantity
was higher than that produced in the rich medium. It’s important to
underline that in planktonic growth condition the biomass reached in
BHI is always higher than that obtained in GG medium (data not
shown). Likely, the presence of a lower availability of nutrients could
induce a greater production of biofilm since the biofilm matrix can
improve the capture of nutrients (Flemming et al., 2016; Shrout et al.,
2012; Tolker-Nielsen and Tolker-Nielsen, 2015), and therefore the
higher biofilm production could be a strategy to survive in poor nu-
trient conditions. It’s interesting to note that at 0 °C in the GG medium,
the bacterium produced biofilm to the same extent as in BHI at 15 °C,
indicating that also at low temperatures the energetic cost related to the
biofilm production is adequate to the advantages deriving from the
biofilm formation. The CLSM analysis on the biofilms produced by
PhTAC125 in GG and BHI revealed that the medium composition has a
key role also in the definition of the biofilm structure. Actually, the
investigation revealed that the biofilm obtained in the GG medium was
more compact than the biofilm developed in the rich medium.
It is useful to remark that the temperature and the media compo-
sition not only affect the amount and the compactness, but also the
typology, of the biofilm. Indeed, the PhTAC125 biofilm accumulates
mainly at the air-liquid interface at 15 °C in both BHI and GG media and
at 0 °C only in BHI, while, interestingly, it forms biofilm mainly at the
solid-liquid interface at 0 °C in the GG medium. Although a correlation
between the typology of a biofilm and the growth medium has recently
been published (Paytubi et al., 2017), to the best of our knowledge, this
is the first report of the effect of the temperature on the typology of
biofilm (i.e. in the spatial localization of biofilm). Indeed, the bacterium
in GG medium produced a liquid-air biofilm if grown al 15 °C, while in
the same medium it produced a biofilm on solid-liquid interface when
grown at 0 °C. Anyway, it is remarkable to note that PhTAC125 is able
to efficiently produce both submerged biofilms and pellicles and that
the PhTAC125 pellicles obtained in the two media resulted to be dif-
ferent. The pellicles obtained in the BHI was slimier and stickier than
those obtained in the GG which, in contrast, seemed to be more
compact and better structured. Moreover, the PhTAC125 GG pellicles
displayed a higher hydrophobicity compared to the PhTAC125 BHI
pellicles.
The A–L biofilm formation has been described for various bacteria
and proceeds through several stages (Armitano et al., 2013). In the
early stages, a thin layer of cells appears at the air-liquid interface
(Armitano et al., 2013) and, subsequently, the three-dimensional
structures develop as the pellicle grows and thickens (O’Toole et al.,
2000). The exact mechanisms underpinning the initial stages of the
pellicle formation (i.e. how the cells reach the interface) have not been
well-characterized. However, the cell motility seems to strongly influ-
ence the A–L biofilm formation, which requires upward swimming
capabilities (Kobayashi, 2007). In fact, it has been reported that many
bacteria show defects in pellicle formation when the genes involved in
the flagellum synthesis are mutated, and, in some species, the ability to
form a pellicle is completely abolished (Lemon et al., 2007; Serra et al.,
2013). Since several authors have reported that motility might facilitate
the bacteria localization near the A–L interface and thereby contribute
to the A–L biofilm formation, the different motility of the PhTAC125
cells in the four studied conditions was explored and the bacterium
resulted to be slower in the GG than in the BHI medium. This result
could explain why the bacterium was unable to form pellicles at 0 °C in
the GG medium, but it does not completely clarify why in this condition
PhTAC125 was able to form an S-L biofilm. Unpublished proteomic data
from our laboratory revealed that the major pilin MshA of type IVa
mannose-sensitive hemagglutinin pili is overexpressed when PhTAC125
is grown at 0 °C in a GG medium. Interestingly, type IVa mannose-
sensitive hemagglutinin pili are critical for the initial attachment to a
surface and for the S-L biofilm formation in several bacteria, such as
Vibrio cholerae (Watnick et al., 1999) and Pseudoalteromonas tunicata
(Dalisay et al., 2006). In particular, MshA pili are crucial for the “or-
biting” of near-surface motility trajectories (Utada et al., 2014) and it
has been demonstrated that when the mannose is added to the medium,
in order to saturate the MshA pili binding, the orbiting motility of V.
cholerae is ablated and the initial surface attachment is impaired (Utada
et al., 2014). To assess if the capability of PhTAC125 to form an S-L
biofilm in the GG medium at 0 °C was related to the type IV mannose-
sensitive hemagglutinin pili, the bacterium was grown in the GG
medium at 0 °C in the presence and absence of mannose and the biofilm
formation was evaluated (Fig. S5). The presence of mannose reduced
the formed biofilm suggesting that, as in V. cholera, also in PhTAC125 at
0 °C in the GG medium the surface attachment was mediated by type IV
pili and it occurred mainly in these conditions due to the type IV pili
overexpression and the reduced motility.
All the data obtained on the biofilm characterization have demon-
strated that the specific features like the typology, hydrophobicity,
biomass, thickness, and compactness, of PhTAC125 biofilms obtained in
different conditions, were deeply different. To assess if these differences
might be related to a possible different chemical composition of the
biofilm matrix components, the biofilm structures were further in-
vestigated by Raman microspectroscopy. This technique has been re-
cently proposed and applied to the chemical characterization of similar
biofilms (Carey et al., 2017; Henry et al., 2017; Takahashi et al., 2017).
Overall, the Raman investigation of the PhTAC125 biofilms indicated a
much higher nucleic acid/protein ratio and an only slightly higher
carbohydrate/protein ratio in the biofilms obtained in the GG medium
compared to those grown in the BHI medium. The high nucleic acid/
protein ratio, reported for the biofilms grown in the GG, could be in
accordance with the observation that the PhTAC125 GG pellicles dis-
played a higher hydrophobicity than the PhTAC125 BHI pellicles. In-
deed, several studies have suggested that eDNA increases the hydro-
phobicity of bacterial cells (Okshevsky and Meyer, 2015). Therefore,
it’s possible to correlate the hydrophobicity of GG pellicles with a
higher content of eDNA, or better with a higher nucleic acid/protein
ratio in the biofilm obtained in GG. Moreover, the different nucleic
acid/protein relative ratio could also account for the reported
Fig. 5. Analysis of the effect of DNase I and proteinase K on PhTAC125 biofilm
formation. The PhTAC125 biofilm formation obtained in the BHI medium or GG
medium at 15 °C or 0 °C for 24 h in the absence and presence of DNase I or
proteinase K at a concentration of 100 μg/ml. The data are reported as a per-
centage of the residual biofilm after the treatment. Each data point represents
the mean ± the SD of six independent samples; the mean values were com-
pared to the untreated control and considered significant when p < 0.05(*
p < 0.05, ** p < 0.01, *** p < 0.001) according to the Student t-test.
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differences in the PhTAC125 biofilm structure (Fig. 3b, roughness
coefficient) due to the known influence of eDNA on biofilm three-di-
mensional architectures (Okshevsky and Meyer, 2015).
Polysaccharides are considered as a significant structural compo-
nent of the biofilm matrix. As predictable, sugar analysis done on the
PhTAC125 biofilms demonstrated the presence of sugars characteristic
of the PhTAC125 lipopolysaccharide (Michela Corsaro et al., 2001) like
galactose, glucosamine, heptose, and mannosamine. Moreover, N-
Acetyl-muramic acid (MurNAc, NAM), ribose and glucose were found.
Muramic acid is one of the components of the peptidoglycan structure
but also found in LPS structures (Zych et al., 1998; Casillo et al., 2015).
As far as we know, it has never been reported as a biofilm component.
Instead, ribose has already been found in biofilms (Hung et al., 2005).
The presence of glucose in all the samples and the occurrence of a
cellulose synthase gene cluster in the PhTAC125 genome (Römling and
Galperin, 2015) prompted us to investigate the presence of cellulose in
the PhTAC125 biofilm matrix. Cellulose is a significant extracellular
matrix component of the biofilms of several ecologically diverse bac-
teria, and it mediates cell-cell interactions, cell adherence and biofilm
formation on biotic and abiotic surfaces (Römling and Galperin, 2015).
Four principal types of cellulose synthase operon have been found in
various bacterial genomes, in the PhTAC125 genome was found
(Römling and Galperin, 2015) an E. coli-like type of bcs operon which is
widespread among the members of beta and gamma subdivisions of
proteobacteria, the expression of the cellulose synthase gene cluster is
generally stimulated during biofilm formation (Zogaj et al., 2001;
Prigent-Combaret et al., 2012). The data reported demonstrated that
the cellulose is a constituent of PhTAC125 biofilm matrix in all the
tested conditions.
Although the Antarctic bacterium synthesizes cellulose as poly-
saccharidic component present in the matrix in all the tested conditions,
when the different relative content of eDNA and proteins is modulated,
it produces biofilm matrices with different characteristics in terms of
hydrophobicity, porosity, and roughness.
Last part of the research work was dedicated to assessing if the
environmental conditions also influence the PhTAC125 biofilm devel-
opment process. In particular, the role of proteins and eDNA in the
‘initial adhesion’ and ‘early biofilm formation’ steps were studied when
the bacterium was grown in the GG or BHI media. The results obtained
revealed that the treatment with DNase I did not lead to any reduction
in the biofilm development but, interestingly, in the GG at 0 °C the
nuclease addition led to an increase in the biofilm biomass. For some
bacteria, eDNA, besides its structural role, is required for the initial
attachment to surfaces, whereas in other bacteria it plays a role during
the transition from the attachment phase to the biofilm maturation
phase (Okshevsky et al., 2015). Data reported suggested that the eDNA
has a marginal role in the PhTAC125 early biofilm formation both in the
GG or BHI. On the other hand, proteins have a key role in Antarctic
bacterium biofilm formation in the BHI medium, whereas they did not
have a great impact on the biofilm formation in the GG medium. The
reported differences in the role of proteins and of eDNA in early biofilm
formation steps suggest that the environmental conditions also influ-
ence the molecular mechanisms responsible for biofilm establishment
and formation.
In conclusion, the capability of PhTAC125 to adopt different biofilm
structures in response to changes in its environment appears to be an
interesting adaptation strategy and the results herein described give the
first hints in biofilm formation in cold environments.
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2. Polar marine bacteria as source of novel anti-biofilm molecules 
 
Marine microorganisms from Antarctica can synthesize a broad range of potentially 
valuable bioactive compounds. Previous studies revealed that supernatants obtained 
from bacterial cultures of cold-adapted bacteria belonging to Flavobacterium, 
Pseudoalteromonas, Pseudomonas, Psychrobacter and Psychromonas genera 
showed anti-biofilm activity against different pathogenic strains1. 
With the aim of identifying new anti-biofilm molecules, two different libraries were 
constructed, starting from a selection of Polar marine bacteria (Tab. 1), and screened 
against Staphylococcus epidermidis: a “small metabolite” library, considering that 
natural products like secondary metabolites are often involved in quorum sensing 
modulation and biofilm inhibition2, and a “protein/peptide” library, since it is reported 
that there are many molecules of proteinaceous nature with anti-biofilm activity3-5. 
 
Table 1: Polar marine bacteria used in this study 
 
Strain Origin Reference and/or source 
Flavobacterium sp. TAB 87 Antarctic sea water Liège collection 
Pseudoalteromonas 
haloplanktis TAB23 Antarctic sea water 
6Feller G. et al., 1992 
Pseudoalteromonas 
haloplanktis TAE56 
Antarctic sea water 
(algae necrosed 
suspended in sea water) 
Liège collection 
Pseudoalteromonas 
haloplanktis TAE57 
Antarctic sea water 
(algae necrosed 
suspended in sea water) 
Liège collection 
Pseudoalteromonas 
haloplanktis TAE79 
Antarctic sea water 
(algae necrosed 
suspended in sea water) 
Liège collection 
Pseudoalteromonas 
haloplanktis TAE80 
Antarctic sea water 
(algae necrosed 
suspended in sea water) 
Liège collection 
Pseudomonas sp.TAA207 Antarctic sea water (marine sediment) Liège collection 
Pseudomonas sp.TAD18 Antarctic sea water Liège collection 
Psychrobacter sp.TAD1 Antarctic sea water Liège collection 
Psychrobacter arcticus 273-4 Siberian permafrost sediment cores 
7Bakermans et al., 2006 
Psychromonas arctica Arctic sea water (Svalbard islands, Arctic) 
8Groudieva et al., 2003 
 
 
This chapter is organized in two paragraphs: 
 
 the first paragraph describes the construction of the “small metabolite” library 
and its screening against S. epidermidis; 
 the second paragraph describes the construction of the “protein/peptide” 
library and its screening against S. epidermidis. 
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Polar bacterial extracts inhibiting Staphylococcus epidermidis biofilm 
formation: looking for novel anti-biofilm agents 
 
Abstract 
 
With the aim to identify new anti-biofilm molecules, a “small metabolite” library was 
constructed starting from Polar marine bacteria. In this study, total organic extracts 
were obtained from the planktonic cultures of several Polar strains and their anti-
biofilm activity was analysed on Staphylococcus epidermidis. A preliminary analysis 
revealed the great potential of the extracts obtained from Pseudomonas sp. TAA207 
and Psycrobacter sp. TAD1, able to inhibit S. epidermidis biofilm formation with 
different specificity of action. A fractionation of the total organic extracts in 
intracellular and extracellular samples demonstrated, for both the analyzed bacteria,  
the localization of the active molecule/s in the intracellular compartment. Suitable 
purification strategies were set up for the selected samples. Obtained results 
revealed that the active molecule produced by Pseudomonas sp. TAA207 was the 
pentadecanal, the same molecule identified to be responsible for the anti-biofilm 
activity of Pseudoalteromonas haloplanktis TAC125. The purification protocol 
proposed for Psycrobacter sp. TAD1 led to the obtainment of two different active 
fractions, likely containing molecules of different nature. Further analysis are still 
ongoing aiming to the identification of the active molecules. 
 
 
Introduction 
 
In nature, bacteria predominantly exist as communities of sessile cells that develop 
as biofilms1-2. By generating a matrix, bacteria in biofilms create a physically distinct 
habitat that provides shelter, promotes the accumulation of nutrients and 
fundamentally alters both the physicochemical environment of the biofilm and 
interactions among the organisms therein3. In the biofilm state, bacteria are 
significantly more resistant to external assault, including attack by antibiotics, 
biocides and disinfectants. In industrial fields, biofilms are responsible for biofouling 
and contamination of process water4, deterioration of the hygienic quality of drinking 
water5 and microbially influenced corrosion6. Within a host environment, they are 
insensitive to antiseptics and basic host immune responses. This enables bacteria 
within biofilms to be the cause, in clinical settings, of many persistent infections of 
live tissue and contaminations of medical device surfaces. For all these reasons, 
microbial biofilms have great negative impacts on the world’s economy and pose 
serious problems to industry, public health and medicine. 
Staphylococci are the most important etiological agents of biofilm associated-
infections on indwelling medical devices. The capacity of biofilm production is 
dependent on the pathogenic potential of staphylococcal strains as well as the host’s 
resistance to infections. The colonized devices become the focus of infection and can 
cause localized and generalized infections7. 
Within the past two decades, the dramatically rapid and continuous emergence of 
antibiotic resistance has directed the interest of research towards the discovery of 
novel anti-biofilm compounds8. 
In an effort to find viable sources of anti-biofilm agents, many researchers have 
started to extract and analyze natural products from a myriad of plants and marine 
organisms9-11. Only recently scientists have begun to understand the extreme 
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diversity present in marine microorganisms such as viruses, bacteria, fungi and 
phytoplankton. Whole genome functional annotation of marine bacteria has 
highlighted that 20-33% of the genome encoding capacity encodes for unknown or 
orphan proteins. Moreover, marine organisms possess a vast diversity of metabolic 
capabilities, because of their varied adaptations to a diverse range of physical and 
chemical conditions of marine ecosystems, and thus may represent a unique source 
of biomolecules that holds great potential12.  
Interestingly, recent studies have shown that there is a remarkably high hit rate of 
marine-based compounds with anti-biofilm activity13-14. Within the marine 
environment, cold-adapted marine bacteria are able to produce compounds endowed 
with antimicrobial, anti-fouling and various pharmaceutically relevant activities15. 
In this work, Polar marine bacteria belonging to Flavobacterium, Pseudoalteromonas, 
Pseudomonas, Psychrobacter and Psychromonas genera were analyzed for their 
ability to produce anti-biofilm molecules active against Staphylococcus epidermidis. 
In particular, total organic extracts obtained from the planktonic cultures of Polar 
marine bacteria were tested on Staphylococcus epidermidis biofilm. For the most 
promising samples suitable purification strategies were set up in order to identify the 
molecules responsible for the anti-biofilm activity. 
 
 
Materials and Methods 
 
Bacterial strains and culture conditions 
Bacterial strains used in this work are listed in Table 1. Polar bacteria were grown in 
flasks in synthetic medium GG16 (D-Gluconic acid, sodium salt 10 g/L, L-Glutamic 
acid, sodium salt 10 g/L, NaCl 10 g/L; NH4NO3 1 g/L; KH2PO4•7H2O 1 g/L; 
MgSO4•7H2O 200 mg/L; FeSO4•7H2O 5 mg/L; CaCl2•2H2O 5 mg/L) at 15°C under 
vigorous agitation (180 rpm) until the stationary phase of growth (72-90 h). S. 
epidermidis O-47 was grown in Brain Heart Infusion broth (BHI, Oxoid, UK) at 37°C. 
Planktonic cultures were performed under vigorous agitation (180 rpm) while biofilm 
formation was assessed in static condition. All strains were maintained at -80°C in 
cryovials with 15% of glycerol. 
 
Organic extracts preparation 
Polar bacterial cultures were collected and subjected to a liquid-liquid extraction as 
initial separation technique to process the whole cultures, to obtain “total organic 
extracts”. Subsequently, for the most promising samples, cell-free supernatants and 
cell pellets were processed separately, to obtain “extracellular extracts” and 
“intracellular extracts”.  
In detail, to prepare total organic extracts, the whole Polar bacterial cultures, 
obtained as previously described, were recovered and frozen at -80°C until use. 
Liquid-liquid extraction was performed without adding cryoprotectants. Polar bacterial 
cultures were thawed and then stirred with an equal volume of ethyl acetate (Assay 
Percent Range ≥ 99.5%) (Sigma-Aldrich) and mixed at 1% with acid formic (Assay 
Percent Range = 90%) (JT Baker). Each solution was stirred at least for 30 min and 
then it was centrifuged at 3000 rpm for 30 min. The resulting two phases were 
separated and the organic phase was recovered and dried using a rotary evaporator 
Rotavapor (Buchi R-210) at a temperature lower than 40°C. The resulting total 
organic extracts, named TE, were aliquoted in 4 mg dry weight samples and stored 
at -20°C. 
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To prepare extracellular and intracellular extracts, supernatants and cell pellets 
deriving from the Polar bacterial cultures previously described were recovered by 
centrifugation at 6,000 rpm at 4°C for 50 min. After centrifugation, the supernatants 
were separated from the cells and were sterilized by filtration through membranes 
with a pore diameter of 0.22 μm. Cell pellets were resuspended in an opportune 
volume of sterile distilled water. Resuspended cell pellets and cell-free supernatants 
were frozen at -80°C until use. Liquid-liquid extraction was performed on cell pellets 
and supernatants of cold-adapted bacteria separately, without adding 
cryoprotectants, as previously described. The resulting intracellular and extracellular 
extracts, named IE and EE respectively, were aliquoted in 4 mg dry weight samples 
and stored at -20°C. 
 
Biofilm formation of Staphylococcus epidermidis 
Organic extracts were screened for their anti-biofilm activity against S. epidermidis O-
47. Quantification of in vitro biofilm production was based on the method described 
by Christensen with slight modifications17. The organic extracts were first solubilized 
in dimethylsulfoxide (DMSO), subsequently a working solution of each extract to be 
tested was diluted in BHI. Briefly, the wells of a sterile 96-well flat-bottomed 
polystyrene plate were filled with 100 μl of an opportune dilution of an overnight 
culture of S. epidermidis O-47. 100 μl of working solution of organic extracts were 
added into each well with a final concentration of 4 mg ml-1 and a DMSO 
concentration of 4% v/v, since this DMSO concentration does not interfere with cell 
growth and bacteria viability18. The plates were incubated aerobically for 20 h at 37°C 
in static condition. Biofilm formation was measured using crystal violet staining. After 
incubation, planktonic cells were gently removed; each well was washed three times 
with double-distilled water and patted dry with a piece of paper towel in an inverted 
position. To quantify biofilm formation, each well was stained with 0.1% crystal violet 
and incubated for 15 min at room temperature, rinsed twice with double-distilled 
water, and thoroughly dried. The dye bound to adherent cells was solubilized with 
20% (v/v) glacial acetic acid and 80% (v/v) ethanol. After 30 min of incubation at 
room temperature, OD590nm was measured to quantify the total biomass of biofilm 
formed in each well. Each data point is composed of three independent experiments 
each performed at least in 6-replicates. 
 
Silica gel chromatography  
The intracellular extracts from Pseudomonas sp. TAA207 (TAA207-IE, 100 mg)  and 
Psycrobacter sp. TAD1 (TAD1-IE, 113 mg) were both purified on a silica gel column. 
The columns (30 mL, 50 x 0.7 cm for TAA207-IE and 49 mL, 32 x 0.7 cm for TAD1-
IE, respectively) were initially eluted with CHCl3:CH3OH ranging from 100 to 70 % of 
CHCl3, and then with CHCl3:CH3OH:H2O 9/3/0.5 v/v/v. Only for TAD1-IE, a further 
elution with CHCl3:CH3OH:H2O 6/4/0.5 v/v/v was performed. 
Active fractions were analyzed on a Agilent Technologies gas chromatograph 6850A 
equipped with a mass selective detector 5973N and a Zebron ZB-5 capillary column 
(Phenomenex, 30m x 0.25 mmi.d., flow rate 1 cm3/min, He as carrier gas), by using 
the following temperature program: 150°C for 3 min, from 150 to 300°C at 15°C/min, 
at 300°C for 5 min. 
 
Statistics and reproducibility of results 
Data reported were statistically validated using Student t-test comparing mean 
absorbance of treated and untreated samples The significance of differences 
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between mean absorbance values was calculated using a two-tailed Student’s t-test. 
A p value <0.05 (* p <0.05, ** p <0.01, *** p <0.001) was considered significant. 
 
 
Results 
 
Total organic extracts from Polar marine bacteria 
A selection of nine Polar marine bacteria belonging to Pseudoalteromonas, 
Pseudomonas, Psycrobacter and Psychromonas genera (Tab. 1) were analyzed for 
their capability to produce anti-biofilm molecules active against S. epidermidis O-47, 
a strong biofilm producer agr-mutant, isolated from clinical septic arthritis and kindly 
provided by Prof. Gotz17. Polar marine bacteria were grown in planktonic conditions, 
under vigorous shaking, until the stationary phase of growth at 15°C. A synthetic 
medium based on gluconate and glutammate (GG)16 was chosen as culture medium 
in order to minimize the potential interference of culture medium on the organic 
extraction step. The bacterial growths were monitored over a period of 72 h; at the 
achievement of stationary phase, the whole bacterial cultures were recovered and 
frozen at -80°C, without adding cryoprotectants, in an attempt to induce cell lysis by 
cold shock, and thus recover intra- and extracellular components. Polar bacterial 
cultures were then subjected, as reported in materials and methods section, to a 
liquid-liquid extraction, using ethyl acetate as extraction solvent, since it is a very 
useful tool for bioseparations, frequently used in the downstream recovery of 
fermentation products, such as antibiotics or secondary metabolites. 
 
Analysis of the anti-biofilm activity of total organic extracts on S. epidermidis O-47 
Total organic extracts, obtained as previously described, were screened for their anti-
biofilm activity against S. epidermidis O-47. The quantification of biofilm production 
was based on a microtiter plate assay (MTP): an opportune dilution of bacterial 
culture in exponential growth phase was added into the wells of a sterile 96-well flat-
bottomed polystyrene plate in absence and in presence of total organic extracts (TE). 
A concentration of 4 mg ml-1 was tested for each sample; after 20 h incubation, 
biofilm formation was evaluated. Figure 1 shows the percentage reduction of S. 
epidermidis O-47 biofilm production after treatment with total organic extracts.  
 
 
 
Fig 1: Effect of total organic extracts from cold-adapted bacteria on S. epidermidis O-47 biofilm formation. Data 
are reported as percentage of residual biofilm after the treatment. Each data point represents the mean ± SD of 
five independent samples. Biofilm formation was considered unaffected in the range 90-100%. Differences in 
mean absorbance were compared to the untreated control and considered significant when p< 0.05 (* p< 0.05, ** 
p < 0.01, *** p < 0.001) according to t-Student test. 
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Reported data demonstrated that most of the tested total organic extracts from Polar 
marine bacteria induced a reduction in biofilm formation. Among all, some samples 
showed a mild anti-biofilm effect, such as P. haloplanktis TAB23, P. haloplanktis 
TAE79 and P. haloplanktis TAE56 total organic extracts (TAB23-TE, TAE79-TE, 
TAE56-TE), while total organic extracts from Pseudomonas sp. TAA207 and 
Psycrobacter sp. TAD1 (TAA207-TE, TAD1-TE) resulted strongly active against S. 
epidermidis O-47 and were thus chosen for further investigations. 
 
Analysis of dose-dependence and species specificity of total organic extracts anti-
biofilm activity 
Total organic extracts from Pseudomonas sp. TAA207 and Psycrobacter sp. TAD1 
showed an interesting anti-biofilm activity on S. epidermidis O-47. Therefore, in order 
to investigate if TAA207-TE and TAD1-TE were able to inhibit the biofilm formation of 
different S. epidermidis strains, their anti-biofilm activity was evaluated against: S. 
epidermidis RP62A, S. epidermidis XX-17 and S. epidermidis O-47. S. epidermidis 
RP62A is a reference strain isolated from an infected catheter. The clinical isolate O-
47 is a naturally occurring agr mutant19 while the S. epidermidis XX-17 is an ica 
defective mutant20. These genetic differences have an impact on the ability to form 
biofilm of the different strains.  
The analysis of the anti-biofilm activity of the selected total organic extracts (Fig. 2) 
revealed that TAA207-TE reduced the biofilm production of two of the tested S. 
epidermidis strains, resulting able to interfere with the biofilm formation process of S. 
epidermidis O-47 and RP62A strains, but the same sample did not display anti-
biofilm effect against S. epidermidis XX17, suggesting the ica genes as possible 
target of this anti-biofilm compound. Whereas, TAD1-TE reduced the biofilm 
formation of both the three S. epidermidis strains, showing a non-species-specific 
activity, and thus indicating that the anti-biofilm compound/s produced by 
Psycrobacter sp.TAD1 is different from that produced by Pseudomonas sp.TAA207. 
  
Figure 2: Effect of total organic extracts from Pseudomonas sp.TAA207 and Psycrobacter sp.TAD1 on biofilm 
formation of three S. epidermidis strains. Data are reported as percentage of residual biofilm after the treatment. 
Each data point represents the mean ± SD of five independent samples. Biofilm formation was considered 
unaffected in the range 90-100%. Differences in mean absorbance were compared to the untreated control and 
considered significant when p< 0.05 (* p< 0.05, ** p < 0.01, *** p < 0.001) according to t-Student test. 
 
 
Because of its ability to form a strong biofilm, S. epidermidis O-47 strain has been 
used to evaluate the dose-responsive effect of total organic extracts. In particular, S. 
epidermidis O-47 was incubated in presence of serial dilutions of TAA207-TE and 
TAD1-TE, starting from a concentration of 4 mg ml-1. Figure 3 shows a clear dose-
dependence of the anti-biofilm activity of TAA207-TE, whereas TAD1-TE anti-biofilm 
activity was evident only at sample concentrations of 4 mg ml-1 and 2 mg ml-1. 
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Figure 3: Dose-dependent effect of total organic extracts from Pseudomonas sp.TAA207 and Psycrobacter 
sp.TAD1 on S. epidermidis O-47 biofilm formation. Data are reported as percentage of residual biofilm after the 
treatment. Each data point represents the mean ± SD of four independent samples. Biofilm formation was 
considered unaffected in the range 90-100%. Differences in mean absorbance were compared to the untreated 
control and considered significant when p< 0.05 (* p< 0.05, ** p < 0.01, *** p < 0.001) according to t-Student test. 
 
 
Evaluation of the anti-biofilm activity of intracellular and extracellular organic extracts  
In order to reduce the composition complexity of the analyzed samples, liquid-liquid 
extraction was performed on cell pellets and cell-free supernatants of Pseudomonas 
sp. TAA207 and Psycrobacter sp. TAD1 cultures separately and then the anti-biofilm 
activity of the obtained extracts was evaluated. In detail, the selected Polar marine 
bacteria were grown in planktonic conditions at 15°C in GG medium until the 
stationary phase of growth. Cell pellets and supernatants were separated by 
centrifugation, then the liquid-liquid extraction was carried out, for each bacterial 
strain, on both samples independently. For sake of simplicity, the organic extracts 
deriving from cell pellets of bacterial cultures were defined as IE (Intracellular 
extract), while the extracts from cell-free supernatants were defined as EE 
(Extracellular extract), respectively. 
Serial dilutions of Pseudomonas sp. TAA207 and Psycrobacter sp. TAD1 intracellular 
and extracellular extracts were tested on S. epidermidis O-47 starting from a 
concentration of 1 mg ml-1, since, on the basis of the dose-dependence study, this 
concentration was sufficient to detect a clear anti-biofilm effect. 
 
 
Figure 4: Effect of Intracellular and Extracellular extracts from Pseudomonas sp.TAA207 (A) and Psycrobacter 
sp.TAD1 (B) on S. epidermidis O-47 biofilm formation. Data are reported as percentage of residual biofilm after 
the treatment. Each data point represents the mean ± SD of five independent samples. Biofilm formation was 
considered unaffected in the range 90-100%. Differences in mean absorbance were compared to the untreated 
control and considered significant when p< 0.05 (* p< 0.05, ** p < 0.01, *** p < 0.001) according to t-Student test. 
 
 
A B 
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As reported in Figure 4, TAA207-IE and TAD1-IE had a strong anti-biofilm activity, 
inducing an evident reduction of S. epidermidis O-47 biofilm formation, whereas 
TAA207-EE and TAD1-EE did not show any inhibitory effect. Therefore, 
Pseudomonas sp.TAA207 and Psycrobacter sp.TAD1 intracellular extracts were 
subjected to further purification steps. 
 
Fractionation of Pseudomonas sp.TAA207 and Psycrobacter sp.TAD1 intracellular 
extract by Silica Gel Chromatography  
In order to develop a preliminary purification protocol, TAA207-IE and TAD1-IE were 
subjected to different elution conditions on Thin Layer Chromatography (TLC) in 
order to identify the condition for a preparative scale purification step. 
 
Silica gel column chromatography was used to partition of TAA207-IE and TAD1-IE. 
A suspension of first eluent (100% CHCl3) with the stationary phase powder of silica 
gel was prepared and then carefully poured into the column. Then TAA207-IE and 
TAD1-IE were dissolved in chloroform and loaded into the column separately. After 
loading phase, previously chosen solvents  were slowly eluted through the column in 
order of their increasing polarity. A final washing elution step with CHCl3:CH3OH:H2O 
6:4:0.5 v/v was added for TAD1-IE fractionation. Collected fractions, of 4 ml each, 
were dried and then suspended in dimethylsulfoxide (DMSO). In the anti-biofilm 
assay, one chromatography fraction every three was tested against S. epidermidis O-
47, thus simplifying the explorative analysis, at a concentration of 200 µg ml-1. 
 
 
Figure 5: Effect of Pseudomonas sp.TAA207 intracellular extract chromatographic fractions on S. epidermidis O-
47. Biofilm formation was evaluated in presence of 200 µg ml-1 of each fraction. Data are reported as percentage 
of residual biofilm. Biofilm formation was considered unaffected in the range 90-100%. Differences in mean 
absorbance were compared to the untreated control and considered significant when p< 0.05 (* p< 0.05, ** p < 
0.01, *** p < 0.001) according to t-Student test. 
 
 
As shown in Figure 5, TAA207-IE chromatographic fraction F63 displayed a strong 
biofilm reduction, suggesting the presence of the active agent. To obtain information 
about the composition complexity, the fraction F63 was acetylated and analysed by 
GC-MS. The analysis revealed the presence of the pentadecanal, the anti-biofilm 
molecule produced by another Polar bacterium Pseudoalteromonas haloplanktis 
TAC12519, thus suggesting that the anti-biofilm activity shown by this fraction is 
attributable to the pentadecanal. No further analysis were necessary, since the anti-
biofilm activity of the pentadecanal was deeply analysed19. 
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Figure 6: Effect of Psicrobacter sp.TAD1 intracellular extract chromatographic fractions on S. epidermidis O-47. 
Biofilm formation was evaluated in presence of 200 µg ml-1 (2% DMSO) of each fraction. Data are reported as 
percentage of residual biofilm. Biofilm formation was considered unaffected in the range 90-100%. Differences in 
mean absorbance were compared to the untreated control and considered significant when p< 0.05 (* p< 0.05, ** 
p < 0.01, *** p < 0.001) according to t-Student test. 
  
 
Whereas, as shown in Fig 6, two strongly active chromatographic fractions were 
identified, F35 and F71. In this case, the GC-MS analysis of these fractions didn’t 
show the presence of the pentadecanal. This result leaves hope for a forthcoming 
identification of new anti-biofilm molecules. 
 
 
Discussion 
 
From a previous study, it had been proved that Polar marine bacteria were able to 
produce molecules endowed with anti-biofilm activity against different 
Staphylococcus aureus, Staphylococcus epidermidis and Pseudomonas aeruginosa 
strains20. A physicochemical characterization of the active samples revealed that the 
molecules responsible for the activities were of a different nature, creating 
expectations of a possible identification of different anti-biofilm agents. In this work, a 
selection of total organic extract obtained from Polar marina bacteria were screened 
against S. epidermidis looking for small metabolites with anti-biofilm properties. 
Several extract showed a mild inhibiting effect, but two of them resulted extremely 
active, i.e. the total organic extracts obtained from Pseudomonas sp. TAA207 and 
Psycrobacter sp. TAD1 (TAA207-TE and TAD1-TE), which were selected for further 
analysis. First, intracellular and extracellular extracts from both the selected bacteria 
were separately obtained and tested in order to identify the origin of the active 
compounds. In both cases, the intracellular extracts (TAA207-IE and TAD1-IE) 
turned out to be the active samples. The purification protocol proposed for TAA207-
IE led to the obtainment of only one active fraction, whose analysis by GC-MS 
revealed the presence of the pentadecanal. Pentadecanal was discovered to be a 
small anti-biofilm molecule, active against S. epidermidis, produced by the Antarctic 
bacterium Pseudoalteromonas haloplanktis TAC12519, which were able to synthesize 
this molecule only when grown in sessile condition in a rich culture medium17. 
Surprisingly, these culture conditions completely differ from those of Pseudomonas 
sp. TAA207, which produced the pentadecanal in planktonic conditions in a synthetic 
medium. Furthermore, P. haloplanktis TAC125 secreted the pentadecanal in the 
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extracellular environment, whereas, in this case, it is located in the intracellular 
compartment of Pseudomonas sp. TAA207. Finally, for P. haloplanktis TAC125 a 
putative gene sequence responsible for the pentadecanal synthesis was proposed, 
but an in silico analysis of Pseudomonas sp. TAA207 genome did not reveal the 
presence of this gene (data not shown). Taken together, these results indicated that 
Pseudomonas sp. TAA207 and P. haloplanktis TAC125 were able to produce the 
same molecule, endowed with the same anti-biofilm activity against S. epidermidis, 
but, interestingly, no connection seemed to exist between them. Further studies will 
be carried out on this fascinating aspect, in order to clarify the role of the 
pentadecanal in Pseudomonas sp. TAA207 and P. haloplanktis TAC125 physiology. 
On the other hand, the purification protocol proposed for TAD1-IE led to the 
obtainment of two different active fractions, likely containing molecules of different 
nature. In this case, the GC-MS analysis didn’t show the presence of the 
pentadecanal in these fractions. Given the capability of TAD1-TE to indiscriminately 
act on both the three tested S. epidermidis strains, species-specificity analysis of the 
obtained fractions will likely lead to the identification of at least one molecule with a 
specific anti-biofilm effect on S. epidermidis XX-17, or, even better, an anti-biofilm 
agent endowed with a broad spectrum of action. Further analysis are still ongoing 
trying to identify the structures of the molecules responsible for Psycrobacter sp. 
TAD1 anti-biofilm activity against S. epidermidis. It is essential to underline that 
Psycrobacter sp. TAD1 turned out to be one of the most promising anti-biofilm agents 
producer20, showing impressive capabilities of biofilm inhibition also on 
Staphylococcus aureus and Pseudomonas aeruginosa strains. Therefore, in this 
contest, future studies will aim at a deeper analysis of Psycrobacter sp. TAD1, its 
genomic and metabolic features, and their influence on its anti-biofilm activity. 
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Anti-biofilm proteins from Polar marine bacteria to control Staphylococcus 
epidermidis biofilm formation 
 
Abstract 
 
The present study aims to the discovery of novel anti-infective approaches for the 
prevention of the biofilm formation process or the treatment of the mature biofilms. It 
was demonstrated that Polar marine bacteria belonging to Pseudoalteromonas, 
Psychrobacter, and Psychromonas species were able to destabilize the biofilm matrix 
of different Staphylococcus aureus, Staphylococcus epidermidis and Pseudomonas 
aeruginosa strains without killing cells. In this work, a protein/peptide library was 
constructed starting from cell-free supernatants of Polar marine bacteria, in which the 
anti-biofilm activity was due to molecules of proteinaceous nature. Preliminary 
activity-guided purification protocols were set up for the two most promising strains, 
Pseudoalteromonas haloplanktis TAB23 and Pseudoalteromonas haloplanktis 
TAE80. Obtained results demonstrated that both the Polar bacteria produce anti-
biofilm proteins endowed with different and strong biological activities, but the 
obtained active fractions were still mixtures of several proteins. An optimization of the 
purification protocols is needed in order to purify and identify the anti-biofilm proteins 
produced. 
 
 
Introduction 
 
Microbial biofilms have great negative impacts on the world’s economy and pose 
serious problems to industry, public health and medicine. Biofilms are communities of 
microorganisms that can attach to both abiotic and biotic surfaces and thus being 
implicated in the development of Healthcare-associated infections (HAIs)1. One of the 
main causes is recognized to be the colonization and the biofilm formation of 
staphylococcal species. In particular, Staphylococcus epidermidis represents the 
most common source of infections on indwelling medical devices2. This likely stems 
from the fact that S. epidermidis is a permanent and ubiquitous colonizer of human 
skin, and consequently, the device contamination during insertion is highly probable. 
Its ability to colonize a surface and form a biofilm is an important virulence factor3. 
The complex and resistant structure of the biofilms protect bacteria from the most 
common therapeutic treatment, therefore the necessity of novel anti-infective 
strategies is becoming increasingly urgent. The discovery of antifouling or 
antimicrobial surfaces can be a possible approach to prevent the bacterial adhesion, 
and therefore inhibiting the initial steps of the biofilm formation process4. Another 
uprising strategy is the use of effective anti-biofilm molecules, such as quorum 
sensing modulators5, which interfere with bacterial signaling pathways inducing the 
detachment phase, or biofilm-dispersing enzymes, which degrade matrix 
components destabilizing the biofilm structure6. 
Extracellular matrix of bacterial biofilms is a highly hydrated set of biopolymers such 
as polysaccharides, lipids, proteins and nucleic acids produced by the bacteria 
themselves which form an extracellular polymeric substance (EPS)7. Therefore, 
enzymes like glycosidases as well as proteases or deoxyribonuclease can degrade 
bacterial matrix and facilitate the antimicrobial agent penetration enhancing the 
treatment efficacy8-9. 
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Several biofilm-dispersing enzymes are implicated in active biofilm dispersal. One 
well-studied biofilm-dispersing enzyme is dispersin B, a glycoside hydrolase 
produced by A. actinomycetemcomitans10, which degrades poly-N-acetylglucosamine 
(PNAG), a biofilm matrix polysaccharide that mediates the attachment of the cells to 
abiotic surfaces and facilitates the aggregation of bacteria. Another example is 
Deoxyribonuclease I (DNase I), which is capable of digesting the extracellular DNA 
(eDNA) present within the biofilm structures11. 
Reported data from our group demonstrated the capacity of Polar marine bacteria to 
produce and secrete anti-biofilm molecules of proteinaceous nature active against 
Staphylococcus aureus, Staphylococcus epidermidis and Pseudomonas aeruginosa 
strains12. Based on these results, in this work a “protein/peptide” library was 
constructed, starting from cell-free supernatants of Polar marine bacteria, and 
screened for anti-biofilm activity against S. epidermidis O-47. Preliminary activity-
guided purification protocols were set up. 
 
 
Materials and Methods 
 
Bacterial strains and culture conditions 
Bacterial strains used in this work are listed in Table 1. Bacteria were grown in Brain 
Heart Infusion broth (BHI, Oxoid, UK). Biofilm formation was assessed in static 
condition and planktonic cultures were performed under vigorous agitation (180 rpm). 
Polar marine bacterial strains were grown at 15°C and 4 °C while staphylococci were 
grown at 37°C. All strains were maintained at -80°C in cryovials with 15% of glycerol. 
 
Preparation of cell-free supernatants from Polar marine bacteria 
Polar marine bacteria were grown in planktonic conditions at 15°C under vigorous 
agitation (180 rpm) until the stationary phase of growth (30-48 h). Supernatants were 
recovered by centrifugation at 8,000 rpm at 4°C for 30 min, sterilized by filtration 
through membranes with a pore diameter of 0.22 μm and stored at 4°C until use. 
 
Design of a “protein/peptide” library from Polar marine bacteria 
Cell-free supernatants from Polar marine bacteria, obtained as previously described, 
were screened for their anti-biofilm activity against S. epidermidis O-47. The active 
samples were selected for the construction of the library. In order to identify the 
positive hits, all the active supernatants were subjected to a proteinase K treatment. 
In detail, cell-free supernatants were incubated in presence and in absence of 
proteinase K (Sigma Aldrich, St Louis, MO) at a final concentration of 1 mg ml-1 for 1 
h at 37°C. As control, only BHI was incubated for 1 h at 37°C with the proteinase K. 
After the incubation, all the samples were tested against S. epidermidis O-47; 
supernatants which have partially or almost totally lost the anti-biofilm activity after 
the treatment were identified as the hits of the library. 
 
Biofilm formation of staphylococci 
Static biofilm assay. Biofilm formation of staphylococci was evaluated in the presence 
and in the absence of supernatants, as previously described9. In detail,  the wells of a 
sterile 24-well flat-bottomed polystyrene plate were filled with 500 μl of BHI.  An 
overnight cultures of S. epidermidis was diluted and added into each well at a cell 
concentration of about 0.001 OD600nm. Each well was filled with 500 μl of BHI and 500 
μl of each supernatant, respectively. In this way each supernatant was used diluted 
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1:2 with a final concentration of 50%. As control, the first row contained bacteria 
grown only in BHI (untreated bacteria). The plates were incubated aerobically for 24 
h at 37°C. Biofilm formation was measured using crystal violet staining. After 
incubation, planktonic cells were gently removed; each well was washed three times 
with PBS and thoroughly dried. Each well was then stained with 0.1% crystal violet 
and incubated for 15 min at room temperature, rinsed twice with double-distilled 
water, and thoroughly dried. The dye bound to adherent cells was solubilized with 
20% (v/v) glacial acetic acid and 80% (v/v) ethanol. After 30 min of incubation at 
room temperature, the OD590nm was measured to quantify the total biomass of biofilm 
formed in each well. Each data point was composed of six independent samples. 
Surface coating assay. A volume of 10 μl of cell-free supernatant, or 10 μl of 
BHI/Tris-HCl as control, was deposited at the center of a well of a 24-well tissue-
culture-treated polystyrene microtiter plate in three-replicate. The plate was left 
overnight under laminar hood to allow complete evaporation of the liquid. The wells 
were then filled with 1 ml of BHI broth containing an opportune dilution of S. 
epidermidis O-47 (about 0.001 OD600nm) and incubated at 37°C. After 18 h, wells 
were rinsed with water and stained with 1 ml of 0.1% crystal violet. Stained biofilms 
were rinsed with water and dried, and the wells were photographed by a camera. 
 
Ammonium sulphate precipitation 
Ammonium sulphate at 50% and 100% saturation (314 g l-1 and 761 g l-1) was added 
slowly to the culture filtrate with stirring at 4°C respectively. After the (NH4)2SO4 had 
completely dissolved it was stored overnight in the cold, to allow the protein to 
precipitate. The solution was then centrifuged at 13,000 rpm at 4°C for 30 min. The 
precipitates were resuspended in a buffer 50 mM Tris/HCl pH 8, 200 mM NaCl and 
then dialyzed against the same buffer to remove salts, using a semipermeable 
membrane with a cutoff of 3 kDa. 
 
Analytical techniques 
Centricon tubes (Millipore, Billerica, MA, USA) with 10 kDa MWCO filters were used 
to approximately determine the molecular weight of the anti-biofilm molecules. 
Freeze drying or lyophilization has been used to concentrate protein samples after 
dialysis, removing the water from frozen samples by sublimation and desorption. 
TCA precipitation has been used to concentrate protein samples for SDS-PAGE 
analysis. Briefly, 10% (v/v) of TCA 100% was added into each sample and incubated 
over night at 4°C followed by centrifugation at 13,000 rpm for 30 minutes. Protein 
pellets were washed with cold acetone 90% and centrifuged at 13,000 rpm for 30 
minutes. Samples were dried in a stove to eliminate any acetone residue. For SDS-
PAGE, 4x Laemmli sample buffer was added, samples were boiled at 95°C for 5 min 
and loaded on to polyacrylamide gel. Colloidal Coomassie was used for the 
visualization of proteins separated by SDS-PAGE. 
 
Chromatographic Techniques 
SEC: Size-Exclusion Chromatography was performed using a HiLoad™ 16/600 
Superdex™ 75 column (GE Healtcare) by using an ÄKTA Explorer FPLC (GE, 
Amersham). The column was washed and equilibrated with 2,5 column volumes of 
degassed elution buffer (50 mM Tris/HCl, 200 mM NaCl, pH 8). Sample was loaded 
with a flow-rate of 0,1 ml min-1 and eluted for 1,5 column volumes with a flow-rate of 
0,7 ml min-1, following the conjugated rings of tryptophan and tyrosine absorbance at 
280 nm and protein absorbance at 220 nm. 
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HIC: Hydrophobic Interaction Chromatography was performed using a HiPrep™ 
Phenyl HP 16/10 column (GE Healtcare) by using an ÄKTA Explorer FPLC (GE, 
Amersham). The column was washed and equilibrated with 2,5 column volumes of 
degassed binding buffer (50 mM Tris-HCl, 1 M (NH4)2SO4, pH 7). Sample was loaded 
with a flow-rate of 1 ml min-1 and eluted with 5 column volumes of degassed elution 
buffer (50 mM Tris-HCl) creating a discontinuous gradient of (NH4)2SO4, from 100% 
to 0%. At last the column was washed with 3 column volumes of bi-distilled water in 
both the flow directions with a flow-rate of 3 ml min-1. 
AEC: Anion Exchange Chromatography was performed using a HiPrep™ Q HP 
column (GE Healtcare) by using an ÄKTA Explorer FPLC (GE, Amersham). The 
column was washed and equilibrated with 2,5 column volumes of degassed binding 
buffer (Tris-HCl 20 mM). Sample was loaded with a flow-rate of 1 ml min-1 and eluted 
with 5 column volumes of degassed elution buffer (50 mM Tris-HCl, 1 M NaCl) 
creating a discontinuous gradient of NaCl, from 0% to 100%. 
 
Statistics and reproducibility of results 
Reported data were statistically validated using Student t-test comparing mean 
absorbance of treated and untreated samples The significance of differences 
between mean absorbance values was calculated using a two-tailed Student’s t-test.  
 
 
Results 
 
Design and screening of a “protein/peptide” library from Polar marine bacteria 
Previously reported data demonstrated the capability of Polar marine bacteria to 
interfere with the biofilm formation process of some pathogenic strains9. With the 
purpose to identify novel anti-biofilm molecules of proteinaceous nature, active 
against S. epidermidis, the construction of a “protein/peptide” library was set up 
starting from our collection of Polar marine bacteria. In detail, Polar marine bacteria 
(Tab. 1) were grown in planktonic condition in BHI medium at 15°C until the 
stationary phase of growth. The anti-biofilm activity of the collected cell-free 
supernatants was evaluated against S. epidermidis O-47. Supernatants that induced 
a biofilm reduction were selected as library samples. To identify the samples in which 
the activity was due to a protein or a peptide, all the samples were subjected to a 
proteinase K treatment and then tested again on S. epidermidis O-47. Supernatants 
which have partially or almost totally lost the anti-biofilm activity after the treatment 
with proteinase K were qualified as positive hits (Tab. 2), given their likely content of 
an anti-biofilm molecule of proteinaceous nature. 
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Figure 1: A) Anti-biofilm activity of cell-free supernatants obtained from Polar Marina bacteria against different S. 
epidermidis strains. Each data point represents the mean ± SD of three different samples. B) Protein/peptide 
library samples and hits. Hits were selected on the basis of the anti-biofilm activity lost after proteinase K 
treatment of the samples. Data sets resulted statistically significant according to t-Student test. 
 
 
Among the identified hits, two were selected for further analysis:  
- P. haloplanktis TAB23 supernatant (SN-TAB23), because it showed the strongest 
inhibitory effect on S. epidermidis O-47 biofilm formation; 
- P. haloplanktis TAE80 supernatant (SN-TAE80), given its interestingly ability to 
prevent biofilm formation of S. epidermidis O-47 by modifying the polystyrene surface 
properties12.  
 
Preliminary molecular weight analysis 
In order to approximately determinate the anti-biofilm compound molecular weight, 
SN-TAB23 and SN-TAE80 were filtered using a Centricon centrifugal tube with 10 
kDa MWCO filter. Then, the retained and the rejected fractions were tested against 
S. epidermidis O-47; the analysis of the biofilm formation revealed that only the 
retained fractions of SN-TAB23 and SN-TAE80 showed an anti-biofilm effect (data 
not shown), indicating that the activity can probably be due to a protein, rather than to 
a small peptide. 
 
Set up of preliminary purification strategies 
To separate the proteins from the molecule mixture in the supernatants, SN-TAB23 
and SN-TAE80 were subjected to an ammonium sulphate precipitation at different 
percentages of salt saturation. Precipitates obtained at 50% and 100% saturation of 
ammonium sulphate were collected by centrifugation and then suspended and 
dialyzed against an appropriate buffer to remove salts and then subjected to freeze-
drying to obtain more concentrated samples. Lyophilized powders were finally 
suspended in a small volume of buffer and tested to verify the anti-biofilm activity on 
S. epidermidis O-47 biofilm. Samples so obtained were indicated as SN-TAB23 50, 
SN-TAB23 100, SN-TAE80 50 and SN-TAE80 100. 
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Figure 2: Effect of P. haloplanktis TAB23 and P. haloplanktis TAE80 supernatants on S. epidermidis O-47 biofilm 
after ammonium sulphate precipitation at 50% and 100% salt saturation. Data are reported as percentage of 
residual biofilm. Each data point represents the mean ± SD of three different samples. Data sets resulted 
statistically significant according to t-Student test. 
 
 
Obtained data (Fig. 2) showed that the supernatants of P. haloplanktis TAB23 and P. 
haloplanktis TAE80 retained in both cases the anti-biofilm activity. This result 
suggested that ammonium sulphate precipitation was an effective step to reduce the 
complexity of the supernatants and thus facilitate the purification of the anti-biofilm 
compound produced by the selected Polar bacteria. Moreover, data indicated that 
50% saturation of ammonium sulphate was enough to achieve a high recovery of the 
anti-biofilm compound and a good removal of interfering proteins that precipitate at 
100% saturation of ammonium sulphate, therefore SN-TAB23 50 and SN-TAE80 50 
were selected for the further purification steps. 
 
 
Pseudoalteromonas haloplanktis TAB23 
 
P. haloplanktis TAB23 supernatant was precipitated with ammonium sulphate at 50% 
saturation, suspended in a small volume of buffer and subjected to a Hydrophobic 
Interaction Chromatography (HIC). The analysis of the anti-biofilm activity of the 
collected fractions (data not shown) didn’t reveal the presence of a single active 
fraction, but, on the contrary, all fractions possessed a low, and not significative, 
inhibiting effect on S. epidermidis. Therefore, a Size-Exclusion Chromatography 
(SEC) was selected as first chromatographic step. Fractions F1 to F7 (Fig. 3A) were 
collected, normalized to protein content (10 µg ml-1) and then analyzed for their anti-
biofilm activity on S. epidermidis O-47, using an appropriate control. As shown in Fig. 
3B, the fraction F1, corresponding to the first peak in chromatogram, displayed the 
greatest anti-biofilm activity. Interestingly, also the latest fraction F7 showed a slight 
inhibiting effect.  
 
93 
 
 
Fig 3: A) SEC chromatogram. Red line: absorbance (220 nm); blue line: absorbance (280 nm). B) Evaluation of 
the anti-biofilm activity of the SEC collected fractions on S. epidermidis O-47. Data are reported as percentage of 
residual biofilm. Each data point represents the mean ± SD of three different samples. Data sets resulted 
statistically significant according to t-Student test. 
 
 
A SDS-PAGE was performed to analyze the protein separation and the profile 
complexity of the chromatographic fractions (data not shown). A partial separation of 
SN-TAB23 50 total content of proteins was obtained, but the sample corresponding 
to both fraction F1 and F7 were complex mixtures of different proteins. Since F1 
fraction showed the greatest anti-biofilm activity, it was selected for a further 
purification step. F1 fraction was subjected to an Anion exchange chromatography 
(AEC). Proteins were eluted with an increasing percentage (0% to 100%) of NaCl. As 
shown in the chromatogram (Fig. 4A) four main peaks were collected, dialyzed to 
remove salts and freeze-dried to obtain more concentrated samples. Lyophilized 
powders were finally suspended in a small volume of an appropriate buffer, 
normalized to protein content (10 µg ml-1) and tested for their anti-biofilm activity on 
S. epidermidis O-47. Collected data (Fig. 4B) showed that only the unbound sample 
were able to impair the pathogen biofilm formation. 
Fig 4: A) AEC chromatogram. Red line: absorbance (220 nm); blue line: absorbance (280 nm). B) Evaluation of 
the anti-biofilm activity of the SEC collected fractions on S. epidermidis O-47. Data are reported as percentage of 
residual biofilm. Each data point represents the mean ± SD of three different samples. Data sets resulted 
statistically significant according to t-Student test. 
 
 
A SDS-PAGE was carried out to analyze the protein profile complexity of the 
chromatographic fractions, but, unfortunately, the unbound fraction, which exhibited 
the anti-biofilm activity, was still a mixture of several proteins. 
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Pseudoalteromonas haloplanktis TAE80 
 
P. haloplanktis TAB23 supernatant was precipitated with ammonium sulphate at 50% 
saturation (SN-TAE80 50), suspended in an appropriate buffer, and subjected to a 
Hydrophobic Interaction Chromatography (HIC). As shown in chromatogram (Fig. 
5A), several peaks were collected corresponding to unbound proteins and protein 
fractions eluted with a decreasing and discontinuous gradient of ammonium sulphate. 
Each collected fraction was dialyzed to remove salts and subsequently freeze-dried 
to obtain more concentrated samples. Lyophilized powders were finally suspended in 
a small volume of an appropriate buffer, normalized to protein content (10 µg ml-1) 
and tested for their anti-biofilm activity on S. epidermidis O-47. 
Figure 5: A) HIC chromatogram. Red line: absorbance (220 nm); blue line: absorbance (280 nm); B) Evaluation of 
the anti-biofilm activity of the HIC collected fractions on S. epidermidis O-47. Data are reported as percentage of 
residual biofilm. Each data point represents the mean ± SD of three different samples. Data sets resulted 
statistically significant according to t-Student test. 
 
 
As shown in Fig. 5B, the biofilm formation assay revealed a dispersion of the anti-
biofilm activity, probably due to the presence of different active proteins. Therefore, 
with the purpose of purify and identify the protein/s endowed with the anti-adhesive 
properties, each collected fraction was also evaluated by the surface coating assay. 
To do this, a drop of each fraction was deposited onto the surface of a well of a 24-
well flat-bottomed polystyrene plate and after its evaporation, the biofilm formation 
capability of S. epidermis O-47 was evaluated. 
 
 
 
Figure 6: Surface coating assay of SN TAE80 50 and its chromatographic fractions after HIC. NT: S. 
epidermidis O-47 untreated biofilm.  
 
 
Surprisingly, the surface coating assay (Fig. 6) revealed that fraction F5, which 
displayed the greatest anti-biofilm activity, resulted the only fraction exhibiting anti-
adhesive properties. These data suggest that the previous chromatographic step 
allowed a good separation of the proteins in the sample, so probably the anti-biofilm 
effect of all the chromatographic fractions is due to the presence of more than one 
active protein. Therefore, in order to purify the anti-biofilm molecule endowed also 
with the anti-adhesive properties, fraction F5, eluted in absence of ammonium 
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sulphate and thus containing high hydrophobic proteins,  was selected for a further 
purification step. Fraction F5 was subjected to an Anion Exchange Chromatography 
(AEC) using a HiPrep™ Q HP column (GE Healtcare). As shown in chromatogram 
(Fig. 7A), several peaks were collected corresponding to unbound proteins and to 
protein fractions eluted with an increasing percentage (0% to 100%) of sodium 
chloride. Each collected fraction was dialyzed to remove salts and subsequently 
freeze-dried to obtain more concentrated samples. Lyophilized powders were finally 
suspended in a small volume of an appropriate buffer, normalized to protein content 
(10 µg ml-1) and tested for their anti-biofilm activity on S. epidermidis O-47 (Fig. 7B). 
 
Figure 7: A) AEC chromatogram. Red line: absorbance (220 nm); blue line: absorbance (280 nm).  B) Evaluation 
of the anti-biofilm activity of the HIC collected fractions on S. epidermidis O-47. Data are reported as percentage 
of residual biofilm. Each data point represents the mean ± SD of three different samples. Data sets resulted 
statistically significant according to t-Student test. 
 
 
Each chromatographic fraction was also tested using the surface coating assay. As 
shown in Fig. 8, fraction F4 which, also in this case, displayed the greatest anti-
biofilm activity, exhibited also anti-adhesive properties. 
 
Figure 8: Surface coating assay with anionic exchange fraction F4. NT: S. epidermidis O47 biofilm untreated  
 
 
A SDS-PAGE was carried out to analyze the protein profile complexity of the 
chromatographic fraction which exhibited anti-biofilm activity and anti-adhesive 
properties. As shown in Fig. 9, F4 fraction eluted in absence of sodium chloride and 
thus containing proteins with high isoelectric point, was, unfortunately, still a mixture 
of several proteins, therefore an optimization of the purification protocol resulted 
fundamental. 
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Figure 9: SDS-PAGE stained with Coomassie brilliant blue. Protein profile of chromatographic fractions after AEC. 
M: molecular weight marker. 
 
 
Given the complexity of the samples obtained after the selected purification steps, an 
alternative approach has been tried to identify the anti-biofilm protein/s produced by 
P. haloplanktis TAE80. An in silico comparative analysis of P. haloplanktis TAE80 
and P. haloplanktis TAE79 genomes was performed. P. haloplanktis TAE79 and P. 
haloplanktis TAE80 are philogenetically very close13, but, as previously described9, 
P. haloplanktis TAE79 was not able to produce any protein endowed with anti-
adhesive properties. Therefore, a comparison between all putative proteins encoded 
by the two strains was performed looking for the sequences present only in P. 
haloplanktis TAE80. All the highlighted interesting sequences were then analyzed 
looking for the presence of a signal peptide, since the anti-biofilm protein/s produced 
P. haloplanktis TAE80 was found in the culture supernatant, and therefore secreted 
in the extracellular environment. Only two sequence were obtained from the analysis 
and their main features were listed below (Fig. 10). 
 
Figure 10: Putative proteins sequences of P. haloplanktis TAE80 and predicted properties. 
 
 
It is interesting to note that the identified putative proteins, hypothetically encoding for 
the anti-biofilm protein/s of P. haloplanktis TAE80, resulted both characterized by 
similar molecular weight ( 14 kDa) and high hydrophobicity and isoelectric point 
values.  
 
 
Discussion 
 
In a previous study, it was demonstrated that Polar marine bacteria belonging to 
Flavobacterium, Pseudoalteromonas, Pseudomonas, Psychrobacter, and 
Psychromonas species displayed an anti-biofilm activity against different 
Staphylococcus aureus, Staphylococcus epidermidis and Pseudomonas aeruginosa 
strains. Cell-free supernatants deriving from sessile and planktonic Polar bacterial 
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cultures showed this activity with several differences in terms of specificity and 
efficiency. 
In this work, with the aim to identify novel anti-biofilm molecules of proteinaceous 
nature, a “protein/peptide” library was designed. Polar marine bacteria were grown in 
planktonic condition until the stationary phase of growth in a rich medium at 15°C. 
Cell-free supernatants were treated with proteinase K and tested against S. 
epidermidis O-47, a strong biofilm producer strain, in order to identify the samples 
whose anti-biofilm activity was due to a protein or a peptide. Among all, two 
supernatants were shown to have an interesting anti-biofilm effect: the supernatant 
obtained from Pseudoalteromonas haloplanktis TAB23, endowed with the strongest 
biofilm-inhibiting activity, and the supernatant obtained from Pseudoalteromonas 
haloplanktis TAE80, which was not only able to act reducing the biofilm biomass, but 
was also able to impair the adhesion capability of the staphylococcal cells. 
A preliminary physicochemical characterization of the samples revealed that the 
active molecules of both P. haloplanktis TAB23 and P. haloplanktis TAE80 are of a 
molecular weight higher than 10 kDa, indicating that the activity could probably be 
due to a protein, rather than to a small peptide. Preliminary activity-guided purification 
protocols were set up, in order to identify the active proteins. 
As regard P. haloplanktis TAB23, the hydrophobic interaction chromatography 
caused a loss of the anti-biofilm activity, which resulted scattered in all the collected 
fractions. This result indicated that HIC was not useful for P. haloplanktis TAB23 
proteins separation, therefore a size-exclusion chromatography was performed as 
first chromatographic step. The anti-biofilm activity analysis of the collected SEC 
fractions denoted the presence of one strongly active fraction (F1) eluted as first 
peak, suggesting the large dimensions of the proteins contained therein. Moreover, 
the mild anti-biofilm effect showed by the last collected fraction (F7) seemed to 
demonstrate the ability of P. haloplanktis TAB23 to produce more than one active 
protein. Nonetheless, a ion exchange chromatography was performed on fraction F1, 
but from the anti-biofilm assay performed on the AEC fractions it was possible to note 
a reduction of the biofilm inhibiting effect of the loaded sample, compared with the 
stronger inhibiting effect of the F1 fraction. Apparently, the manipulation steps 
preceding the AEC step have partially affected the activity of the anti-biofilm agent/s 
present in F1 fraction, including dialysis and lyophilization and buffer exchange 
(different salt concentrations). These results suggested the possibility that P. 
haloplanktis TAB23 anti-biofilm activity was attributable to the action of a multimeric 
protein, in which the single monomeric components are probably also able to show a 
slight effect, thus justifying the strong activity of the F1 SEC fraction, containing 
proteins with high molecular weight, and the mild activity showed by the F7 SEC 
fraction, containing proteins with lower molecular weight. And again, this hypothesis 
could also explain the loss of the activity of the sample over time, during which the 
multimeric protein could be subject to dissociation reactions. 
As regard P. haloplanktis TAE80, the proposed purification protocol highlighted the 
presence of more than one protein endowed with anti-biofilm activity, one interfering 
with the biofilm maturation process, and the other inhibiting the adhesion of bacteria 
to a surface. Therefore, in order to the identify the protein/s responsible for the anti-
adhesive effect, F5 HIC fraction was subjected to a further purification step. In this 
case, the ion exchange chromatography allowed the obtainment of only one fraction 
with anti-adhesive properties, but the protein profile analysed by SDS-PAGE 
revealed a still high complexity of the sample. 
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Uunfortunately, it was difficult to purify the active protein/s produced by P. 
haloplanktis TAB23 and P. haloplanktis TAE80, because, in first instance, these 
bacteria resulted able to produce more than one active molecule, therefore the use of 
an activity-guided purification protocol is not a useful tool for the purification of native 
proteins, which, by more, are endowed with strong biological activities. 
This is the reason why an alternative approach was used to identify the anti-adhesive 
protein/s produced by P. haloplanktis TAE80. Exploiting their phylogenetic proximity, 
a comparative analysis of P. haloplanktis TAE80 and P. haloplanktis TAE79 
genomes was performed, looking for putative proteins present in one but not the 
other, since P. haloplanktis TAE79 was proved not to show anti-adhesive properties. 
Then, considering that P. haloplanktis TAE80 secreted the active protein/s in the 
extracellular environment, only two putative proteins, whose sequences included 
peptide signal for secretion, were selected. Interestingly, the predicted 
physicochemical properties of these putative proteins seemed to correspond to those 
of the anti-adhesive protein/s present in the active fractions. The creation of P. 
haloplanktis TAE80 deletion mutants for these protein sequences could allow to a 
lack in the anti-adhesive activity and thus to the identification of, at least, one of the 
active proteins produced by P. haloplanktis TAE80. 
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ABSTRACT
Staphylococcus epidermidis is a significant nosocomial pathogen in predisposed hosts because of its 
capability of forming a biofilm on indwelling medical devices. The initial stage of biofilm formation 
has a key role in S. epidermidis abiotic surface colonization. Recently, many strategies have been 
developed to create new anti-biofilm surfaces able to control bacterial adhesion mechanisms. In 
this work, the self-assembled amphiphilic layers formed by two fungal hydrophobins (Vmh2 and 
Pac3) have proven to be able to reduce the biofilm formed by different strains of S. epidermidis 
on polystyrene surfaces. The reduction in the biofilm thickness on the coated surfaces and the 
preservation of cell vitality have been demonstrated through confocal laser scanning microscope 
analysis. Moreover, the anti-biofilm efficiency of the self-assembled layers on different medically 
relevant materials has also been demonstrated using a CDC biofilm reactor.
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Introduction
Biofilms are structured multicellular communities of 
bacteria that colonize biotic and abiotic surfaces. The 
bacteria living in biofilms are a continuous source of 
infection, especially in a hospital setting, because of the 
cells detaching from the biofilms which cover indwell-
ing medical devices. An encouraging approach to attract, 
retard or repel biofilm formation is modification of the 
surface properties of a material, namely its mechanical and 
chemical properties, structure and polarity (Rosenhahn 
et al. 2008). The physico-chemical properties of abiotic 
surfaces play a key role in cell adhesion and biofilm devel-
opment. Electrostatic forces, surface wettability, roughness 
and Lifshitz–Van der Waals forces positively or negatively 
influence microbial adhesion to a surface (Palmer et al. 
2007). The anti-biofilm support surfaces, functionalized 
by surface chemistry, can affect the biocompatibility of the 
materials (Wang et al. 2007; Zhang et al. 2011). A possible 
approach to change the surface features consists of the use 
of self-assembling proteins able to stably coat the surfaces 
(Gu et al. 2017).
Fungal hydrophobins are small amphiphilic proteins 
self-assembling at hydrophobic/hydrophilic interfaces and 
thus changing the wettability of different supports. They 
are involved in various phases of fungal growth, eg helping 
the submerged hyphae to breach the air–water interface, 
and facilitating the air dispersion of spores (Bayry et al. 
2012). Despite the fact that they share a motif of eight 
conserved cysteines, involved in four-disulfide bridges 
and a large percentage of hydrophobic amino acids, their 
sequence conservation is very low. Conventionally, hydro-
phobins are split into two classes based on the stability 
of the layers that they form. In particular, Class I hydro-
phobins form amyloid like fibrils which can be dissolved 
only in the presence of strong acids (trifluoroacetic or 
formic acid), being stable to solvent or detergent wash-
ing (Wösten and Scholtmeijer 2015). Due to their pecu-
liar characteristics, several potential applications of this 
protein family have been proposed, including the stabili-
zation of emulsions, drug delivery and surface modifica-
tion (Khalesi et al. 2012). The latter offers a non-covalent 
alternative to the conventional methods used to create 
 chemical (nano)patterns on surfaces (De Stefano et al. 
2007), to adsorb proteins without losing activity (Qin, 
Hou, et al. 2007; Wang et al. 2010; Longobardi et al. 2015) 
or to reduce the friction of the surfaces in order to avoid 
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is released by means of increased cell lysis (Christner et al. 
2012) that in S. epidermidis is determined to a large extent 
by the activity of the autolysin AtlE (Biswas et al. 2006).
In this paper, a new strategy for the reduction of 
S. epidermidis adhesion to abiotic surfaces has been 
explored by coating selected materials with hydro-
phobins. The study has been performed using three 
S. epidermidis strains, differing in biofilm structure and 
composition, and coating different surfaces of medical 
interest with the two hydrophobins Pac3 and Vmh2.
Materials and methods
Microbial strains, media and growth conditions
The bacterial strains used in this work were: S. epidermidis 
O-47 isolated from clinical septic arthritis, a naturally 
occurring non-functional agr mutant and a strong biofilm 
producer (Vuong et al. 2003), kindly provided by Prof.. 
Gotz (Heilmann et al. 1996); S. epidermidis RP62A, a ref-
erence strain isolated from an infected catheter (ATCC 
collection no. 35984) and S. epidermidis XX17, a clinical 
isolate from an infected catheter (Artini et al. 2013). The 
bacteria were grown in brain heart infusion broth (BHI, 
Oxoid, Basingstoke, Hampshire, UK). Biofilm formation 
was assessed in static conditions.
Pleurotus ostreatus (Jacq.: Fr.) Kummer (type: Florida; 
ATCC No. MYA-2306) was maintained at 4°C through 
a periodic transfer on potato dextrose agar (BD Difco, 
Franklin Lakes, NJ, USA) plates in the presence of 0.5% 
yeast extract. The mycelia were inoculated in 1 l flasks con-
taining 500 ml of potato dextrose broth (24 g l−1) supple-
mented with 0.5% yeast extract, grown for 10 days at 28°C 
with shaking (150 rpm). Acremonium sclerotigenum MUT 
4872 from the Mycotheca Universitatis Taurinensis was 
grown for 10 days at 20°C in a 1 l flask containing 500 ml 
of XNST30 broth (malt extract 3 g l−1, yeast extract 3 g l−1, 
sodium chloride 30 g l−1, glucose 10 g l−1, peptone 5 g l−1).
Hydrophobin purification
Vmh2 purification
The protein was extracted from P. ostreatus mycelium. The 
mycelium was separated from the medium by filtration, 
using Whatman filter paper, and abundantly washed with 
60% ethanol, 2% hot sodium dodecyl sulfate (SDS) and 
water. Next, the mycelium was lyophilized and treated 
with 100% trifluoroacetic acid (TFA) in a water bath son-
icator for 30 min and centrifuged for 10 min at 3,200 × g. 
The supernatant was recovered and dried under nitro-
gen flux, dissolved in 60% ethanol and centrifuged for 
20 min at 3,200 × g. The ethanol was removed from the 
solution under vacuum at 40°C using a rotavapor, the pel-
let was freeze-dried, and then the lipids were extracted 
tissue injury in relation to biomedical applications (Misra 
et al. 2006). Therefore, the use of hydrophobin coatings 
to obtain anti-biofilm surfaces could be a good method 
for the prevention of biofilm formation. However, Rieder 
et al. (2011) showed that the coating of the Class I hydro-
phobins H*Protein A and H*Protein B has no impact on 
Escherichia coli biofilm or on the mixed waste water com-
munity. Nevertheless, it is worth continuing with research 
in this area because different hydrophobins can form lay-
ers with different superficial properties, such as hydropho-
bicity or charge. Furthermore, different bacterial species 
use different mechanisms for surface adhesion and biofilm 
formation. Therefore, the negative results described for 
 E. coli do not exclude a possible anti-biofilm action of other 
hydrophobins on other bacterial species. Accordingly, in 
this work, two Class I hydrophobins, the well-characterized 
Vmh2 from Pleurotus ostreatus (Longobardi et al. 2012; 
Gravagnuolo et al. 2016) and the recently isolated hydro-
phobin from Acremonium sclerotigenum (Cicatiello et al. 
2016), here named Pac3, were studied in relation to 
their capability of preventing Staphylococcus epidermidis 
 biofilm formation on different surfaces.
S. epidermidis is a human commensal that normally 
colonizes the human skin and mucous membranes, rep-
resenting a major component of the saprophytic bacte-
rial flora of these habitats (Kloos 1980). In predisposed 
hosts, S. epidermidis has become a significant nosocomial 
pathogen. Indeed, it represents the most frequent etiologic 
agent involved in infections of indwelling medical devices 
because it is a ubiquitous saprophytic skin colonizer. It 
can cause indwelling medical device contamination by 
virtue of its capability of adhering and forming biofilms 
on biotic and abiotic surfaces (Otto 2008). Biofilm for-
mation is a complex process and extensive research has 
led to the characterization of the biofilm lifecycle, which 
encompasses three main stages: initial attachment, micr-
ocolony and macrocolony formation, and detachment or 
disassembly. The initial attachment of S. epidermidis to 
foreign materials is a pivotal step toward the establishment 
of a device-associated infection. Many factors specifically 
involved in mediating bacterial–surface interactions have 
been identified and characterized. Some genetic evidence 
suggests that bacterial binding to unmodified polystyrene 
is fostered by the S. epidermidis autolysin AtlE (Heilmann 
et al. 1996), a bacterial peptidoglycan (PGN)-hydrolase. 
AtlE plays a key role in the degradation of the bacterial cell 
wall, in primary adhesion and in stable bacterial surface 
binding, even though the molecular mechanisms have not 
yet been well established (Biswas et al. 2006; Otto 2014). 
Furthermore, extensive research has focused on the role 
of extracellular DNA (eDNA) in the primary attachment 
of S. epidermidis, independently of the S. epidermidis 
genetic background (Qin, Ou, et al. 2007). Indeed, eDNA 
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in a mixture of water−methanol−chloroform 2:2:1 vv−1. 
The protein pellet was recovered by removing the liquid 
phase and treated with TFA for 30 min in a bath sonica-
tor, redried, dissolved in 60% ethanol, and centrifuged 
(90 min at 12,000 × g).
Pac3 purification
The protein was extracted from the culture broth of 
A. sclerotigenum. The culture broth was separated from 
the mycelia by filtration using Whatman filter paper, and 
agitated in a Waring blender to produce foam. Next, the 
recovered foam was treated with 20% trichloroacetic 
acid, incubated over night at 4°C in a static condition and 
 centrifuged for 1 h at 3,300 × g. Afterwards, the precipitate 
was collected, freeze-dried, treated with 100% TFA, soni-
cated in a water bath sonicator for 20 min, dried in a stream 
of nitrogen and dissolved in 60% ethanol. Moreover, the raw 
extract in 60% ethanol solution was dried and the lipids 
were extracted in a mixture of water–methanol–chloroform 
2:2:1 vv−1. After centrifugation, the protein was recovered 
by removal of the liquid phases and treated with TFA for 
20 min in a bath sonicator, dried again, dissolved in 60% 
ethanol, and centrifuged (20 min at 12,000 × g).
Atomic force microscopy (AFM)
An XE-100 AFM (Park Systems, Suwon, Korea) was used 
for the imaging of the biomolecules. Surface imaging was 
obtained in non-contact mode using silicon/aluminum 
coated cantilevers (PPP-NCHR 10 M; Park Systems; tip 
radius less than 10 nm) 125 μm long with a resonance 
frequency of 200 to 400 kHz and a nominal force constant 
of 42 N m−1. The scan frequency was typically 0.5 Hz per 
line. When necessary, the AFM images were processed 
by flattening, in order to remove the background slope, 
and the contrast and brightness were adjusted. For sample 
preparation, muscovite mica with a surface area of ~1 cm2 
was used as the substratum. The mica was freshly cleaved 
using adhesive tape prior to each deposition in order to 
ensure its cleanliness. Two-μl aliquots of the samples at a 
protein concentration of 100 μg ml−1 were directly depos-
ited by casting onto the freshly cleaved substratum, dried 
by evaporation at room temperature under a ventilated 
fume hood and washed with 60% ethanol.
Hydrophobin coating of polystyrene multiplate 
wells and disks of different materials
Into each well of a 96-well flat-bottomed polystyrene plate 
were placed 200 μl of 60% ethanol solutions of the hydro-
phobins at different concentrations, and the plates were 
kept under a laminar flow hood overnight to functionalize 
the bottom and the walls of the wells. Afterwards, all the 
solutions were evaporated and each well was washed with 
60% ethanol to remove the excess of protein.
Glass, steel, titanium and Teflon (PTFE) disks (diam-
eter 1.3 cm) were firstly cleaned with 10% trichloroacetic 
acid and ethanol, then functionalized with 3 ml of 60% 
ethanol solution of 50 μg ml−1 of Pac3 and 100 μg ml−1 of 
Vmh2 in a Petri dish. The support surfaces were incubated 
for 3 min for each side, dried and washed with 60% etha-
nol solution to remove the excess protein. Contact angle 
measurements were performed on a KSV Instruments 
Ltd (Helsinki, Finland) CAM 200 Optical Contact Angle 
Meter coupled with drop shape analysis software. Each 
contact angle was calculated as the average of four drops 
of 5 μl of water, spotted on different points of the different 
surfaces.
Biofilm assays
The quantification of in vitro biofilm production was based 
on the method described by Christensen et al. (1985) with 
slight modifications (Artini et al. 2013). In brief, an over-
night culture of each of the three S. epidermidis strains 
(O-47, RP62A, XX17) grown in BHI was diluted to a cell 
concentration of ~ 0.001 (OD) 600 nm. A volume of 200 μl 
of the culture was added to each well of a 96-well flat- 
bottomed polystyrene plate, previously functionalized. As 
a negative control, the same culture was added to wells 
treated with only 60% ethanol solution. The plates were 
incubated aerobically for 24 h at 37°C. Planktonic cells 
were gently removed after the incubation; each well was 
washed three times with PBS and dried by gently tapping 
in an inverted position on a piece of paper towel. The bio-
film formation was measured using crystal violet staining. 
In detail, each well was stained with 0.1% crystal violet 
and incubated for 15 min at room temperature, rinsed 
twice with double-distilled water, and thoroughly dried. 
The dye bound to the adherent cells was solubilized with 
20% (vv−1) glacial acetic acid and 80% (vv−1)  ethanol. After 
incubation for 30 min at room temperature, the optical 
density was measured at 590  nm to quantify the total 
 biomass of the biofilm formed in each well. Each data 
point was obtained from three independent experiments, 
each performed at least in triplicate.
The surface coating assay was performed as follows: a 
volume of 10 μl of hydrophobin solution, or 60% ethanol 
solution as a negative control, was transferred to the center 
of a well of a six-well tissue-culture-treated polystyrene 
microtiter plate. The plate was incubated at room tem-
perature to allow complete evaporation of the liquid in 
sterile conditions. The wells were then filled with 4 ml of 
an overnight culture of S. epidermidis O-47 grown in BHI 
diluted to a cell concentration of about 0.001 (OD) 600 nm 
and incubated at 37°C in a static condition. After 24 h, the 
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a series of .tif files with a file-depth of 16 bits. For each 
condition two independent biofilm samples were used.
CDC biofilm reactor assay
A CDC biofilm reactor (Biosurface Technologies, 
Bozeman, MT, USA) was used for the biofilm growth. 
Small disks used for this experiment were made with the 
following materials: PTFE, glass, stainless steel and tita-
nium. Two disks for each material were used as controls. 
They were mounted on the disk holders, and inserted into 
the CDC biofilm reactor; 400 ml of BHI were added and 
autoclaved before use. After the sterilization, the disks 
were functionalized with the hydrophobins (as described 
above) and mounted in sterile conditions.
Overnight cultures of S. epidermidis (grown under 
shaking conditions at 37°C) were diluted at a ratio of 1:100 
and inoculated into the glass vessel of the CDC reactor 
aseptically to obtain a final concentration ~106 CFU ml−1. 
Growth was maintained at 37°C under mild agitation 
(60  rpm) with a magnetic stirrer. After 18  h, the disks 
were aseptically removed and the biofilm was dissolved. 
Biofilm formation was measured using crystal violet stain-
ing. In detail, each disk was first washed with distilled 
water, stained with 0.1% crystal violet and incubated for 
15  min at room temperature. Next, all the disks were 
rinsed twice with double-distilled water, and thoroughly 
dried. The dye bound to the adherent cells on each disk 
was solubilized with 20% (vv−1) glacial acetic acid and 80% 
(vv−1) ethanol. After incubation for 30 min at room tem-
perature, the disks were removed and the optical density of 
the resulting solution was measured at 590 nm to quantify 
the total biomass of biofilm formed on each support sur-
face. Three duplicate CDC biofilm chamber experiments 
were performed.
Statistics
The data reported were statistically validated using the 
Student’s t-test comparing the mean absorbance of the 
treated and untreated samples. The significance of the dif-
ferences between the mean absorbance values was calcu-
lated using a two-tailed Student’s t-test. A p-value of < 0.05 
was considered significant.
Results
Characterization of the hydrophobin layers
The purified Vmh2 and Pac3 hydrophobins were depos-
ited and dried on the hydrophilic mica surface to ana-
lyze the morphology of their layers by AFM analysis. The 
acquired images (Figure 1) clearly show a difference in 
the self-assembling structures of the two proteins. On 
wells were rinsed with water and stained with 4 ml of 0.1% 
crystal violet. The stained biofilms were rinsed with water 
and dried, and the wells were photographed.
The biofilm initial attachment assay was carried out 
as previously reported (Nithya and Pandian 2010) with 
slight modifications. In brief, an overnight culture of 
S. epidermidis O-47 grown in BHI was diluted to a cell 
concentration of about 0.01 (OD) 600 nm. A volume of 
200 μl of the culture was added to each well of a 96-well 
flat-bottomed polystyrene plate, previously functionalized 
with hydrophobins. As a negative control, the same culture 
was added to wells treated with only 60% ethanol solu-
tion. The plates were incubated aerobically for 1 h at 37°C 
to allow the adherence of bacterial cells to the surface. 
After incubation, the plates were processed as previously 
described. Each data point was obtained from three inde-
pendent experiments, each performed at least in triplicate.
Bacterial viability and biofilm thickness determined 
by confocal laser scanning microscopy (CLSM)
For confocal microscopy biofilms were formed on 
 polystyrene in Nunc™ Lab-Tek® 8-well chamber slides 
(no 1,77,445; Thermo Scientific, Ottawa, ON, Canada). 
In brief, overnight cultures of S. epidermidis O-47 grown 
in BHI were diluted to a cell concentration of about 0.001 
(OD) 600 nm and inoculated into each well of a chamber 
slide, previously functionalized with hydrophobins. As 
a negative control, the same culture was added to wells 
treated only with 60% ethanol solution. The bacterial 
culture was incubated at 37°C for 20 h in the presence of 
hydrophobins in order to assess its anti-biofilm activity 
and its influence on cell viability. Biofilm cell viability was 
determined with the FilmTracer™ LIVE/DEAD® Biofilm 
Viability Kit (Molecular Probes, Invitrogen, Carlsbad, CA, 
USA) following the manufacturer’s instructions. After 
rinsing with filter-sterilized PBS, each well of the chamber 
slide was filled with 300 μl of a working solution of fluo-
rescent stains, containing the SYTO® 9 green fluorescent 
nucleic acid stain (10 μM) and propidium iodide, and the 
red-fluorescent nucleic acid stain (60 μM), and incubated 
for 20–30 min at room temperature, protected from light. 
All the excess stain was removed by rinsing gently with fil-
ter-sterilized PBS. All microscopic observations and image 
acquisitions were performed with a confocal laser scan-
ning microscope (CLSM) (LSM700-Zeiss, Oberkochen, 
Germany) equipped with an Ar laser (488 nm), and a He–
Ne laser (555 nm). Images were obtained using a 20×/0.8 
objective. The excitation/emission maxima for these dyes 
were ~480/500 nm for the SYTO® 9 stain and 490/635 nm 
for propidium iodide. Z-stacks were obtained by driving 
the microscope to a point just out of focus on both the 
top and bottom of the biofilms. Images were recorded as 
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Vmh2 in this condition, but only sponge-like structures. 
Because of the different morphology of the two protein 
layers, both hydrophobins were tested for S. epidermidis 
biofilm inhibition.
S. epidermidis biofilm on hydrophobin coated 
polystyrene surfaces
The binding of bacteria to abiotic materials is a pivotal 
step toward the establishment of a device-associated 
infection. The influence of the deposition of Vmh2 and 
Pac3 on polystyrene surfaces in S. epidermidis biofilm for-
mation was evaluated using three S. epidermidis strains. 
The functionalization of polystyrene multi-wells was 
performed using Vmh2 and Pac3 solutions at concentra-
tions from 50 to 200 μg ml−1. The hydrophobin  coating 
effect on biofilm formation was assessed on the three 
S. epidermidis strains (Figure 2). The data are reported as 
the percentage of residual biofilm obtained by growing 
S. epidermidis on hydrophobin coated wells with respect 
to that obtained on uncoated ones. Biofilm formation on 
Vmh2 coated surfaces was strongly inhibited for all tested 
S. epidermidis strains (Figure 2a). The inhibition was 
higher than 50% at 100 μg ml−1 (33.2% residual biofilm 
for S. epidermidis O-47, 6.9% for S. epidermidis RP62A, 
and 18.3% for XX17, respectively). In the case of Pac3, 
a substantial inhibition of biofilm formed was observed 
even at the lowest concentration used. For this reason 
Pac3 solutions at 5 and 10 μg ml−1 were tested (Figure 2b). 
Distinct anti-biofilm activity was also obtained using 
5 μg ml−1 (15.7% residual biofilm for S. epidermidis O-47, 
20.8% for S. epidermidis RP62A, and 14.7% for XX17, 
respectively). Biofilm inhibition on the Pac3 and Vmh2 
coated surfaces was dose-dependent in the case of the 
S. epidermidis RP62A and O-47 but not in the case of the 
S. epidermidis XX17 biofilm.
Pac3 amyloid-like-structures were formed, typical of 
Class I hydrophobins, while no fibrils were observed for 
Figure 1. AfM images of Pac3 and Vmh2 at 100 μg ml−1 deposited on a mica surface and washed with 60% ethanol. The scale bar is 1 μm 
in (a) and (c) and 250 nm in images (b) and (d). for each sample the non-contact phase and morphology are reported.
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Figure 2. The effect of a Vmh2 and a Pac3 coating on the biofilm 
formation by different S. epidermidis strains. Biofilm formation was 
evaluated after 24 h incubation on polystyrene plates previously 
coated with the hydrophobin solutions. The data are reported as 
the percentage of residual biofilm for each tested S. epidermidis 
strain. The black line represents the biofilm obtained on uncoated 
polystyrene plates. Each data point represents the mean ± the SD 
of four independent samples; the mean values were compared to 
the untreated control and considered significant when p < 0.05 
(* p < 0.05, ** p < 0.01, *** p < 0.001) according to the Student 
t-test.
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by hydrophobins occurred by means of inhibition of the 
initial attachment of bacterial cells to the surface.
The prevention of S. epidermidis O-47 biofilm forma-
tion was further investigated by CLSM. CLSM was used 
to analyze the structure of the biofilm and to assess cell 
viability. As shown in Figure 4, S. epidermidis biofilm 
thickness was significantly reduced on polystyrene sur-
faces coated with Vmh2 at 100 μg ml−1, in comparison 
with the uncoated surfaces. The biofilm thickness reduc-
tion was evident on Pac3 coated surfaces with a notable 
alteration in the S. epidermidis O-47 biofilm architecture 
at both the tested concentrations. Moreover, the viability 
of the cells embedded in the biofilm on the hydrophobin 
coated polystyrene surfaces was evaluated by live/dead 
staining. As shown in Figure 4, the cells exposed to the 
hydrophobin coated polystyrene surfaces were alive. The 
green stain indicates viable cells while red indicates dead 
cells, therefore the lack of red staining demonstrated that 
the hydrophobins had no bactericidal activity on the 
S. epidermidis cells. It is worth noting that most known 
anti-biofilm molecules display antibacterial activity (bac-
tericidal or bacteriostatic). Therefore, the hydrophobins 
affected the adhesive properties of S. epidermidis, and did 
not impair cell viability, a behavior that should prevent the 
development of escape mutants.
Analysis of S. epidermidis biofilm formation on 
different hydrophobin coated surfaces
The capability of the two hydrophobins to coat four dif-
ferent biomedically relevant materials (PTFE, glass, stain-
less steel and titanium) was evaluated by WCA analysis. 
Indeed, a specific feature of the hydrophobin coatings is 
the modification of the wettability of the surfaces, due 
to the peculiar amphiphilic nature of these proteins. In 
Figure 5 measurements of the WCAs of the coated and 
uncoated surfaces are shown. In all cases, the change 
in surface wettability demonstrated the presence of the 
hydrophobin layers, stable also after ethanol washing.
Biofilm formation by S. epidermidis was first evaluated 
on the bare materials in a CDC biofilm reactor. This appa-
ratus permits the growth of biofilm on the two faces of 
disks made of specific materials. These disks are exposed 
to shear forces by a swirling paddle in the base of the 
reactor (Williams and Bloebaum 2010). S. epidermidis 
RP62A was able to produce a variable quantity of bio-
film on all the tested materials and the greater biofilm 
production was achieved on the hydrophilic substratum 
glass (Figure 6a). Next, the hydrophobin coated materials 
were used in the CDC biofilm reactor to test the capa-
bility of S. epidermidis RP62A to form a biofilm on these 
supporting materials (Figure 6b). The results are reported 
as percentages of biofilm formation on pre-coated disks 
Further analyses were performed to understand the 
hydrophobin mode of action and to determine which 
step biofilm formation was affected by the hydrophobin 
coatings. In particular, S. epidermidis initial attachment 
was explored. As reported in Figure 3a, both Vmh2 and 
Pac3 inhibited S. epidermidis biofilm formation after 1 h 
of bacterial growth (the biofilm was reduced by ~44% by 
Vmh2 and by ~62% by Pac3, respectively).
To confirm that the anti-biofilm activity of the protein 
layers was related to their capability to modify surface 
properties, a surface coating assay was performed. In this 
case, only the central area of the bottom of a well was 
coated by the deposition of a single drop of the protein 
solutions and the ability of the coated surfaces to repel 
biofilm formation by S. epidermidis O-47 was tested. 
This strain was selected because it is the strongest biofilm 
producer among those used in this work. As shown in 
Figure 3b, only the hydrophobin coated regions were able 
to repel biofilm formation. All these results demonstrate 
that the prevention of S. epidermidis biofilm formation 
Figure 3. (a) The effect of Vmh2 and Pac3 functionalization on the 
initial attachment of S. epidermidis o-47. Biofilm formation was 
evaluated after incubation for 1h on polystyrene plates previously 
functionalized with hydrophobin solutions. The data are reported 
as the percentage of residual biofilm. The black line represents the 
biofilm obtained in uncoated polystyrene plates. Each data point 
represents the mean ± SD of four independent samples; the mean 
values were compared to the untreated control and considered 
significant when p < 0.05 (* p < 0.05, ** p < 0.01, *** p < 0.001) 
according to the Student t-test. (b) Analysis of the surfactant 
capability of hydrophobin solutions on S. epidermidis o-47. The 
center of each well of a six-well tissue-culture-treated polystyrene 
microtiter plate was coated with 10  μl of each solution. Biofilm 
formation was evaluated after 24 h incubation using crystal violet 
staining and then photographed. The areas where biofilm was 
not present appear unstained.
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Discussion
In this paper, the effect of surface modification of abi-
otic materials on biofilm formation has been explored, 
in comparison with that on untreated disks. Although 
to a different degree, both Pac3 and Vmh2 were able to 
prevent S. epidermidis biofilm formation on all the tested 
materials.
Figure 4. The effect of a hydrophobin coating on S. epidermidis o-47 biofilm structure and cell viability. (a) ClSM of S. epidermidis o-47 
biofilm on an uncoated polystyrene well; (b) ClSM of S. epidermidis o-47 biofilm on Vmh2-coated polystyrene wells; and (c) ClSM of 
S. epidermidis o-47 biofilm on Pac3-coated polystyrene wells. The bacteria were grown in an eight-well chamber slide for 20 h and then 
stained with liVE/DEAD reagents. The green fluorescence (SYTo9) indicates viable cells and the red fluorescence (Pi) indicates dead cells. 
The Z-stack analysis of the S. epidermidis o-47 biofilm in all tested conditions is reported.
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pathogen, frequently causing infections associated with 
implanted foreign materials (Rupp and Fey 2001).
Although it is known that hydrophobins can coat dif-
ferent surfaces, changing their physico-chemical proper-
ties, the structural characteristics of the layers formed by 
Class I hydrophobins can differ, showing different mor-
phologies (Lo et al. 2014). In order to obtain information 
on the specific structural morphologies of the Pac3 and 
Vmh2 layers, these layers were analyzed using the AFM 
technique. The images acquired (Figure 1) show that Pac3 
formed the typical amyloid-like fibrils, while in the same 
conditions Vmh2 formed sponge-like structures. It is 
worth noting that the amyloid-like fibrils of Vmh2 had 
previously been observed in specific conditions (Houmadi 
et al. 2008, 2012). These results suggest that Pac3 has a 
greater propensity to form amyloid structures in com-
parison with Vmh2. Because of the structural differences 
between the layers formed, both proteins were used in the 
following analyses.
The first analysis was performed using three S. epider-
midis strains, differing in biofilm structure and compo-
sition, and the two hydrophobins for the coating of the 
polystyrene surface. Depending on the strain tested, the 
anti-biofilm activity was more or less marked. Indeed, 
biofilm reduction in the O-47 strain in the presence of 
Pac3 coating was about 85%, while it was only 40% in case 
of Vmh2, at the same protein concentration (50 μg ml−1). 
On the other hand, the effect of the two hydrophobins (at 
50 μg ml−1) on biofilm formation by the RP62A strain was 
quite similar. Therefore the differences in the anti-biofilm 
efficiency of the coating should be affected by both the 
specific layer and the strain used. Coating characteristics 
(eg morphology,) as well as differences in biofilm forma-
tion and structure in each strain can affect the reported 
activity.
The action of the hydrophobin surface coating on 
S. epidermidis biofilm formation was explored on  different 
materials used for medical devices. Stainless steel and 
titanium are commonly used for orthopedic surgical 
instruments and joint replacement devices. A major use 
of PTFE is for the manufacture of prostheses adopted for 
the anterior cruciate ligament repair procedure. PTFE is 
also used in graft augmentation devices to protect biolog-
ical grafts, and in microporous hydrophobic membranes 
used in products such as vented blood warmers, in-line 
suction filters and vented suction containers (Lauderdale 
et al. 2010). These studies, performed in a CDC biofilm 
reactor, revealed that glass was the most susceptible sur-
face to S. epidermidis biofilm growth. Nevertheless, all the 
other tested materials were efficiently colonized by the 
bacterial cells.
S. epidermidis biofilm formation was always reduced 
when all the materials were coated with hydrophobins, 
studying the impact of hydrophobin coated surfaces on 
S. epidermidis biofilm formation. Indeed, coagulase- 
negative S. epidermidis has become a serious nosocomial 
Figure 5. WCA analysis of different surfaces, upon coating with 
50 μg ml−1 of Pac3 and 100 μg ml−1 of Vmh2. The data reported 
represent the means  ±  SD of independent WCA measurements 
on four drops.
Figure 6.  (a) Analysis of the capability of S. epidermidis RP62A 
to form a biofilm on different materials. Biofilm formation was 
performed in a CDC biofilm reactor. (b) The effect of a Vmh2 and 
a Pac3 coating on different materials on S. epidermidis RP62A 
biofilm formation in a CDC biofilm reactor. The data are reported 
as the percentage of residual biofilm. The black line represents 
the biofilm obtained on uncoated materials. Data reported 
represent the means ± SD of three measurements and the mean 
values were compared to the untreated control and considered 
significant when p < 0.05 (* p < 0.05, ** p < 0.01, *** p < 0.001) 
according to the Student t-test.
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polystyrene surfaces in S. aureus biofilm formation has 
been preliminarily investigated. Neither the Pac3 nor Vmh2 
coated surfaces have proven able to prevent S. aureus bio-
film formation (data not shown), thus suggesting that the 
mechanism responsible for the anti-biofilm activity of the 
tested hydrophobin layers on S. epidermidis involves eDNA. 
A detailed study on the hydrophobin–eDNA interaction 
will be the subject of future investigations.
In conclusion, in this work novel properties of hydro-
phobin layers have been assessed, demonstrating their 
anti-biofilm activity with respect to S. epidermidis. This 
hydrophobin layer feature probably does not depend on 
interactions with bacterial proteins and polysaccharides 
but could depend on an interaction with matrix eDNA. 
These observations are interesting in view of the possible 
industrial applicative uses of hydrophobins in medical 
fields. Furthermore, new insights into the interaction 
mechanism between different bacterial species and abiotic 
surfaces have been provided.
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